JP2002533301A - Heterocyclic carboxamide-containing thiourea inhibitors of herpesvirus, including substituted phenylenediamines - Google Patents

Abstract

(57) [Summary] For the treatment of herpes virus-related diseases including human cytomegalovirus, herpes simplex virus, Epstein-Barr virus, varicella-zoster herpes virus, human herpes viruses -6 and -7, and Kaposi herpes virus Useful compounds of formula (I) Wherein R ₁ -R ₅ are independently selected from hydrogen or substituents; R ₉ -R ₁₂ are independently selected from hydrogen or substituents, provided that at least one of R _9-12 is hydrogen. G is a monocyclic heteroaryl; X is a bond, -NH, alkyl of 1-6 carbon atoms, alkenyl of 1-6 carbon atoms, alkoxy of 1-6 carbon atoms, 1 Thioalkyl of 6 carbon atoms, alkylamino of 1-6 carbon atoms or (CH) J; J is alkyl of 1-6 carbon atoms, cycloalkyl of 3-7 carbon atoms, It is phenyl or benzyl.

Description

DETAILED DESCRIPTION OF THE INVENTION

[0001]

TECHNICAL FIELD OF THE INVENTION

Invention is a member of the background the herpes virus family of 8 virus have been identified (Roizman,
B. 1996. Herpesviridae. P. 2221-2230. BN Fields, DM Kn
ipe and PM Howley (Editor), Fields Virology, Third Edition Lippincott-Raven Publ
ishers, Philadelphia, PA). Each member of this family is characterized by an enveloped virus containing a proteinaceous coat and a nucleocapsid, the latter of which is a relatively long double-stranded DNA genome of the virus (ie, about 80-250 kilograms). Base). Members of the human alphaherpesvirinae family are neurotrophic and include herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) and varicella-zoster herpesvirus (VZV). Human beta-herpesviruses are cytomegalovirus (HCMV), human herpesvirus 6 (HHV-6) and human herpesvirus 7 (HHV-7). Gammaherpesvirus is lymphotropic,
Epstein-Barr virus (EBV) and Kaposi herpes virus (HHV-8) are included. Each of these herpes viruses is a cold sore and genital herpes (HSV-1 and HSV-2 [Whitley, RJ 1996. Herpes Simplex Viruses, p. 2297-234].
2. BN Fields, DM Knipe and PM Howley (Editor), Fields Virology, Chapter
3rd edition Lippincott-Raven Publishers, Philadelphia, PA]); varicella and shingles (VZV [Arvin, A. 1996. Varicella-Zoster Virus. P. 2547-2585. BN Fields]
, DM Knipe and PM Howley (Editor), Fields Virology, Third Edition Lippincott-
Raven Publishers, Philadelphia, PA]); Infectious mononucleosis (EBV [Rickinson,
AB and Kieff, E. 1996.Epstein-Barr Virus, p. 2397-2446.BN Fields,
DM Knipe and PM Howley (Editor), Fields Virology, Third Edition Lippincott-Ra
ven Publishers, Philadelphia, PA]); Pneumonia and Retinitis (HCMV [(Britt, WJ
And Alford, CA 1996.Cytomegalovirus, p. 2493-2523.BN Fields, D.
M. Knipe and PM Howley (Editor), Fields Virology, Third Edition Lippincott-Raven
Publishers, Philadelphia, PA)]; Sudden rash (HHV-6 [(Pellet, PE and B
lack, JB 1996. Human Herpesvirus 6, p. 2587-2608.BN Fields, DM
Knipe and PM Howley (Editor), Fields Virology, Third Edition Lippincott-Raven Pu
blishers, Philadelphia, PA)] and HHV-7 [Frenkel, N. and Roffman, E. 1996.
Human Herpesvirus 7, p. 2609-2622.BN Fields, DM Knipe and PM Ho
wley (editor), Fields Virology, 3rd edition Lippincott-Raven Publishers, Philade
lphia, PA]); and Kaposi's sarcoma (HHV-8 [Neipel, F., Albrecht, JC and Fle]
ckenstein, B. 1997.Cell-homologous genes in the Kaposi's sarcoma-assoc
iated rhadinovirus human herpesvirus 8: determinants of its pathogenicit
y? J. Virol. 71: 4187-92, 1997]). HCMV
Are discussed in further detail below. After the initial infection, the herpes virus establishes a latency within the infected individual and remains there for the remainder of the individual's life. Periodic reactivation of the latent virus is clinically relevant. In the case of HSV, the reactivated virus can be transmitted to the infant during birth, causing skin or eye infections, central nervous system infections or disseminated infections (ie, multiple organs or systems). Shingles,
Clinical manifestations of VZV reactivation. Treatment of HSV and VZV generally involves acyclovir (Glaxo Wellcome), which targets the virus-encoded DNA polymerase,
Antiviral drugs such as ganciclovir (Roche) and foscarnet (Asta).

HCMV is a ubiquitous opportunistic pathogen that infects 50-90% of the adult population (Britt, W
J. and Alford, CA 1996. Cytomegalovirus, p. 2493-2523. BN Fields,
DM Knipe and PM Howley (Editor), Fields Virology, Third Edition Lippincott-R
aven Publishers, Philadelphia, Pa). Primary infection with HCMV is neutral chromophilic (h
eterophile) Negative mononucleosis has been noted, but generally has no symptoms. The virus is transmitted horizontally by sexual contact, breast milk and saliva. In utero transmission of HCMV from a pregnant mother to the fetus occurs and is often responsible for serious clinical consequences. HCMV remains latent in an infected human for the remainder of his or her life. Cellular immunity plays a central role in controlling reactivation from latency. Impaired cellular immunity leads to reactivation of latent HCMV in seropositive humans.

[0003] HCMV disease is associated with poor or immature cellular immunity. There are three major groups of humans with HCMV disease (reviewed by Britt and Alford, 1996). (1) In immunocompromised (AIDS) patients, HCMV is one of the two most common pathogens that cause clinical disease (the other is Pneumocystis (
Pneumocystis)). Infections of the adrenal glands, lungs, GI tract, and other organs, including the central nervous system, are also frequently reported, but the most common manifestation of HCMV in AIDS is retinitis. 90% of AIDS patients have active HCMV infection; 25-40
% (〜85,000 patients in the United States) suffer from life-threatening or visual HCMV disease. HCMV is the cause of death in 10% of people with AIDS. (2)
HCMV reactivation or reinfection is common among kidney, liver, heart and allogeneic bone marrow transplant patients because of the immune system suppression to reduce the risk of transplant rejection. Pneumonia is the most common HCMV disease in these patients and is found in up to 70% of these transplant patients. (3) Congenital infection with HCMV accounts for 1% of all births, about 4 per year.
Happens at 0K. Up to 25% of these infants show symptoms of HCMV disease during the age of 0-3 years. HCMV disease is progressive in children and causes mental retardation and neurological abnormalities. Recent studies suggest that treatment with anti-HCMV drugs may reduce morbidity in these children.

[0004] Several antiviral drugs are currently commercially available (Bron, D., R. Snoeck and L.
Lagneaux. 1996.New insights into the pathogenesis and treatment of cyto
Megalovirus. Exp. Opin. Invest. Drugs 5: 337-344; Crumpacker, C. 1996. Ga
nciclovir. New Eng. J. Med. 335: 721-729; Sachs, S. and F. Alrabiah. 1996.
Novel herpes treatments; a review. Exp. Opin. Invest. Drugs 5: 169-183)
. These include the hematopoietic cytotoxic nucleoside analog ganciclovir (Ro
che); nephrotoxic pyrophosphate analog foscarnet (Astra); and acute nephrotoxic nucleoside phosphonate cidofovir (Gilead).
) Is included. Each of these agents targets the viral encoded DNA polymerase, is typically administered intravenously due to their low bioavailability, and is responsible for significant toxicity as described above . Ganciclovir-resistant mutants that occur clinically are often cross-resistant to cidofovir. Thus, there is a need for safer (ie, less toxic) orally bioavailable antiviral drugs directed against novel viral targets.

[0005] Phenylthiourea has been disclosed for use in various pharmaceutical applications. Armistead, et al., WO 97/40028, teach phenylureas and thioureas as inhibitors of the inosine monophosphate dehydrogenase (IMPDH) enzyme, which has been taught to play a role in viral replication diseases such as herpes. .

[0006] Widdowson, et al., WO 96/25157, teaches phenylurea and thiourea compounds of the following formula for treating diseases caused by chemokines, interleukin-8.

[0007]

Embedded image

[0008] Morin, Jr., et al., US Pat. No. 5,593,993, teaches certain phenylthiourea compounds for the treatment of AIDS and inhibition of the replication of HIV and related viruses.

Therefore, human cytomegalovirus, herpes simplex virus, Epstein-
Bar virus, varicella-zoster herpes virus, human herpes virus-6 and -7
It is an object of the present invention to provide a compound for suppressing and / or treating a disease associated with herpes virus including Kaposi herpes virus and a pharmaceutically acceptable salt thereof.

[0010] According to the description the invention of the invention, formula:

[0011]

Embedded image

Wherein R ₁ -R ₅ are independently hydrogen, alkyl of 1-6 carbon atoms, alkenyl of 2-6 carbon atoms, alkynyl of 2-6 carbon atoms, 1-6 number of perhaloalkyl carbon atoms, cycloalkyl of 3 to 10 carbon atoms, 3 to 10 carbon membered heterocycloalkyl, aryl, heteroaryl, _{halogen, -CN, -NO 2, -CO 2} R 6 , -COR ₆ , -OR ₆ ,-
SR ₆ , -SOR ₆ , -SO ₂ R ₆ , -CONR ₇ R ₈ , -NR ₆ N (R ₇ R ₈ ), -N (R ₇ R ₈ ) or WY- (CH ₂ ) _n -Z
Wherein at least one of R ₁ -R ₅ is not hydrogen; or R ₂ and R ₃
Or R ₃ and R ₄ together are a 3-7 membered heterocycloalkyl or 3-7
R ₆ and R ₇ are independently hydrogen, alkyl of 1 to 6 carbon atoms, perhaloalkyl or aryl of 1 to 6 carbon atoms; R ₈ is hydrogen, 1 Is alkyl of -6 carbon atoms, perhaloalkyl of 1-6 carbon atoms, cycloalkyl of 3-10 carbon atoms, heterocycloalkyl of 3-10 members, aryl or heteroaryl, or R ₇ and R ₈ can together form a 3-7 membered heterocycloalkyl; R ₉ -R ₁₂ are independently hydrogen, alkyl of 1-4 carbon atoms, 1-4 Perhaloalkyl of carbon atoms, halogen, alkoxy or cyano of 1-4 carbon atoms, or R ₉ and R ₁₀ or R ₁₁ and R ₁₂ together form an aryl of 5-7 carbon atoms. Wherein at least one of R _9-12 is hydrogen Not; W is O, or is NR _6, or is absent; Y is - (CO) - or - (CO ₂₎ - or where absent; Z is 1 to 4 carbon atoms Alkyl, -CN, -CO ₂ R ₆ , COR ₆ , -CONR ₇ R ₈ , -OCOR ₆ , -NR ₆ COR ₇ , -OCONR ₆ , -OR ₆ , -SR ₆ , -SOR ₆ , -SO ₂ R ₆ , SR ₆ N (R ₇ R ₈ ), —N (R ₇ R ₈ ) or phenyl; G is a monocyclic heteroaryl; X is a bond, —NH, 1-6 carbon atoms Alkyl, alkenyl of 1 to 6 carbon atoms,
J is alkoxy of 1 to 6 carbon atoms, thioalkyl of 1 to 6 carbon atoms, alkylamino of 1 to 6 carbon atoms or (CH) J; J is alkyl of 1 to 6 carbon atoms, And n is an integer from 1 to 6 or a pharmaceutical salt thereof.

In one preferred embodiment of the invention, at least one of R ₁ -R ₅ is not hydrogen. In other preferred embodiments of the invention, R ₁ -R ₅ are independently hydrogen, alkyl of one carbon atom, halogen, perhaloalkyl of one carbon atom, OR ₆ or N (R ₇ R ₈ ) is there. Preferably one of R ₁ -R ₅ is not hydrogen. Most preferably, two of R ₁ -R ₅ are not hydrogen. R ₃ and R ₅ or R ₄ and R ₅ Preferred compounds of the present invention is halogen or CF ₃ preferably independently.

In one preferred embodiment of the present invention, R ₉ -R ₁₂ are selected from halogen, methyl, methoxy and cyano.

In one aspect of the invention, G is preferably thiazolyl, thiadiazolyl, oxazolyl or furyl. More preferably G is furan. G is preferably unsubstituted.

In one embodiment of the present invention, X is a bond or C ₁ -C ₄ alkyl. Preferably, when X is C ₁ -C ₄ alkyl, said alkyl is straight-chain alkyl.

Preferred compounds of the present invention are the following compounds, including their pharmaceutical salts: furan-2-carboxylic acid {4- [3- (5-chloro-2,4-dimethoxy-phenyl) -thioureido ] -2,5-Dimethoxy-phenyl} -amide, furan-2-carboxylic acid {4- [3- (5-chloro-2,4-dimethoxy-phenyl) -thioureido] -3-trifluoromethyl-phenyl} -Amide, furan-2-carboxylic acid {3-chloro-4- [3- (5-chloro-2,4-dimethoxy-phenyl)-
Thioureido] -phenyl} -amide, furan-2-carboxylic acid {5-chloro-4- [3- (5-chloro-2,4-dimethoxy-phenyl)-
Thioureido] -2-methyl-phenyl} -amide, furan-2-carboxylic acid {5-chloro-4- [3- (5-chloro-2,4-dimethoxy-phenyl)-
Thioureido] -2-hydroxy-phenyl} -amide, furan-2-carboxylic acid {4- [3- (5-chloro-2,4-dimethoxy-phenyl) -thioureido] -3-cyano-phenyl} -amide, Furan-2-carboxylic acid {4- [3- (5-chloro-2,4-dimethoxy-phenyl) -thioureido] -3-methyl-phenyl} -amide, furan-2-carboxylic acid {4- [3- (5-chloro-2,4-dimethoxy-phenyl) -thioureido] -2-methoxy-5-methyl-phenyl} -amide, furan-2-carboxylic acid {4- [3- (5-chloro-2,4 -Dimethoxy-phenyl) -thioureido] -3-methoxy-phenyl} -amide, furan-2-carboxylic acid {4- [3- (5-chloro-2,4-dimethoxy-phenyl) -thioureido] -2-tri Fluoromethyl-phenyl} -amide, furan-2-carboxylic acid {2-chloro-4- [3- (5-chloro-2,4-dimethoxy-phenyl)-
Thioureido] -phenyl} -amide, furan-2-carboxylic acid {4- [3- (5-chloro-2,4-dimethoxy-phenyl) -thioureido] -2-cyano-phenyl} -amide, 5- [3 -(5-chloro-2,4-dimethoxy-phenyl) -thioureido] -2-[(furan-2-carbonyl) -amino] -benzoic acid, furan-2-carboxylic acid {4- [3- (5- Chloro-2,4-dimethoxy-phenyl) -thioureido] -2-phenylcarbamoyl-phenyl} -amide, furan-2-carboxylic acid {2-benzoyl-4- [3- (5-chloro-2,4-dimethoxy) -Phenyl) -thioureido] -phenyl} -amide, furan-2-carboxylic acid {4- [3- (5-chloro-2,4-dimethoxy-phenyl) -thioureido] -2-methyl-phenyl} -amide, Furan-2-carboxylic acid {4- [3- (5-chloro-2,4-dimethoxy-phenyl) -thioureido] -naphthalen-1-yl} -amide, and furan-2-carboxylic acid {4- [3 -(5-chloro-2,4-dimethoxy-phenyl) -thio Ureido] -2-methoxy - phenyl} - amide, and pharmaceutically salts.

Alkyl, as used herein, refers to straight or branched lower alkyl of 1 to 6 carbon atoms. Representative alkyl groups include methyl, ethyl, propyl, isopropyl, butyl, isobutyl, t-butyl, pentyl, and hexyl.

Alkenyl, as used herein, refers to a straight or branched lower alkyl of 2 to 6 carbon atoms containing at least one carbon-carbon double bond. Alkenyl includes vinyl groups.

Alkynyl, as used herein, refers to a straight or branched lower alkyl of 2 to 6 carbon atoms containing at least one carbon-carbon triple bond.

[0021] The alkyl, alkenyl and alkynyl groups of the present invention can be substituted or unsubstituted.

Cycloalkyl refers to a saturated monocyclic or bicyclic ring system of 3 to 10 carbon atoms. Representative cycloalkyl groups include cyclopentyl, cyclohexyl, and cycloheptyl. The cycloalkyl groups of the present invention can be substituted or unsubstituted.

Heterocycloalkyl is aziridinyl, azetidinyl, imidazolidinyl,
N, S and O, including but not limited to morpholinyl, thiomorpholinyl, piperazinyl, pyrazolidinyl, piperidinyl and pyrrolidinyl
Refers to a 3-10 membered saturated monocyclic or bicyclic ring system having 1-3 heteroatoms selected from: The heterocycloalkyl groups of the present invention can be substituted or unsubstituted.

Aryl, as used herein, refers to an aromatic monocyclic or bicyclic ring of 5 to 10 carbon atoms. Representative aryl groups include phenyl, naphthyl, and biphenyl. The aryl groups of the present invention can be substituted or unsubstituted.

Heteroaryl, as used herein, includes but is not limited to thiazolyl, thiadiazolyl, oxazolyl, furyl, indolyl, benzothiazolyl, benzotriazolyl, benzodioxyl, indazolyl and benzofuryl. , N, S or O refers to a 5- to 10-membered aromatic mono- or bicyclic ring having 1-3 heteroatoms. Preferred heteroaryls include quinolyl, isoquinolyl, naphthalenyl, benzofuranyl, benzothienyl, indolyl, pyridyl, pyrazinyl, thienyl, furyl, pyrrolyl, isoxazolyl, oxazolyl, isothiazolyl, thiazolyl, pyrazolyl, triazolyl, thiadiazolyl and imidazolyl. The heteroaryl groups of the present invention can be substituted or unsubstituted.

A perhaloalkyl is a 1-6 wherein 3 or more hydrogens are replaced by halogen.
Refers to an alkyl group of carbon atoms.

Phenyl, as used herein, refers to a six membered aromatic ring.

Halogen, as used herein, refers to chlorine, bromine, iodine and fluorine.

Unless otherwise limited, substituents are unsubstituted, alkyl of 1-6 carbon atoms, cycloalkyl of 1-6 carbon atoms, 1-6 membered heterocycloalkyl, 1-6 Perhaloalkyl, alkylamino, dialkylamino, aryl or heteroaryl of carbon atoms of

[0030] Carbon number refers to the number of carbons in the carbon backbone and does not include carbon atoms present in substituents such as alkyl or alkoxy substituents.

When terms are used in combination, the definitions of each individual part of the combination apply unless otherwise defined. For example, alkylcycloalkyl is an alkyl-cycloalkyl group wherein alkyl and cycloalkyl are as described above.

The pharmaceutically acceptable salts include compounds of the above general formula and phosphoric acid, sulfuric acid, hydrochloric acid, hydrobromic acid, citric acid, maleic acid, succinic acid, fumaric acid, acetic acid, lactic acid, nitric acid, sulfone Acid addition salts which can be formed from pharmaceutically acceptable acids such as acids, p-toluenesulfonic acid, methanesulfonic acid and the like.

The compounds of the present invention contain chiral centers and give various stereoisomers of the compounds, such as racemic mixtures as well as individual optical isomers. In certain preferred embodiments of the invention, the compounds of the invention are substantially pure optical isomers. Substantially pure means
It means that the composition contains more than 75% of the desired isomer and may contain up to 25% of the undesired isomer. In a more preferred embodiment, the pure optical isomer is more than 90% of the desired isomer. In one preferred embodiment, when the target is VZV, the (S) isomer is preferred. The individual isomers can be prepared directly or by asymmetric or stereospecific synthesis or by the usual separation of optical isomers from a racemic mixture.

The compounds of the present invention can be prepared by one skilled in the art of organic synthesis using the methods described below utilizing readily available reagents and starting materials unless otherwise stated. Thus, the compounds of the present invention are prepared according to the following scheme.

The novel compounds of the present invention are prepared according to the following reaction scheme.

Referring to methods 31 and 34, the substituents R ₁ -R ₅ are either neat or in a suitable solvent such as tetrahydrofuran, acetonitrile, ethyl acetate, dichloromethane or N, N-dimethylformamide. Reacting an appropriately substituted amine 2 wherein X is as described above with an appropriately substituted isothiocyanate 3 wherein the substituents R ₉ -R ₁₂ and G are as described above to give the desired thiourea 1. Can be Similarly, in a conventional solvent such as those described above, suitably substituted isothiocyanate 4 wherein substituents R ₁ -R ₅ and X are as described above, and substituents R ₉ -R ₁₂ and G Reaction with an appropriately substituted aniline 5 gives the desired thiourea 1.

[0037]

Embedded image

Alternatively, the appropriately substituted thiourea 1 can be reacted at room temperature with one molar equivalent of 1,1'-in a suitable solvent such as dichloromethane and tetrahydrofuran or a mixture thereof.
One molar equivalent of 1,1'-thiocarbonyl-di- () in a suitable solvent such as thiocarbonyldiimidazole or dichloromethane and tetrahydrofuran or a mixture thereof
Described by Methods 32 and 33 by reacting amines 2 and 5, wherein R ₁ -R ₅ , R ₉ -R ₁₂ and G are as described above, in the presence of any of the 1,2,4) -triazoles It can be prepared as described above.

[0039]

Embedded image

In some cases, subsequent chemical modification of the final thiourea 1 was required. These methods, Methods 35-39, are summarized below.

[0041]

Embedded image

Wherein at least one substituent of R ₁ -R ₅ is 1-hydroxyethoxy or carboxy-methoxy, R ₉ -R ₁₂ and G are as defined above, and X is Can be prepared from the corresponding alkyl ester by alkaline hydrolysis with aqueous sodium or potassium hydroxide in a suitable solvent such as methanol, tetrahydrofuran or a mixture thereof at room temperature according to methods 35 and 36.

A thiourea wherein at least one substituent of R ₁ -R ₅ is 1-acyloxyethoxy or methanesulfonoxyethoxy, R ₉ -R ₁₂ and G are as defined above and X is equal to a bond 1 is a benzoate or methanesulfonate in the presence of a suitable tertiary amine base such as triethylamine or diisopropylethylamine in a suitable solvent such as dichloromethane at room temperature according to Methods 37 and 38. It can be prepared from the corresponding 1-hydroxyethoxy derivative by acylation with any suitable acylating agent.

Thiourea 1 wherein at least one substituent of R ₁ -R ₅ is 1-aminoethoxy, R ₉ -R ₁₂ and G are as defined above and X is equal to the bond By reaction with a suitable secondary amine, such as dimethylamine, in a suitable solvent mixture, such as tetrahydrofuran and water, at room temperature.
It can be prepared from ethoxy derivatives.

Thiourea 1 wherein at least one substituent of R ₁ -R ₅ is 1-aminoalkyl, R ₉ -R ₁₂ and G are as defined above, and X is equal to the bond, Can be prepared from the corresponding 1-azidoalkyl derivative by reaction with stannous chloride in a suitable solvent such as methanol, ethanol and the like at room temperature.

The intermediate isothiocyanates 3 and 4 shown above in Methods 31 and 34 can be substituted with R ₁ -R ₅
, R ₉ -R ₁₂ and G are as defined above, and X is as defined above, with one molar equivalent of 1,1 ′ Staab, HA and Walther, G. Justus Liebigs Ann. Chem. 657, 1 by reacting with -thiocarbonyldiimidazole.
Prepared according to method 41 (below) according to method 04 (1962).

[0047]

Embedded image

Intermediates 2 and 5 can be prepared according to the following protocol: By methods 1A-1G, amines 2 and R ₉ -R where R ₁ -R ₅ are as defined above and X is as defined above Amine 5, wherein ₁₂ is as defined above, is known to those skilled in the art and can be found in RJ Lindsay, Comprehensive Organic Chemistry (edited by Sutherland), Volume 2, Chapter 6.3.1, Aromatic Amines,
It can be prepared by reduction of an appropriately substituted nitrobenzene according to various methods described in 1979. Such methods include the reduction of nitrobenzene to form aniline upon exposure to: a) pure or methanol or ethanol at various temperatures from room temperature to the reflux temperature of the solvent. Any iron powder in an alcoholic solvent such as and a strong acid such as hydrochloric acid (method 1A) or b) pure or in an alcoholic solvent such as methanol or ethanol at various temperatures from room temperature to the reflux temperature of the solvent. Any iron powder and glacial acetic acid (Method 1B
C) iron powder and ammonium chloride water, either pure or in an alcoholic solvent such as methanol or ethanol, at various temperatures from room temperature to the reflux temperature of the solvent (method 1C); or d) room temperature to solvent Strong mineral acids such as tin and hydrochloric acid, either pure or in alcoholic solvents such as methanol or ethanol, at various temperatures up to the reflux temperature of (method 1D) or e) R ₁ -R ₅ and R ₉ When -R ₁₂ is selected from Cl, Br, I,-(OSO ₂ ) -CF ₃ or-(OSO ₂ ) -1- (4-methylphenyl), methanol at 1 atmosphere or more By catalytic reduction such as with palladium on hydrogen and carbon in a suitable solvent such as ethanol or ethyl acetate (Method 1E) or; f) when R ₁ -R ₅ and R ₉ -R ₁₂ are Cl, Br, I , - (OSO ₂₎ -CF ₃ or - (OSO ₂₎ -1- (4- methylphenyl) G) by catalytic reduction such as with cyclohexene and palladium on carbon in a suitable solvent such as methanol or ethanol at various temperatures from room temperature to the reflux temperature of the solvent, if selected from: (g) Aqueous sodium hydrosulfite in an alcohol solvent at various temperatures from room temperature to the reflux temperature of the solvent (Method 1G).

Alternatively, according to methods 3A-3C, amine 2 wherein R ₁ -R ₅ is as defined above and X is as defined above, and aniline 5 wherein R ₉ -R ₁₂ is as defined above are known to those skilled in the art. And Gree
ne, Protective Groups in Organic Synthesis , Volume 2, Chapter 7, 1991 and prepared by cleavage of the aniline nitrogen-carbon bond of the amide and carbamate derivatives of these anilines according to the various methods described in the references therein. Can be.
Such methods include the following: a) dissolving an appropriately substituted arylamino-tert-butyl-carbamate in a suitable solvent such as neat or dichloromethane at a temperature between 0 ° C. and room temperature. Exposure to a strong acid such as trifluoroacetic acid (Method 3A) or; b) appropriately substituted arylamino- (2-trimethylsilylethyl) -carbamate at various temperatures from room temperature to the reflux temperature of the solvent. Exposure to a fluoride ion source such as tetrabutylammonium fluoride or potassium fluoride in aqueous acetonitrile or tetrahydrofuran or a mixture thereof (method 3B); or c) bringing the appropriately substituted arylamino-trifluoroacetamide to room temperature Alcohols such as methanol or ethanol at various temperatures from to the reflux temperature of the solvent Exposure to a strong base such as sodium or potassium hydroxide or sodium or potassium carbonate in a solvent (method 3C).

Alternatively, according to Method 11, amine 2 wherein R ₁ -R ₅ is as defined above, X is as defined above, and at least one substituent of R ₁ -R ₅ is defined as vinyl, Essentially in V. Farina and GP Roth Advances in Metal-Organic Chemistry , Volume 5,
1-53, 1996 and references therein, at various temperatures from room temperature to the reflux temperature of the solvent, in a suitable solvent such as tetrahydrofuran or N-methylpyrrolidinone, tris (dibenzylidine acetone). Using a palladium catalyst such as -bipalladium and a ligand such as triphenylarsine, an appropriately substituted bromo- or iodo-aniline such as 3-chloro-4-iodo-aniline and vinyl such as tributylvinyltin. It can be prepared by palladium catalyzed coupling with a trialkyltin reagent.

Alternatively, according to method 42, R ₁ -R ₅ are as defined above and X is equal to a bond;
And amine 2 wherein at least one substituent of R ₂ or R ₄ is defined as dialkylamino is essentially JF Hartwig and J. Louie Tetrahedron Letters 36 (21), 3
609 (1995) in a suitable solvent such as tetrahydrofuran or toluene at various temperatures from room temperature to 100 ° C. and a palladium catalyst such as bis (dibenzylidineacetone) palladium in a sealed tube. a ligand such as -o-tolylphosphine and at least two such as lithium bis- (trimethylsilyl) amide
Prepared by palladium-catalyzed amination of an appropriately substituted 3- or 5-bromo- or iodo-aniline, such as 3-amino-5-bromobenzotrifluoride, with a secondary amine under conditions using molar equivalents of a strong base can do.

Alternatively, according to method 43, an amine 2 wherein R ₁ -R ₅ is as defined above, X is as defined above, and at least one substituent of R ₂ or R ₄ is defined as alkyl
Can be reacted with tetrahydrofuran or the like at various temperatures from room temperature to the reflux temperature of the solvent under conditions using a palladium catalyst such as [1,1'-bis (diphenylphosphino) ferrocene] palladium (II) chloride-dichloromethane complex. 9-
3- or 5-bromo- or iodo-aniline, suitably substituted by an alkene in the presence of a suitable base such as borabicyclo [3.3.1] nonane and aqueous sodium hydroxide, for example 3-amino-5-bromobenzo It can be prepared by palladium catalyzed alkylation of trifluoride.

Acyl and carbamoylamine derivatives utilized as starting materials in Methods 3A-3C are known to those skilled in the art and are described in Greene, Protective Groups in Organic Synthes is , Volume 2, Chapter 7, 1991 and references therein. It can be prepared by derivatization of the corresponding amine as described in Methods 2A-2G according to the various methods described. Such methods include: a) acetone, tetrahydrofuran, dimethylformamide, at various temperatures from room temperature to the reflux temperature of the solvent to produce the corresponding arylamino-tert-butyl-carbamate. With di-tert-butyl-dicarbonate in the presence or absence of one molar equivalent or more of a tertiary amine such as triethylamine or N, N-diisopropylethylamine in a suitable solvent such as dichloromethane or the like B) reacting with triamine or diisopropylethylamine in a suitable solvent such as dimethylformamide at room temperature to form the corresponding arylamino- (2-trimethylsilylethyl) -carbamate. 1- [2- (trimethylsilyl) ethoxy in the presence of a tertiary amine such as Aryloxycarbonyl - oxy] reaction of benzotriazole and a suitable substituted aniline (Method 2B) or; c) triethylamine to produce the corresponding arylamino amides or N,
Carboxylation either pure or in a suitable solvent such as tetrahydrofuran, dimethylformamide, dichloromethane, pyridine, etc. in the presence of one molar equivalent or more of a tertiary amine base such as N-diisopropylethyl-amine Reaction of an anhydride or acid anhydride with an appropriately substituted aniline (method 2C) or d) pure or tetrahydrofuran at various temperatures from room temperature to the reflux temperature of the solvent to form the corresponding nitroarylaminoamide; In the absence of one molar equivalent or more of a tertiary amine base, such as triethylamine or N, N-diisopropylethylamine, in any suitable solvent such as 1,4-dioxane, etc. Reaction with an appropriately substituted nitroaniline (method 2D) or; e) the corresponding arylaminoamide Benzotriazol-1-yloxy-tris- (dimethylamino) -phosphonium hexafluorophosphate, 2- (1H-benzohexaphosphate) at room temperature in a suitable solvent such as dichloromethane, dimethylformamide, etc. Triazole-1-yloxy) -1,1,3,3-tetra-methyluronium, dicyclohexylcarbodiimide, etc. in the presence of a tertiary amine such as triethylamine or diisopropylethylamine in the presence of a coupling agent. Reaction of the acid with an appropriately substituted aniline (Method 2E) or; f) a suitable solvent such as dichloromethane, dimethylformamide, etc. at various temperatures from 0 ° C. to room temperature to form the corresponding carboxylic acid esters When less of a carboxylic acid anhydride and R ₁ -R ₁₂ in the presence of a suitable base such as pyridine at medium One substituent is defined as -WY- (CH _{2) n} -Z, wherein, W, Y and Z arylamino -tert- butyl are as defined above - are suitably protected such as carbamate G) with acetone, tetrahydrofuran, dimethylformamide, dichloromethane and the like at various temperatures from room temperature to the reflux temperature of the solvent to produce the corresponding arylamino-tert-butyl-carbamate. At least _one of di-tert-butyl-dicarbonate and R ₁ -R _{5 in} the absence of one molar equivalent or more of a tertiary amine such as triethylamine or N, N-diisopropylethylamine in a suitable solvent such as Reaction with an appropriately substituted aniline wherein one substituent is defined as hydroxyl (Method
2G).

The nitrobenzene intermediate, which is finally converted to amines 2 and 5 by the methods shown above in Methods 1A-1G, can be prepared according to Methods 4A, 4C, 4E-4F.

Referring to Methods 4A, 4C and 4E-4H, R ₂ and R ₄ are as defined above, and R ₁ , R ₃ and / or R ₅ are alkoxy, thioalkoxy, alkylsulfenyl, alkylsulfinyl and The nitrobenzene intermediate that is ultimately converted to amine 2, defined as dialkylamino, is 2-, 4-, appropriately substituted by methods including
And / or by nucleophilic substitution of 6-fluoro-, chloro-, bromo-, iodo-, trifluoromethylsulfonyl- or (4-methylphenyl) sulfonyl-substituted nitrobenzene: a) from room temperature to solvent In the presence or absence of one molar equivalent or more of a base such as sodium carbonate, potassium carbonate, sodium hydroxide, potassium hydroxide, sodium hydride, potassium hydride and the like at various temperatures up to the reflux temperature of An appropriately substituted 2- or 4-halo- or sulfonate ester of nitrobenzene or benzonitrile, either pure or in a suitable solvent such as tetrahydrofuran, dioxane, acetonitrile, N, N-dimethylformamide or dimethylsulfoxide, and an alcohol B) from room temperature to the reflux temperature of the solvent. Pure or tetrahydrofuran at different temperatures,
Sodium previously formed with an appropriately substituted 2- or 4-halo- or sulfonate ester of nitrobenzene or benzonitrile in any suitable solvent such as dioxane, acetonitrile, N, N-dimethylformamide or dimethylsulfoxide; Reaction with lithium or potassium phenoxide (Method 4H)
Or c) pure or tetrahydrofuran at various temperatures from room temperature to the reflux temperature of the solvent;
Appropriately substituted 2- or 4-halo- or sulfonate esters of nitrobenzene or benzonitrile in any suitable solvent such as dioxane, acetonitrile, N, N-dimethylformamide or dimethylsulfoxide with ammonia, primary Or reaction with a secondary amine (Methods 4C, F); d) suitably substituted nitrobenzene or benzonitrile in a suitable solvent such as tetrahydrofuran at various temperatures from 0 ° C. to the reflux temperature of the solvent. -Or
Preformed sodium of 4-halo- or sulfonate ester and amine,
Reaction with lithium or potassium salts (method 4G) or; e) pure or tetrahydrofuran at various temperatures from room temperature to the reflux temperature of the solvent;
Reaction of a suitably substituted 2- or 4-halo- or sulfonate ester of nitrobenzene or benzonitrile with sodium sulfide in any suitable solvent such as dioxane, acetonitrile, N, N-dimethylformamide or dimethylsulfoxide And subsequent direct addition of the alkyl halide to the reaction mixture (
Method 4E).

Alternatively, referring to Methods 5C and 6, the nitrobenzene intermediate that is finally converted to amine 2, wherein at least one substituent R ₁ -R ₅ is defined as alkoxy, is
It can be prepared from the corresponding substituted hydroxy-nitrobenzene by methods including the following: a) acetone, N, N-dimethylformamide, tetrahydrofuran or dimethylsulfoxide at various temperatures from room temperature to the reflux temperature of the solvent. Of an alkyl or dialkyl sulfonate ester with hydroxy-nitrobenzene in the presence of a base such as potassium carbonate, sodium carbonate, potassium hydroxide, sodium hydroxide, potassium hydride or sodium hydride in a suitable solvent such as reaction(
Method 5C); or b) Diethyl ether or tetrahydrofuran at various temperatures from 0 ° C. to the reflux temperature of the solvent, essentially according to the method described in Mitsunobu , O. Synthesis 1981, 1 and references therein. Reaction of hydroxy-nitrobenzene with an alkyl alcohol, triphenylphosphine and a dialkyl azodicarboxylate reagent such as diethyl azodicarboxylate in such an anhydrous aprotic solvent (method 6).

Furthermore, with reference to methods 5A and 5E, at least one substituent R ₁ -R ₅ is defined as alkoxy and is utilized as a starting material in methods 3A-3C which are finally converted to amines 2. Carbamoylamine derivatives can be halogenated in a suitable solvent such as acetone, toluene or N, N-dimethylformamide in the presence of a suitable base such as potassium carbonate at various temperatures from room temperature to the reflux temperature of the solvent. Can be prepared from the corresponding substituted hydroxyarylamino-tert-butyl-carbamate by reaction with alkyl, trifluoromethane-sulfonate, 4-methylbenzenesulfonate, dialkylsulfonate, ethylene carbonate, and the like.

Alternatively, with reference to methods 7A-G, R₁And / or R_ThreeIs alkoxy and R _Two And / or R_FourIs halogen, and X is equal to the bond,
The nitrobenzene intermediate to be converted is a standard halogenated, including:
Can be prepared by reaction: a) aqueous sodium hypochlorite and 2- or 4-hydroxy-nitrobenzene at room temperature
(Methods 7A and 7B); or b) chloroform, dichloromethane at room temperature in the presence or absence of silver trifluoroacetate
Bromine and 2-hydroxy-4-methoxy in a suitable solvent such as
Or reaction with 2,4-dimethoxynitrobenzene (Methods 7C and 7D) or; c) dichloroiodine at room temperature in a suitable solvent such as
Reaction of benzyltrimethylammonium citrate with 2,4-dimethoxynitrobenzene (
D) Bicarbonate in a suitable solvent mixture such as dichloromethane and methanol at room temperature
Benzyltrimethylammonium dichloroiodate in the presence of sodium
Reaction with droxy-4-methoxynitrobenzene (method 7F) or; e) a suitable solvent such as tetrachloroethane at various temperatures from room temperature to the reflux temperature of the solvent.
3,5-dichloro-1-fluoropyridine triflate and 2,4-dimethoxy in the appropriate solvent
Reaction with nitrobenzene (Method 7G).

Referring to Method 8, the final conversion to amine 2 wherein R ₄ = -CF ₃ , R ₁ -R ₃ and R ₅ -R ₈ are as defined above and X equals a bond The nitrobenzene intermediate is prepared in a sealed reaction vessel at various temperatures from room temperature to the reflux temperature of the solvent in a suitable solvent such as N, N-dimethylformamide, etc. in the presence of cuprous iodide and potassium fluoride. With the corresponding substituted 4-iodo by reaction with trimethyl (trifluoromethyl) silane
-It can be prepared from nitrobenzene.

Referring to Methods 19A and 19B, R ₄ = -HNCOCH ₂ NR ₇ R ₈ or -HNCOCH ₂ SR ₆ , R ₁ -R ₃ and
The nitrobenzene intermediate that is ultimately converted to amine 2, wherein R ₅ -R ₈ is as defined above and X is equal to the bond, is tetrahydrofuran and / or water at various temperatures from room temperature to the reflux temperature of the solvent. Dimethylamine in a suitable solvent such as a mixture,
By reaction with a suitable secondary amine such as morpholine or the like or at various temperatures from room temperature to the reflux temperature of the solvent in a suitable solvent such as tetrahydrofuran, 1,4-dioxane, etc. It can be prepared from the corresponding substituted 4- (N-chloroacetyl) -nitroaniline by reaction with a suitable thiol in the presence of such a suitable base.

Referring to Method 25, the nitrobenzene intermediate that is finally converted to amine 2, wherein at least one substituent of R ₁ -R ₅ is defined as triflate and X is equal to a bond,
From the corresponding phenol by reaction with trifluoromethane-sulfonic anhydride in the presence of a tertiary amine such as triethylamine or diisopropyl-ethylamine in a suitable solvent such as dichloromethane at various temperatures from 0 ° C. to room temperature Can be prepared.

Referring to Methods 9, 9B and 10, Methods 3A- wherein at least one substituent R ₁ -R ₅ is finally converted to amine 2, defined as either alkylsulfenyl or alkylsulfinyl The carbamoylamine derivative utilized as a starting material in 3C can be obtained by mixing a suitable oxidizing agent such as dimethyloxirane or sodium periodate with a suitable 4-alkylthioacyl at room temperature in a suitable solvent mixture such as acetone and dichloromethane or water. -Arylamino or carbamoylarylamino derivatives.

Referring to Method 12, final conversion to amine 2 wherein R ₄ is defined as 1-hydroxyethyl, R ₁ -R ₃ and R ₅ are as defined above, and X equals a bond Way 3A-3
The carbamoylamine derivative utilized as a starting material in C can be prepared by converting the corresponding 4-vinylcarbamoylaniline to hydrogen in the presence of mercuric acetate in a suitable solvent such as tetrahydrofuran, 1,4-dioxane, and water at room temperature. It can be prepared by reacting with sodium borohydride.

Referring to Method 13, the amine 2 is finally defined where R ₄ is defined as 2-hydroxyethyl, R ₁ -R ₃ and R ₅ are as defined above, and X is as defined above. Method 3A Converted
The carbamoylamine derivative utilized as a starting material in -3C can be prepared by reacting the corresponding carbamoylamine derivative in the presence of glacial acetic acid in a suitable solvent such as It can be prepared by reacting vinylcarbamoylaniline with sodium borohydride.

Referring to Method 14, final conversion to amine 2, wherein R ₄ is defined as 1-azidoethyl, R ₁ -R ₃ and R ₅ are as defined above, and X is as defined above How to be 3A-3C
The carbamoylamine derivative utilized as a starting material in is a dialkyl azodicarboxylate such as diethyl azodicarboxylate and triphenylphosphine in a suitable solvent mixture such as tetrahydrofuran and dichloromethane at various temperatures from 0 ° C. to room temperature. It can be prepared by reacting the corresponding 4- (1-hydroxyethyl) carbamoylaniline with hydrazoic acid in the presence.

Referring to Method 15, R_FourIs defined as 3-dimethylaminoprop-1-ynyl; R₁-R _Three And R_FiveIs as defined above and X is equal to the bond, final conversion to amine 2
Carbamoylamine Derivatives Used as Starting Materials in Process 3A-3C
Can be converted to bis (triphenylphosphine) at various temperatures from room temperature to the reflux temperature of the solvent.
) In the presence of palladium (II) chloride and cuprous iodide
The corresponding 4-iodine in a suitable tertiary amine solvent such as diisopropylethylamine
Reacting carbamoylaniline with 1-dimethylamino-2-propyne
Can be prepared.

Referring to Method 16, R ₂ is defined as 3-dimethylaminoacryloyl, R ₁ -R ₃ and R ₅ are as defined above, and X is equal to a bond. The carbamoylamine derivative utilized as a starting material in the converted methods 3A-3C is 0
The corresponding 4- (3-dimethylaminoprop-1-ynyl) carbamoylaniline can be converted to a suitable solvent such as 3-chloroperoxybenzoic acid in a suitable solvent mixture such as dichloromethane and methanol at various temperatures from ℃ to room temperature. It can be prepared by reacting with a peracid.

Referring to Methods 17 and 18, R ₄ is defined as either 4-isoxazol-5-yl or 4- (1H-pyrazol-3-yl) and R ₁ -R ₃ and R ₅ are The carbamoylamine derivative utilized as a starting material in Methods 3A-3C, as defined above, where X is equal to a bond and is ultimately converted to amine 2 at room temperature, such as 1,4-dioxane or ethanol, etc. The corresponding 4- (3-dimethylamino-acryloyl) in any suitable solvent
) Can be prepared by reacting carbamoylaniline with either hydroxylamine hydrochloride or hydrazine hydrate.

Referring to Method 20, R ₄ = —HNCO ₂ Z, R ₁ —R ₃ , R ₅ and Z are as defined above,
The carbamoylamine derivative utilized as a starting material in Methods 3A-3C, where X is equal to a bond and is ultimately converted to amine 2, is a compound such as tetrahydrofuran and dichloromethane at various temperatures from room temperature to the reflux temperature of the solvent. It can be prepared by reacting the corresponding 4-aminocarbamoylaniline with 1,1-carbonyl-di- (1,2,4) -triazole and an appropriately substituted alcohol in a suitable solvent mixture.

Referring to Methods 26 and 30, Methods 3A-3C wherein at least one substituent of R ₁ -R ₅ is defined as dialkylamino and X is as defined above, and is ultimately converted to amine 2. The carbamoylamine derivative utilized as a starting material in is a mixture of either sodium cyanoborohydride or hydrogen gas and 10% palladium on carbon in a suitable solvent such as water, methanol, a mixture of tetrahydrofuran or toluene at room temperature. It can be prepared below by reaction of an appropriately substituted aldehyde.

Referring to Methods 27 and 28, amine 2 wherein at least one substituent of R ₁ -R ₅ is defined as hydroxy and X is as defined above, can be used at various temperatures from room temperature to the reflux temperature of the solvent. By reacting a suitable base such as sodium bicarbonate or sodium hydroxide with a corresponding ester such as an acetate in a suitable solvent mixture such as a methanol-water mixture.

Referring to Method 29, amine 2 wherein at least one substituent of R ₁ -R ₅ is defined as 2-hydroxybenzamide and X is as defined above, at room temperature, such as tetrahydrofuran, diethyl ether and the like In a suitable solvent, lithium borohydride and the corresponding N- (4
-Aminophenyl) phthalimide.

The intermediate amine 2 wherein R ₁ -R ₅ are as defined above and X is equal to either —CH ₂ — or — (CH ₂ ) ₂ — can be prepared by the following method: a) Reduction of appropriately substituted benzo- or phenylacetonitrile with borane-dimethyl sulfide complex in a suitable solvent such as ethylene glycol dimethyl ether, tetrahydrofuran, etc. at various temperatures from room temperature to the reflux temperature of the solvent (Method 44). B) a suitable catalyst such as 5% or 10% palladium on carbon in a suitable solvent such as ethylene glycol monomethyl ether, ethyl acetate, ethanol and the like at room temperature and 4-methyl-benzenesulfonic acid, hydrochloric acid, etc. Reduction under one atmosphere or more of hydrogen in the presence of such an acid (method 50); c) tetrahydrofuran or diethyl at various temperatures from 0 ° C. to room temperature Reduction with lithium aluminum hydride in a suitable solvent such as ether (method 51).

Utilized as a starting material in method 51, wherein R ₁ -R ₅ are as defined above,
X is - (CH _{2) 2} - equal, nitro precursor unsaturated that is ultimately converted to amines 2,
It can be prepared by reacting nitro-methane with a suitably substituted benzaldehyde in the presence of ammonium acetate in a suitable solvent such as acetic acid at various temperatures from room temperature to the reflux temperature of the solvent (Method 53). The benzaldehyde utilized as starting material in Method 53 can be prepared by diisobutylaluminum hydride reduction of an appropriately substituted benzonitrile (Method 52). The substituted benzonitrile utilized as a starting material in Method 52 is prepared by reaction with copper cyanide in a suitable solvent such as N, N-dimethylformamide at various temperatures from room temperature to the reflux temperature of the solvent. (Method 59)
).

For amines 2 where R ₁ -R ₅ are as defined above and X is equal to either —O (CH ₂ ) ₂ NH ₂ or —S (CH ₂ ) ₂ NH ₂ , the required nitrile The precursor may be prepared by reacting bromoacetonitrile with a suitably substituted phenol or thiophenol in the presence of a suitable base such as potassium carbonate in a suitable solvent such as acetone at room temperature according to Method 49. it can.

Alternatively, for amines 2 where R ₁ -R ₅ are as defined above and X is equal to — (CH ₂ ) ₃ —, the nitrile precursor is treated at various temperatures from 0 ° C. to room temperature Phenethanol appropriately substituted with acetone cyanohydrin and triphenylphosphine in the presence of a suitable azodicarboxylic acid ester such as diethyl azodicarboxylate in a suitable solvent such as diethyl ether or tetrahydrofuran, etc.
By reaction with l), it can be prepared essentially according to the method of Wilk, B. Synthetic Comm. 23, 2481 (1993) (method 54).

Alternatively, the intermediate amine 2 wherein R ₁ -R ₅ are as defined above and X is equal to-(CH (CH ₃ ))-can be obtained at various temperatures from room temperature to the reflux temperature of the solvent. The corresponding formamide acid or base catalyst using a suitable acid catalyst such as 6N hydrochloric acid or a suitable base catalyst such as 5N sodium or potassium hydroxide in a suitable solvent mixture such as water and methanol or water and ethanol. It can be prepared by hydrolysis (method 46).

The formamide precursor utilized as a starting material in process 46 and ultimately converted to amine 2 is suitably substituted with ammonium formate, formic acid and formamide at various temperatures from room temperature to the reflux temperature of the solvent. Prepared according to Method 45 by treatment with acetophenone.

Alternatively, amine 2 wherein R ₁ -R ₅ are as defined above and X is equal to-(CH (CH ₃ ))-is essentially an Ituno, S., Sakurai, Y., Ito Prepared by reduction of a suitably substituted O-methyl oxime in the presence of sodium borohydride and zirconium tetrachloride in a suitable solvent such as tetrahydrofuran or diethyl ether at room temperature according to the method of K. Synthesis, 1988, 995. Can be (method 48). necessary
O-methyl oxime can be prepared from the corresponding acetophenone by reaction with methoxylamine hydrochloride and pyridine in a suitable solvent such as ethanol or methanol at various temperatures from room temperature to the reflux temperature of the solvent (Method 47).

Amine 2 wherein R ₁ -R ₅ are as defined above and X is equal to —CH (J) —, wherein J is as defined above, can be prepared according to the method described above (methods 45, 47) And 48) by reduction of an appropriately substituted ketone. These necessary ketones are
If not commercially available, a suitable organic metal such as phenyllithium, isopropylmagnesium bromide or ethylmagnesium bromide in a suitable solvent such as diethyl ether or tetrahydrofuran at various temperatures from -78 ° C to 0 ° C. It can be prepared by reacting a reagent with an appropriately substituted benzaldehyde (method 57). The resulting alcohol is oxidized to the corresponding ketone with a suitable oxidizing agent such as chromium trioxide or pyridinium chlorochromate or pyridinium dichromate in aqueous sulfuric acid and acetone in a suitable solvent such as dichloromethane at room temperature. (Method 58).

The intermediate aniline 5 can be prepared as in Method 3A above. For example, G
Phenylcarbamic acid tert-butyl ester 6 as described above is treated at room temperature with pure trifluoroacetic acid and subsequently neutralized with aqueous sodium hydroxide to give the desired aniline 5. The required carbamate 6 wherein R ₉ -R ₁₂ and G are as described above can be prepared by converting G as described above in a suitable solvent such as dichloromethane, dimethylsulfoxide or dimethylformamide or a mixture thereof in the presence of triethylamine. The substituted acid chloride 8 and R ₉ -R ₁₂ are prepared as shown in Method 2C by reaction of 4-aminophenylcarbamic acid tert-butyl ester 7 above. The carboxylic acid chloride 8 is commercially available or is prepared from the corresponding carboxylic acid by reaction with oxalyl chloride in a suitable solvent such as dichloromethane at room temperature.

[0082]

Embedded image

Alternatively, the carbamate 6 in which R ₉ -R ₁₂ and G are as described above can be prepared at room temperature in a suitable solvent such as dichloromethane, dimethylformamide, etc. to form the corresponding arylaminoamide. Benzotriazol-1-yloxy-tris- (dimethylamino) phosphonium hexafluorophosphate, 2- (1H-benzotriazol-1-yloxy) -1,1,3,3-tetramethyluronium hexafluorophosphate, dicyclo Substituted carboxylic acid 8a wherein G is as described above and optionally substituted in the presence of a tertiary amine base such as triethylamine or diisopropylethylamine in the presence of a suitable coupling agent such as -hexylcarbodiimide and the like. Of 4-aminophenylcarbamic acid tert-butyl ester 7 as prepared in Method 2E. It is.

The carboxylic acids 8a are commercially available or prepared according to literature methods. For example, when G is a substituted thiadiazole, the acid is converted to the corresponding carboxylic acid at room temperature by reaction with a suitable base such as sodium or potassium hydroxide in a suitable solvent mixture such as methanol or ethanol and water. Available from acid esters.

Similarly, G is a substituted or unsubstituted thiazole, a substituted or unsubstituted oxazole, a substituted or unsubstituted isothiazole or a substituted or unsubstituted isoxazole When not commercially available, the corresponding carboxylic acid 8a can be prepared at room temperature by reaction with a suitable base such as sodium or potassium hydroxide in a suitable solvent mixture such as methanol or ethanol and water. Available from methyl esters. These esters are commercially available or can be prepared according to literature methods.

If the carboxylate precursors ultimately converted to acid 8a are not commercially available, they can be prepared by methods known in the literature. For example, 5-substituted -1,2,3-thiadiazole-4-carboxylates are essentially those described by Caron, M .;
J. Org. Chem. 51, 4075 (1986) and Taber, DF, Ruckle, REJ Amer. Ch.
em. Soc. 108, 7686 (1986). For example, treating a beta-ketocarboxylic ester with 4-methylbenzenesulfonyl azide or methanesulfonyl azide in the presence of a tertiary amine base such as triethylamine or diisopropylethylamine in a suitable solvent such as acetonitrile, etc., according to Method 21. This gives the corresponding diazo-beta-ketocarboxylic acid ester. This compound is prepared in a suitable solvent such as benzene or toluene at various temperatures from room temperature to the reflux temperature of the solvent in 2,4-bis (4-methoxyphenyl) -1.
Treatment with 1,3-dithia-2,4-diphosphetane-2,4-disulfide gives the desired 5-substituted -1,2,3-thiadiazole-4-carboxylic acid ester.

Alternatively, the 4-substituted -1,2,3-thiadiazole-5-carboxylates are essentially those of Shafiee, A., Lalezari, I., Yazdani, S., Shahbazian, FM, Par
tovi, TJ Pharmaceutical Sci. 65, 304 (1976). For example, according to methods 22 and 23, an aqueous solution of semicarbazide hydrochloride and an appropriate solvent in a suitable alcoholic solvent such as methanol or ethanol at various temperatures from room temperature to the reflux temperature of the solvent in the presence of a suitable base such as pyridine. Reaction with the substituted beta-ketocarboxylic acid ester gives the corresponding semicarbazone derivative. Treatment of this compound with pure thionyl chloride at 0 ° C., followed by treatment with excess aqueous sodium bicarbonate gives the corresponding 4-substituted -1,2,3-thiadiazole-5-carboxylate. Can be

4-Carboalkoxythiazoles are essentially derived from Schollkopf, U., Porsch, P., La
u, H. Liebigs Ann. Chem. 1444 (1979). For example, N, in a suitable alcoholic solvent such as ethanol at room temperature according to methods 55 and 56.
Reaction of N-dimethylformamide dimethyl acetal with ethyl isocyanoacetate gives the corresponding ethyl 3-dimethylamino-2-isocyano-acrylate. A solution of this compound in a suitable solvent such as tetrahydrofuran at room temperature in the presence of a suitable tertiary amine base such as triethylamine or diisopropylethylamine to give the corresponding 4-carbethoxy-thiazole in the presence of a gaseous sulfur Treat with hydrogen.

Further suitably substituted thiazoles are essentially those of Bredenkamp, MW, Holza
fel CW, van Zyl. WJ Synthetic Comm. 20, 2235 (1990). Suitable unsaturated oxazoles are essentially those described by Henneke, K.
Prepared according to the method of H., Schollkopf, U., Neudecker, T. Liebigs Ann. Chem. 1979 (1979). Substituted oxazoles are essentially Galeotti, N., Montag
ne, C., Poncet, J., Jouin, P. Tetrahedron Lett. 33, 2807 (1992) and Shin,
C., Okumura, K., Ito, A., Nakamura, Y. Chemistry Lett. 1305 (1994).

The following specific examples are illustrative, but not limiting, of the present invention.

[0091]

【Example】

Example 1 (method 1A) 4-Methoxy-3-trifluoromethyl-phenylamine A suspension of 4-methoxy-3-trifluoromethyl-nitrobenzene (2.2 g) and iron powder (1.68 g) (35 mL of ethanol and Treat 15 mL of water) with a concentrated hydrochloric acid solution (0.42 mL) (6 mL of ethanol and 3 mL of water) and heat the mixture to reflux for about 1 hour. Then the mixture is cooled, filtered and concentrated under reduced pressure. The resulting oil is dissolved in ethyl acetate and
Extract with 3% aqueous hydrochloric acid three times. The pooled acid extract is then cooled in an ice bath, made basic with solid potassium carbonate and then extracted with ethyl acetate. The organic extracts were washed with aqueous saturated sodium chloride, dried over anhydrous sodium sulfate, concentrated under reduced pressure, and then passed through a short column of silica gel (using ethyl acetate as eluent) to give an amber color To give the desired compound as an oil.

Using the above procedure and the appropriate starting materials, the following compounds were prepared.

2,6-dichloro-benzene-1,4-diamine 3-chloro-4-methylsulfanyl-phenylamine 2,6-dibromo-benzene-1,4-diamine 3-chloro-4-trifluoromethyl- Phenylamine 3-chloro-4-ethylsulfanyl-phenylamine 4-methoxy-3-trifluoromethyl-phenylamine 3,5-dichloro-4-methoxy-2-methyl-phenylamine 5-chloro-2-ethoxy-4 -Methoxy-phenylamine 5-chloro-4-ethoxy-2-methoxy-phenylamine 5-iodo-2,4-dimethoxy-phenylamine 3,5-diiodo-2,4-dimethoxy-phenylamine 3,5-dibromo -2,4-dimethoxy-phenylamine 5-chloro-2-methoxy-4-methyl-phenylamine 2-chloro-N (1), N (1) -dimethyl-benzene-1,4-diamine 3-chloro- 4-piperidin-1-yl-phenylamine 3-chloro-4-pyrrolidin-1-yl-phenylamine N (1) -benzyl 2-chloro-benzene-1,4-diamine 3-chloro-4- (4-methyl-piperazin-1-yl) -phenylamine 2-chloro-N (1) -methyl-N (1)-( 1-methyl-piperidin-4-yl) -benzene-1,4-diamine 2-chloro-N (1) -methyl-N (1)-(1-methyl-pyrrolidin-3-yl) -benzene-1, 4-diamine 2-chloro-N (1) -methyl-N (1) -phenyl-benzene-1,4-diamine N (1)-(1-benzyl-pyrrolidin-3-yl) -2-chloro-N (1) -Methyl-benzene-1,4-
Diamine 2-chloro-N (1) -cyclopentyl-N (1) -methyl-benzene-1,4-diamine 2-[(4-amino-2-chloro-phenyl)-(2-hydroxy-ethyl) -amino ] -Ethanol 2-chloro-N (1) -hexyl-N (1) -methyl-benzene-1,4-diamine 2-chloro-N (1) -isobutyl-N (1) -methyl-benzene-1, 4-diamine 2-[(4-amino-2-chloro-phenyl) -methyl-amino] -ethanol 2-chloro-N (1)-(3-dimethylamino-propyl) -N (1) -methyl-benzene -1,4-diamine 2-chloro-N (1)-(2-dimethylamino-ethyl) -N (1) -methyl-benzene-1,4-diamine 2-chloro-N (1)-(2- Dimethylamino-ethyl) -benzene-1,4-diamine N (1)-(1-benzyl-piperidin-4-yl) -2-chloro-benzene-1,4-diamine 2-chloro-N (1)- (2-methoxy-ethyl) -N (1) -methyl-benzene-1,4-diamine 2-chloro-N (1)-(3-dimethylamino-propyl) -benzene-1,4-diamine N (1 )-(1-Benzyl-pi Lysin-3-yl) -2-chloro-benzene-1,4-diamine 3-chloro-4- (1-methyl-piperidin-4-yloxy) -phenylamine 3-chloro-4- (2-dimethylamino- (Ethoxy) -phenylamine 3-chloro-4- (3-dimethylamino-propoxy) -phenylamine 3-chloro-4- (1-methyl-pyrrolidin-3-yloxy) -phenylamine 3-chloro-4-cyclohexyloxy -Phenylamine Example 2 (Method 1B) A suspension of 4-bromo-2,4-dimethoxy-phenylamine 4-bromo-2,4-dimethoxy-nitrobenzene (0.48 g) and iron powder (0.42 g) (
(10 mL of acetic acid and 10 mL of ethanol) is heated to 120 ° C. for about 5 hours. Then the mixture is cooled, filtered and concentrated under reduced pressure. Water is added, the mixture is cooled in an ice bath, neutralized with solid potassium carbonate and then extracted with dichloromethane. The organic extracts are washed with aqueous saturated sodium chloride, dried over anhydrous sodium sulphate, concentrated under reduced pressure and then chromatographed on silica gel (eluent).
(Using 20% ethyl acetate in hexane) to give the desired compound as an amber oil.

Example 3 (Method 1C) (4-Amino-2,6-dichloro-phenoxy) -acetic acid tert-butyl ester (4-nitro-2,6-dichloro-phenoxy) -acetic acid tert-butyl ester (1 g ) Solution (
17 mL of ethanol and 8.6 mL of water) were replaced with iron powder (0.861 g) and ammonium chloride (86 mg).
) And heat the mixture to reflux for about 1 hour. Then the mixture is filtered and concentrated under reduced pressure. The resulting oil was partitioned between water and ethyl acetate, then the organic phase was washed with aqueous saturated sodium chloride, dried over anhydrous sodium sulfate and concentrated under reduced pressure to give the desired compound as a pale yellow solid Get as.

Using the above procedures and the appropriate starting materials, the following compounds were prepared.

4-Chloro-benzene-1,2-diamine N- (4-amino-2-chloro-phenyl) -acetamide (4-amino-2,6-dichloro-phenoxy) -acetonitrile (4-amino-2 , 6-Dichloro-phenoxy) -acetic acid tert-butyl ester (2-amino-4-chloro-5-methoxy-phenoxy) -acetonitrile (4-amino-2-chloro-5-methoxy-phenoxy) -acetic acid methyl ester ( 4-amino-2-chloro-5-methoxy-phenoxy) -acetic acid tert-butyl ester (2-amino-4-chloro-5-methoxy-phenoxy) -acetic acid tert-butyl ester N (1) -benzyl-4- Chloro-5-methoxy-benzene-1,2-diamine N- (4-amino-2-chloro-phenyl) -2-fluoro-benzamide N- (4-amino-5-chloro-2-hydroxy-phenyl)- Acetamide N- (4-amino-5-chloro-2-hydroxy-phenyl) -2-fluoro-benzamide furan-2-carboxylic acid (4-amino-2-chloro-phenyl) -Amido (4-amino-2-chloro-phenyl) -carbamic acid ethyl ester N- (4-amino-5-chloro-2-methyl-phenyl) -acetamide N- (4-amino-5-chloro-2- Methyl-phenyl) -2-fluoro-benzamide furan-2-carboxylic acid (4-amino-5-chloro-2-methyl-phenyl) amide N- (4-amino-3-chloro-phenyl) -2-fluoro- Benzamide furan-2-carboxylic acid (4-amino-3-chloro-phenyl) -amide N- (4-amino-2-chloro-phenyl) -2-dimethylamino-acetamide N- (4-amino-2-chloro -Phenyl) -2-piperidin-1-yl-acetamido N- (4-amino-2-chloro-phenyl) -2-morpholin-4-yl-acetamido N- (4-amino-2-chloro-phenyl)- Methanesulfonamide N- (4-amino-2-chloro-phenyl) -benzamide N- (4-amino-2-chloro-phenyl) -2-diethylamino-acetamide N- (4-amino-2-chloro-phenyl ) -2-Pyrrolidin-1-yl-acetamido N- (4-amino-2-chloro-phenyl) -2-azepan-1-yl-acetamido N- (4-amino-2-chloro-phenyl) -2- (2-Methyl-piperidin-1-yl) -acetamide N- (4-amino-2-chloro-phenyl) -2- (3-methyl-piperidin-1-yl) -acetamide 3-chloro-benzene-1, 2-Diamine 4-chloro-N, N-dimethyl-benzene-1,2-diamine Example 4 (Method 1D) 3,5-dichloro-4-phenoxy-phenylamine 3,5-dichloro-4-phenoxy-nitrobenzene (6.1 g) and tin powder (12 g) are added dropwise with concentrated hydrochloric acid (60 mL). Ethanol (60 mL) is added and the mixture is heated at reflux for about 1 hour. The mixture is then cooled in an ice bath and made basic by the addition of solid sodium hydroxide. The resulting suspension is filtered through a pad of diatomaceous earth and extracted three times with ethyl acetate. The combined organic extracts are then washed with aqueous saturated sodium chloride, dried over anhydrous magnesium sulfate and concentrated under reduced pressure to give the desired product as a yellow solid. Recrystallization from ethyl acetate-hexane gives the product as a pale yellow solid.

Using the above procedure and the appropriate starting materials, the following compounds were prepared.

1-furan-2-yl-ethylamine 3-chloro-4-isopropoxy-phenylamine 2-butoxy-5-chloro-4-methoxy-phenylamine 3,5-dichloro-2-methoxy-4-methyl -Phenylamine 2-benzyloxy-5-chloro-4-methoxy-phenylamine 4-benzyloxy-5-chloro-2-methoxy-phenylamine 5-fluoro-2,4-dimethoxy-phenylamine (4-amino- 2,6-dichloro-phenoxy) -acetic acid ethyl ester 3,5-dichloro-4-phenoxy-phenylamine 2- (4-amino-2-chloro-5-methoxy-phenoxy) -acetamide (4-amino-2- Chloro-5-methoxy-phenoxy) -acetonitrile 2- (2-amino-4-chloro-5-methoxy-phenoxy) -ethanol 2- (4-amino-2-chloro-5-methoxy-phenoxy) -ethanol 4- (4-amino-2-chloro-5-methoxy-phenoxy) -butyronitrile 4-amino-2-chloro-5- Toxyl-phenol 2-amino-4-chloro-5-methoxy-phenol 5-chloro-4-methoxy-2-morpholin-4-yl-phenylamine 4-chloro-5-methoxy-N (1), N (1 ) -Dimethyl-benzene-1,2-diamine 5-chloro-4-methoxy-2-piperidin-1-yl-phenylamine 5-chloro-4-methoxy-2-pyrrolidin-1-yl-phenylamine 2-chloro -N (1) -cyclohexyl-N (1) -methyl-benzene-1,4-diamine N (2) -benzyl-4-methoxy-benzene-1,2-diamine 2- (4-amino-2-chloro -Phenoxy) -ethanol 2-chloro-N (1) -cyclohexyl-N (1) -ethyl-benzene-1,4-diamine 4-butoxy-3-chloro-phenylamine (4-amino-2-chloro-phenoxy ) -Acetonitrile 2-chloro-N (1) -cyclohexyl-benzene-1,4-diamine 2-chloro-N (1), N (1) -dipropyl-benzene-1,4-diamine 3-chloro-4- (2,2,2-trifluoro-ethoxy) -phenyla Min 3-chloro-4- (octahydro-quinolin-1-yl) -phenylamine N (1) -allyl-2-chloro-N (1) -cyclohexyl-benzene-1,4-diamine N- (4-amino 2-methoxy-5-methyl-phenyl) -2-fluoro-benzamide furan-2-carboxylic acid (4-amino-2-methoxy-5-methyl-phenyl) amide N- (4-amino-naphthalene-1- Yl) -2-fluoro-benzamide 3-chloro-N, N-dimethyl-benzene-1,2-diamine 3-chloro-4-propoxy-phenylamine 3-iodo-4-methoxy-phenylamine 3-chloro-2 , 4-Dimethoxy-aniline 3-bromo-4-methoxy-phenylamine 3-chloro-4-ethoxy-phenylamine Example 5 (Method 1E) (4-amino-phenyl) -carbamic acid isobutyl ester N- (4- To a solution of (nitro-phenyl) -isobutylamide (2.0 g) in 100 mL of ethylene glycol monomethyl ether was added Add Umm the (275mg).
The mixture is hydrogenated on a Parr hydrogenator under 30 psi of hydrogen at room temperature for 2 hours. The catalyst is then removed by filtration through diatomaceous earth and the filtrate is evaporated to dryness under reduced pressure by azeotroping with heptane three times. Trituration of the residue with heptane gives the desired product as a white solid.

Using the above procedure and the appropriate starting materials, the following compounds were prepared.

2-Methyl-3H-benzimidazol-5-ylamine N- (4-amino-phenyl) -formamide 1H-benzimidazol-5-ylamine (4-amino-phenyl) -carbamic acid isobutyl ester N- (4 -Amino-phenyl) -isobutylamide N- (5-amino-pyridin-2-yl) -2-methyl-benzamide furan-2-carboxylic acid (5-amino-pyridin-2-yl) -amide N- (5 -Amino-pyridin-2-yl) -2-fluoro-benzamide [6- (2,2,2-trifluoro-acetylamino) -pyridin-3-yl] -carbamic acid
ert-butyl ester N- (5-amino-pyridin-2-yl) -2,2,2-trifluoro-acetamide (4-amino-benzyl) -carbamic acid tert-butyl ester 2- (3,5-bis -Trifluoromethyl-phenyl) -ethylamine 1-tert-butyl-1H-imidazol-2-ylamine 3- (3-dimethylamino-propyl) -5-trifluoromethyl-phenylamine Example 6 (Method 1F) N- (4-amino-2-methylphenyl) -2-fluorobenzamide 2-fluoro-N- (2-methyl-4-nitrophenyl) benzamide (4.55 g), cyclohexene (30 mL), ethanol (70 mL), water (30 mL ) And 10% palladium on charcoal (3 g) are heated under reflux for 30 minutes. The mixture is filtered through diatomaceous earth and concentrated under reduced pressure. Dissolve the resulting oil in 50 mL of ethyl acetate and cool to 4 ° C. for 12 hours. Filtration gives the product as a tan solid.

Using the above procedure and the appropriate starting materials, the following compounds were prepared.

N- (4-amino-2-methyl-phenyl) -acetamido 2-methyl-benzoxazol-6-ylamine N- (4-amino-3-methoxy-phenyl) -acetamido 2-acetylamino-5- Amino-benzoic acid N- (4-amino-phenyl) -acetamide [4- (3-amino-benzoylamino) -phenyl] -carbamic acid tert-butyl ester [4- (2-amino-benzoylamino) -phenyl] -Carbamic acid tert-butyl ester N- (4-amino-2-cyano-phenyl) -acetamide N- (4-amino-2,5-dimethoxy-phenyl) -2-fluoro-benzamide furan-2-carboxylic acid ( 4-amino-2,5-dimethoxy-phenyl) -amide N- (4-amino-2-cyano-phenyl) -2-fluoro-benzamide furan-2-carboxylic acid (4-amino-2-methoxy-phenyl) -Amide N- (4-amino-2-methoxy-phenyl) -2-fluoro-benzamide N- (4-amino-2-methoxy-5-methyl N- (4-amino-2-benzoyl-phenyl) -acetamide N- (4-amino-2-benzoyl-phenyl) -2-fluoro-benzamide furan-2-carboxylic acid (4-amino -2-benzoyl-phenyl) -amide N- (4-amino-3-methyl-phenyl) -acetamide N- (4-amino-3-methyl-phenyl) -2-fluoro-benzamide furan-2-carboxylic acid ( 4-amino-3-methyl-phenyl) -amide 5-amino-2-[(2-fluorobenzoyl) amino] -N-phenylbenzamide furan-2-carboxylic acid (4-amino-2-phenylcarbamoyl-phenyl) -Amido N- (4-amino-naphthalen-1-yl) -acetamidofuran-2-carboxylic acid (4-amino-naphthalen-1-yl) -amide N- (4-amino-2-trifluoromethyl-phenyl ) -Acetamide furan-2-carboxylic acid (4-amino-2-cyano-phenyl) -amide furan-2-carboxylic acid (4-amino- 2-trifluoromethyl-phenyl) -amide N- (4-amino-2-methyl-phenyl) -2-fluoro-benzamide furan-2-carboxylic acid (4-amino-2-methyl-phenyl) -amide 5- Amino-2- (2-fluoro-benzoylamino) -benzoic acid 5-amino-2-[(furan-2-carbonyl) amino] -benzoic acid N- (4-amino-2-cyano-phenyl) -2, 2,2-trifluoro-acetamide N- (4-amino-3-methyl-phenyl) -2,6-difluoro-benzamide N- (4-amino-3-trifluoromethyl-phenyl) -acetamide N- (4 -Amino-3-trifluoromethyl-phenyl) -2-fluoro-benzamide N- (4-amino-2-trifluoromethyl-phenyl) -2,2,2-trifluoro-acetamide N- (4-amino- 2-methoxy-phenyl) -2,2,2-trifluoro-acetamide N- (4-amino-2-trifluoromethyl-phenyl) -2-fluoro-N- (2-fluoro-
Benzoyl) -benzamide N- (4-amino-2-trifluoromethyl-phenyl) -2-fluoro-benzamide Example 7 (Method 1G) N- (4-amino-2-chlorophenyl) -2-thiomorpholino-4 -Yl-acetamide N- (2-chloro-4-nitrophenyl) -2-thiomorpholino-4-yl-acetamide (3.0
2 g) The solution (in 200 mL of ethanol) is added to a solution of sodium thiosulfate (12 g) in 60 mL of water. The mixture is heated at reflux for 12 hours, cooled and poured into water. Then the mixture is extracted with ethyl acetate. Ethyl acetate solution with aqueous saturated sodium chloride 2
Wash twice, dry over anhydrous potassium carbonate, filter through a pad of diatomaceous earth, and concentrate under reduced pressure to give an oil. Toluene is added and the solution is cooled to give the desired product as a pale orange crystalline solid.

Using the above procedures and the appropriate starting materials, the following compounds were prepared.

N- (4-amino-2-chloro-phenyl) -2-thiomorpholin-4-yl-acetamide N- (4-amino-2-chloro-phenyl) -2-dipropylamino-acetamide 8 (Method 2A) 3-Chloro-4-iodo-aniline (10 mL) containing (3-chloro-4-iodo-phenyl) -carbamic acid tert-butyl ester diiso-propylethylamine (6.9 mL)
g) solution (in 40 mL of tetrahydrofuran) in di-tert-butyl dicarbonate (8.6
g) is added and the mixture is heated to reflux. After about 15 hours, diisopropylethylamine
(6.9 mL) and a further fraction of di-tert-butyl-dicarbonate (21 g) are added and heating is continued for about 24 hours. The solution is then cooled, concentrated under reduced pressure, diluted with ethyl acetate and washed three times with 5% aqueous hydrochloric acid and subsequently with aqueous saturated sodium chloride. Dry the solution over anhydrous sodium sulfate and then concentrate under reduced pressure to give the desired crude product as a brown oil. Crystallization is induced by the addition of hexane and the recovered solid material is recrystallized from hexane to give the desired product as a white solid.

Using the above procedures and the appropriate starting materials, the following compounds were prepared.

N '-(4-nitro-benzoyl) -hydrazinecarboxylic acid tert-butyl ester (3-chloro-4-iodo-phenyl) -carbamic acid tert-butyl ester (4-bromo-3-chloro-phenyl) -Carbamic acid tert-butyl ester (3-chloro-4-vinyl-phenyl) -carbamic acid tert-butyl ester (3-chloro-4-methylsulfanyl-phenyl) -carbamic acid tert-butyl ester (4-amino-3 -Chloro-phenyl) -carbamic acid tert-butyl ester (4-chloro-2-nitro-phenyl) -carbamic acid tert-butyl ester (3-tert-butoxycarbonylamino-5-chloro-phenyl) -carbamic acid tert-
Butyl ester (4-nitro-benzyl) -carbamic acid tert-butyl ester (3-bromo-5-trifluoromethyl-phenyl) -carbamic acid tert-butyl ester (2-amino-3-chloro-5-trifluoromethyl -Phenyl) -carbamic acid tert-butyl ester Example 9 (Method 2B) (3-chloro-4-vinyl-phenyl) -carbamic acid 2-trimethylsilanyl-ethyl ester 3-chloro containing diisopropylethylamine (5.8 mL) To a solution of 4-vinyl-phenylamine (3.4 g) (in 44 mL of N, N-dimethylformamide) was added 1- [2- (trimethylsilyl) -ethoxycarbonyl-oxy] benzotriazole (7.1 g) and the mixture was concentrated. Three
Stir at room temperature under argon atmosphere for days. The solution is then diluted with water and extracted three times with diethyl ether. The combined organic extracts are washed successively with water, aqueous saturated sodium chloride, dried over anhydrous magnesium sulfate and concentrated under reduced pressure. The residue obtained is chromatographed on silica gel using 10% ethyl acetate in hexane as eluent to give the desired product as a yellow oil.

Example 10 (Method 2C) [4- (2-Fluoro-benzoylamino) -phenyl] -carbamic acid tert-butyl ester mono-N- (t-butoxycarbonyl) -1,4-phenylenediamine (1.58 g) and triethylamine (1.50 mL) in 25 mL of dichloromethane are added o-fluorobenzoyl chloride (1.20 g). A solid forms immediately, which is filtered and washed with fresh solvent to give 1.90 g of a white solid.

Using the above procedure and the appropriate starting materials, the following compounds were prepared.

N- (3-methoxy-4-nitro-phenyl) -acetamide N- (4-amino-phenyl) -isobutylamide 2,2,2-trifluoro-N- (2-methoxy-4-nitro- Phenyl) -acetamide [4- (2-methyl-benzoylamino) -phenyl] -carbamic acid tert-butyl ester acetic acid 2- (4-tert-butoxycarbonylamino-phenylcarbamoyl) -phenyl ester [4- (4-fluoro -Benzoylamino) -phenyl] -carbamic acid tert-butyl ester [4- (3-fluoro-benzoylamino) -phenyl] -carbamic acid tert-butyl ester [4- (2-fluoro-benzoylamino) -phenyl]- Carbamic acid tert-butyl ester [4- (2-methoxy-benzoylamino) -phenyl] -carbamic acid tert-butyl ester [4- (3-methoxy-benzoylamino) -phenyl] -carbamic acid tert-butyl ester [4 -(4-methoxy-benzoylua No) -Phenyl] -carbamic acid tert-butyl ester [4- (2,2-dimethyl-propionylamino) -phenyl] -carbamic acid tert-butyl ester [4- (2-bromo-acetylamino) -phenyl]- Carbamic acid tert-butyl ester [4- (2,2,2-trifluoro-acetylamino) -phenyl] -carbamic acid tert-butyl ester (4-benzoylamino-phenyl) -carbamic acid tert-butyl ester (4- Methanesulfonylamino-phenyl) -carbamic acid tert-butyl ester (4-phenylacetylamino-phenyl) -carbamic acid tert-butyl ester {4-[(thiophen-2-carbonyl) -amino] -phenyl} -carbamic acid tert -Butyl ester [4- (3-nitro-benzoylamino) -phenyl] -carbamic acid tert-butyl ester [4- (3-acetylamino-benzoylamino) -phenyl] -carbamic acid tert-butyl ester [4- (3-Methanesulfonylamino-benzoylamino) -phenyl] -carbamic acid
tert-butyl ester ethyl [3-[[[4-[[(1,1-dimethylethoxy) carbonyl] amino] phenyl] amino] carbonyl] -phenyl] -carbamate [4- (2-trifluoromethyl-benzoylamino ) -Phenyl] -carbamic acid ter
t-butyl ester [4- (2,6-difluoro-benzoylamino) -phenyl] -carbamic acid tert-butyl ester [4- (2-chloro-benzoylamino) -phenyl] -carbamic acid tert-butyl ester [4 -(2-Bromo-benzoylamino) -phenyl] -carbamic acid tert-butyl ester [4- (2-nitro-benzoylamino) -phenyl] -carbamic acid tert-butyl ester {4-[(benzo [b] thiophene -2-carbonyl) -amino] -phenyl} -carbamic acid
tert-butyl ester {4-[(pyridine-4-carbonyl) -amino] -phenyl} -carbamic acid tert-butyl ester {4-[(naphthalene-2-carbonyl) -amino] -phenyl} -carbamic acid tert- Butyl ester {4-[(naphthalene-1-carbonyl) -amino] -phenyl} -carbamic acid tert-butyl ester {4-[(3-bromo-thiophen-2-carbonyl) -amino] -phenyl} -carbamic acid
tert-butyl ester {4-[(biphenyl-2-carbonyl) -amino] -phenyl} -carbamic acid tert-butyl ester N- (4-tert-butoxycarbonylamino-phenyl) -phthalamic acid [4- (2, 3-difluoro-benzoylamino) -phenyl] -carbamic acid tert-butyl ester [4- (2,5-difluoro-benzoylamino) -phenyl] -carbamic acid tert-butyl ester [4- (2,4-difluoro- Benzoylamino) -phenyl] -carbamic acid tert-butyl ester [4- (2-acetylamino-benzoylamino) -phenyl] -carbamic acid tert-butyl ester [4- (2-methanesulfonylamino-benzoylamino) -phenyl ] -Carbamic acid
tert-butyl ester [4- (2,3,4-trifluoro-benzoylamino) -phenyl] -carbamic acid tert-
Butyl ester [4- (2,3,4,5,6-pentafluoro-benzoylamino) -phenyl] -carbamic acid
tert-butyl ester N- (4-tert-butoxycarbonylamino-phenyl) -isophthalamic acid methyl ester 2-methylsulfanyl-N- [4- (2,2,2-trifluoro-acetylamino) -phenyl
] -Benzamide [4- (3-benzyloxy-benzoylamino) -phenyl] -carbamic acid tert-butyl ester [4- (3-butoxy-benzoylamino) -phenyl] -carbamic acid tert-butyl ester {4- [ (5-Difluoromethyl-furan-2-carbonyl) -amino] -phenyl} -carbamic acid tert-butyl ester {4-[(thiophen-3-carbonyl) -amino] -phenyl} -carbamic acid tert-butyl ester { 4-[(5-methyl-furan-2-carbonyl) -amino] -phenyl} -carbamic acid ter
t-butyl ester {4-[(5-bromo-furan-2-carbonyl) -amino] -phenyl} -carbamic acid tert
-Butyl ester (4-hexanoylamino-phenyl] -carbamic acid tert-butyl ester [4- (2-thiophen-2-yl-acetylamino) -phenyl] -carbamic acid tert-butyl ester {4-[(pyridine -3-carbonyl) -Amino] -phenyl} -carbamic acid tert-butyl ester {4-[(4-bromo-furan-2-carbonyl) -amino] -phenyl} -carbamic acid tert
-Butyl ester {4-[(furan-3-carbonyl) -amino] -phenyl} -carbamic acid tert-butyl ester (4-phenoxycarbonylamino-phenyl] -carbamic acid tert-butyl ester {4-[(benzo [ 1,3] dioxol-4-carbonyl) -amino] -phenyl} -carbamic acid tert-butyl ester [4- (3-trifluoromethoxy-benzoylamino) -phenyl] -carbamic acid te
rt-butyl ester N- (2,5-dimethoxy-4-nitro-phenyl) -2-fluoro-benzamide {4-[(furan-2-carbonyl) -amino] -phenyl} -carbamic acid tert-butyl ester [ 4- (2-phenoxy-acetylamino) -phenyl] -carbamic acid tert-butyl ester {4-[(5-nitro-furan-2-carbonyl) -amino] -phenyl} -carbamic acid tert
-Butyl ester {4-[(5-chloro-furan-2-carbonyl) -amino] -phenyl} -carbamic acid tert
-Butyl ester {4-[(3-methyl-furan-2-carbonyl) -amino] -phenyl} -carbamic acid tert
-Butyl ester {4-[(2-methoxy-acetylamino] -phenyl} -carbamic acid tert-butyl ester {4-[(4-furan-3-yl- [1,2,3] thiadiazole-5-carbonyl ) -Amino] -phenyl} -carbamic acid tert-butyl ester {4-[(5-tert-butyl-furan-2-carbonyl) -amino] -phenyl} -carbamic acid
tert-butyl ester N- [3-cyano-4- (2,2,2-trifluoro-acetylamino])-phenyl] -2-fluoro-benzamide furan-2-carboxylic acid [3-cyano-4- ( 2,2,2-trifluoro-acetylamino])-
Phenyl] amide N- [4-acetylamino-2-cyano-phenyl] -2,2,2-trifluoro-acetamide 2,2,2-trifluoro-N- (4-nitro-2-trifluoromethyl- Phenyl) -acetamide N- [4-acetylamino-2-trifluoromethyl-phenyl] -2,2,2-trifluoro-
Acetamide 2-fluoro-N- [4- (2,2,2-trifluoro-acetylamino])-3-trifluoromethyl-phenyl] benzamide furan-2-carboxylic acid [4- (2,2,2- Trifluoro-acetylamino) -3-trifluoromethyl-phenyl] amide 2-fluoro-N- (2-methyl-benzoxazol-6-yl) -benzamide 4- (2-fluoro-benzoylamino) -2-hydroxy -Benzoic acid phenyl ester {4-[(isoxazole-5-carbonyl) -amino] -phenyl} -carbamic acid tert-
Butyl ester N- (4-acetylamino-2-methoxy-phenyl) -2,2,2-trifluoro-acetamide 2-fluoro-N- [3-methoxy-4- (2,2,2-trifluoro- Acetylamino])-phenyl] benzamide 2-fluoro-N- (2-fluoro-benzoyl) -N- (4-nitro-2-trifluoromethyl-
Phenyl) benzamide {4-[(1H-pyrazole-4-carbonyl) -amino] -phenyl} -carbamic acid tert-
Butyl ester {4-[(1H-imidazole-4-carbonyl) -amino] -phenyl} -carbamic acid tert
-Butyl ester {4-[(5-methyl- [1,2,3] thiadiazole-4-carbonyl) -amino] -phenyl} -carbamic acid tert-butyl ester {4-[(5-furan-3-yl -[1,2,3] thiadiazole-4-carbonyl) -amino] -phenyl} -carbamic acid tert-butyl ester 2,2,2-trifluoro-N- (5-nitro-pyridin-2-yl) acetamide {4-[(1-methyl-1H-pyrazole-4-carbonyl) -amino] -phenyl} -carbamic acid tert-butyl ester 4- (2-fluoro-benzoylamino) -2-hydroxy-benzoic acid methyl ester N -(5-chloro-2,4-dimethoxy-phenyl) -oxamic acid isoxazole-5-carboxylic acid (4-amino-phenyl) -amide 2-fluoro-N- (4-nitro-benzyl) -benzamide furan-2 -Carboxylic acid 4-nitro-benzylamide N- (3-chloro-5- (2,2,2-trifluoro-acetylamino) -phenyl] -2,2,2-trifluoro-acetamide De N- (3-Amino-5-chloro-phenyl) -2,2,2-trifluoro-acetamide [4- (2-fluoro-benzoylamino) -benzyl} -carbamic acid tert-butyl ester [4- ( 2,6-difluoro-benzoylamino) -benzyl} -carbamic acid tert-butyl ester 2,6-difluoro-N- (4-nitro-benzyl) -benzamide {4-[(furan-2-carbonyl) -amino] -Benzyl} -carbamic acid tert-butyl ester N- (3-amino-5-chloro-phenyl) -acetamide [4- (3-chloro-benzoylamino) -phenyl} -carbamic acid tert-butyl ester [4- ( 4-chloro-benzoylamino) -phenyl} -carbamic acid tert-butyl ester [4- (4-dimethylamino-benzoylamino) -phenyl} -carbamic acid tert-butyl ester (4-benzenesulfonylamino-phenyl) -carbamine Acid tert-butyl ester [4- (3-trifluoromethyl-benzo Arylamino) - phenyl} - ter carbamic acid
t-Butyl ester 2,2,2-trifluoro-N- (5-nitro-pyrimidin-2-yl) -acetamide Example 11 (method 2D) 2-chloro-N- (2-chloro-4-nitrophenyl) ) Acetamide solution of 2-chloro-4-nitroaniline (19.0 g) and chloroacetyl chloride (30 mL) (15
(In 0 mL of tetrahydrofuran) under reflux for 1 hour. Cool the solution and concentrate under reduced pressure to give a wet yellow solid. Addition of ether (250 mL) yields a yellow solid.

Using the above procedures and the appropriate starting materials, the following compounds were prepared.

N- (4-nitro-3-trifluoromethyl-phenyl) -acetamide (2-chloro-4-nitro-phenyl) -carbamic acid ethyl ester 2-acetylamino-5-nitro-benzoic acid furan-2 -Carboxylic acid (5-chloro-2-hydroxy-4-nitro-phenyl) -amide furan-2-carboxylic acid (2-methyl-4-nitro-phenyl) -amide furan-2-carboxylic acid (2-methoxy- 4-nitro-phenyl) -amide N- (2-chloro-4-nitro-phenyl) -benzamide 2-methoxy-N- (4-nitro-phenyl) -acetamide N- (4-nitro-phenyl) -acrylamide N -(4-Nitro-phenyl) -isobutylamide [4- (acryloylamino) -phenyl] carbamic acid tert-butyl ester (4-nitro-phenyl) -carbamic acid isobutyl ester [1,2,3] thiadiazole-4- Carboxylic acid (5-nitro-pyridin-2-yl) -amide furan-2-carboxylic acid (5-nitro- Lysin-2-yl) -amide 2-fluoro-N- (5-nitro-pyridin-2-yl) -benzamide N- (2-chloro-4-nitro-phenyl) -2-fluoro-benzamide furan-carboxylic acid (2,5-dimethoxy-4-nitro-phenyl) -amide N- (2-cyano-4-nitro-phenyl) -2-fluoro-benzamide 2-fluoro-N- (2-methoxy-4-nitro-phenyl ) -Benzamide 2-methyl-N- (5-nitro-pyridin-2-yl) -benzamide furan-2-carboxylic acid (2-methoxy-5-methyl-4-nitro-phenyl) -amide 2-fluoro-N -(2-methoxy-5-methyl-4-nitro-phenyl) -benzamide N- (2-benzoyl-4-nitro-phenyl) -acetamido N- (2-benzoyl-4-nitro-phenyl) -2-fluoro -Benzamide furan-2-carboxylic acid (2-benzoyl-4-nitro-phenyl) -amide N- (3-methyl-4-nitro-phenyl) -acetamide 2-fluoro-N- (3-methyl-4-nitro -H (Enyl) -benzamide furan-2-carboxylic acid (3-methyl-4-nitro-phenyl) -amide 2-acetylamino-5-nitro-N-phenyl-benzamide 2-[(2-fluorobenzoyl) amino] -5 -Nitro-N-phenylbenzamide furan-2-carboxylic acid (4-nitro-2-phenylcarbamoyl-phenyl) -amide 2-fluoro-N- (4-nitro-naphthalen-1-yl) -benzamide furan-2- Carboxylic acid (4-nitro-naphthalen-1-yl) -amide N- (5-chloro-2-hydroxy-4-nitro-phenyl) -acetamide N- (5-chloro-2-hydroxy-4-nitro-phenyl ) -2-Fluoro-benzamide furan-2-carboxylic acid (2-chloro-4-nitro-phenyl) -amide N- (4-nitro-2-trifluoromethyl-phenyl) -acetamidofuran-2-carboxylic acid ( 2-cyano-4-nitro-phenyl) -amide 2-fluoro-N- (4-nitro-2-trifluoromethyl-phenyl) -ben Zuamide furan-2-carboxylic acid (4-nitro-2-trifluoromethyl-phenyl) -amide 2-fluoro-N- (2-methyl-4-nitro-phenyl) -benzamide N- (5-chloro-2- Methyl-4-nitro-phenyl) -2-fluoro-benzamide furan-2-carboxylic acid (5-chloro-2-methyl-4-nitro-phenyl) -amide 2- (2-fluoro-benzoylamino) -5- Nitro-benzoic acid 2-[(furan-2-carbonyl) -amino] -5-nitro-benzoic acid N- (3-chloro-4-nitro-phenyl) -2-fluoro-benzamide furan-2-carboxylic acid ( 3-chloro-4-nitro-phenyl) -amide 2,6-difluoro-N- (3-methyl-4-nitro-phenyl) -benzamide 2-fluoro-N- (4-nitro-3-trifluoromethyl- (Phenyl) -benzamide furan-2-carboxylic acid (4-nitro-3-trifluoromethyl-phenyl) -amide 2-chloro-N- (2-chloro-4-nitro-phenyl) -acetamide N- (2-chloro (R-4-nitrophenyl) methanesulfonamide furan-2-carboxylic acid [3-methoxy-4- (2,2,2-trifluoro-acetylamino)-
Phenyl] -amide N- (2-chloro-4-nitro-phenyl) -2,2,2-trifluoro-acetamide Example 12 {4-[(4-phenyl- [1,2,3] thiadiazole-5 -Carbonyl) -amino] -phenyl} -tert-butyl carbamate 1- (N-tert-butoxycarbonyl) -1,4-phenylenediamine (0.8 g) and 4-phenyl- [1,2,3] thiadiazole- A solution of 5-carboxylic acid (0.7 g) in 10 mL of dichloromethane is treated with triethylamine (1.3 mL) and benzotriazol-1-yloxy-tris (dimethylamino) -phosphonium hexa-fluorophosphate (1.6 g). After stirring at room temperature, the reaction is diluted with water and extracted with dichloromethane. Organic layer
Wash with 0.5N hydrochloric acid, saturated sodium bicarbonate, and water, then dry over magnesium sulfate, filter, and concentrate under reduced pressure to give the desired product.

Using the above procedure and the appropriate starting materials, the following compounds were prepared.

{4-[(1H-pyrrole-2-carbonyl) -amino] -phenyl} -carbamic acid tert-butyl ester {4-[(pyrazine-2-carbonyl) -amino] -phenyl} -carbamic acid tert -Butyl ester {4-[(5-methyl-thiophen-2-carbonyl) -amino] -phenyl} -carbamic acid
tert-butyl ester {4-[(1-methyl-1H-pyrrole-2-carbonyl) -amino] -phenyl} -carbamic acid
tert-butyl ester {4-[(quinoline-8-carbonyl) -amino] -phenyl} -carbamic acid tert-butyl ester {4-[(benzofuran-2-carbonyl) -amino] -phenyl} -carbamic acid tert- Butyl ester {4-[(isoquinoline-1-carbonyl) -amino] -phenyl} -carbamic acid tert-butyl ester {4-[(quinoline-2-carbonyl) -amino] -phenyl} -carbamic acid tert-butyl ester {4-[(pyridine-2-carbonyl) -amino] -phenyl} -carbamic acid tert-butyl ester {4-[(isoquinoline-4-carbonyl) -amino] -phenyl} -carbamic acid tert-butyl ester {4 -[([1,2,3] thiadiazole-4-carbonyl) -amino] -phenyl} -carbamic acid tert-butyl ester {4-[(1H- [1,2,3] triazole-4-carbonyl)- Amino] -phenyl} -carbamic acid tert-butyl ester [4- (2-methylsulfanyl-benzoylamino) -Phenyl] -carbamic acid tert
-Butyl ester {4-[(quinoline-4-carbonyl) -amino] -phenyl} -carbamic acid tert-butyl ester {4-[(4-methyl- [1,2,3] thiadiazole-5-carbonyl)- Amino] -phenyl} -carbamic acid tert-butyl ester {4-[(4-phenyl- [1,2,3] thiadiazole-5-carbonyl) -amino] -phenyl}-
Carbamic acid tert-butyl ester {4-[(1H-indole-2-carbonyl) -amino] -phenyl} -carbamic acid tert-
Butyl ester [1,2,3] thiadiazole-4-carboxylic acid 4-nitro-benzylamide {4-[([1,2,3] thiadiazole-4-carbonyl) -amino] -benzyl} -carbamic acid tert- Butyl ester acetic acid 4- (4-tert-butoxycarbonylamino-phenylcarbamoyl) -phenyl ester {4-[(quinoline-6-carbonyl) -amino] -phenyl} -carbamic acid tert-butyl ester Example 13 (Method 2F) ) Acetic acid 2- (4-tert-butoxycarbonylamino-2,6-dichloro-phenoxy) -ethyl ester [3,5-dichloro-4- (2-hydroxy-ethoxy) -phenyl] -carbamic acid tert-butyl ester A solution of (0.85 g) in pyridine (14 mL) is treated with acetic anhydride (1.24 mL) and the mixture is stirred for 15 hours at room temperature. The solvent is removed under reduced pressure and the residue is dissolved in ethyl acetate. The solution is then washed twice with aqueous 5% hydrochloric acid, once with aqueous saturated sodium bicarbonate and then with aqueous saturated sodium chloride. The solution is dried over anhydrous magnesium sulfate and the solvent is removed under reduced pressure to give the desired product as a colorless oil. Using the above procedure and the appropriate starting materials, the following compounds were prepared.

Phenylsulfanyl-acetonitrile acetic acid 2- (4-tert-butoxycarbonylamino-2,6-dichloro-phenoxy) -ethyl ester Example 14 (method 2G) (3,5-dichloro-4-hydroxy-phenyl) -Carbamic acid tert-butyl ester To a solution of 2,6-dichloro-4-aminophenol (9.5 g) (in 130 mL of tetrahydrofuran) was added di-tert-butyl-dicarbonate (11.7 g), and the mixture was added to about 15 ml. Heat to reflux for hours. The solution is then cooled, concentrated under reduced pressure, diluted with ethyl acetate and washed successively three times with aqueous 5% hydrochloric acid and then once with aqueous saturated sodium chloride. Dry the solution over anhydrous sodium sulfate and then concentrate under reduced pressure to give the desired crude product. This material is then triturated with cold dichloromethane to give the product as a white solid.

Using the above procedures and the appropriate starting materials, the following compounds were prepared.

(3-Amino-5-chloro-phenyl) -carbamic acid tert-butyl ester Example 15 (Method 3A) 3,5-Dichloro-4-ethoxy-phenylamine trifluoroacetic acid (5 mL) was added to the solid ( 3,5-Dichloro-4-ethoxy-phenyl) -carbamic acid tert-butyl ester (0.97 g) is added and the mixture is stirred for about 45 minutes at room temperature. Water is then added and the mixture is cooled in an ice bath and made basic with solid potassium carbonate. The solution is extracted three times with ethyl acetate, the combined organic phases are washed with aqueous saturated sodium chloride and then dried over anhydrous sodium sulfate. Concentrate under reduced pressure and recrystallize from hexane to give the desired product as a pale yellow crystalline solid.

Using the above procedures and the appropriate starting materials, the following compounds were prepared.

5-bromo-pyridin-3-ylamine 3-chloro-4-methanesulfonyl-phenylamine N- (4-amino-phenyl) -2-methyl-benzamide acetic acid 2- (4-amino-phenylcarbamoyl)- Phenyl ester N- (4-amino-phenyl) -4-fluoro-benzamide N- (4-amino-phenyl) -3-fluoro-benzamide N- (4-amino-phenyl) -2-fluoro-benzamide N- ( 4-amino-phenyl) -2-methoxy-benzamide N- (4-amino-phenyl) -3-methoxy-benzamide N- (4-amino-phenyl) -4-methoxy-benzamide N- (4-amino-phenyl ) -2-Phenyl-acetamide N- (4-amino-phenyl) -2,2-dimethyl-propionamide N- (4-amino-phenyl) -2,2,2-trifluoro-acetamide thiophen-2-carboxylic Acid (4-amino-phenyl) -amide 1H-pyrrole-2-carboxylic acid (4-amino-phenyl) -amide N- (4-amino No-phenyl) -3-nitro-benzamide 3-acetylamino-N- (4-amino-phenyl) -benzamide N- (4-amino-phenyl) -3-dimethylamino-benzamide N- (4-amino-phenyl ) -3-Methanesulfonylamino-benzamide N- (4-amino-phenyl) -2-trifluoromethyl-benzamide N- (4-amino-phenyl) -2,6-difluoro-benzamide N- (4-amino- Phenyl) -2-chloro-benzamide N- (4-amino-phenyl) -2-bromo-benzamide N- (4-amino-phenyl) -2-nitro-benzamide pyrazine-2-carboxylic acid (4-amino-phenyl ) -Amide 5-methyl-thiophen-2-carboxylic acid (4-amino-phenyl) -amide quinoline-8-carboxylic acid (4-amino-phenyl) -amide 1-methyl-1H-pyrrole-2-carboxylic acid ( 4-amino-phenyl) -amide benzo [b] thiophen-2-carboxylic acid (4-amino-phenyl) -amide benzof Lan-2-carboxylic acid (4-amino-phenyl) -amide N- (4-amino-phenyl) -isonicotinamide naphthalene-2-carboxylic acid (4-amino-phenyl) -amide naphthalene-1-carboxylic acid ( 4-amino-phenyl) -amide isoquinoline-1-carboxylic acid (4-amino-phenyl) -amide quinoline-2-carboxylic acid (4-amino-phenyl) -amide 3,5-dichloro-4-ethoxy-phenylamine 4-butoxy-3,5-dichloro-phenylamine isoquinoline-4-carboxylic acid (4-amino-phenyl) -amide [1,2,3] thiadiazole-4-carboxylic acid (4-amino-phenyl) -amide 1H -[1,2,3] triazole-4-carboxylic acid (4-amino-phenyl) -amide 3-bromo-thiophen-2-carboxylic acid (4-amino-phenyl) -amide 4-benzyloxy-3,5 -Dichloro-phenylamine 2- (4-amino-2,6-dichloro-phenoxy) -acetamide (4-amino-2,6-dichloro-phenyl Nonoxy) -acetic acid methyl ester [3- (4-amino-phenylcarbamoyl) -phenyl] -carbamic acid ethyl ester 2-amino-N- (4-amino-phenyl) -benzamide biphenyl-2-carboxylic acid (4-amino -Phenyl) -amide N- (4-amino-phenyl) -2,3-difluoro-benzamide N- (4-amino-phenyl) -2,5-difluoro-benzamide N- (4-amino-phenyl) -2 , 4-Difluoro-benzamide 2-acetylamino-N- (4-amino-phenyl) -benzamide N- (4-amino-phenyl) -2-methanesulfonylamino-benzamide N- (4-amino-phenyl) -2 , 3,4-trifluoro-benzamide N- (4-amino-phenyl) -2,3,4,5,6-pentafluoro-benzamide N- (4-amino-phenyl) -2-methylsulfanyl-benzamide acetic acid 2- (4-amino-2,6-dichloro-phenoxy) -ethyl ester N- (4-amino-phenyl) -isophthalamic acid Methyl ester N- (4-amino-phenyl) -3-benzyloxy-benzamide N- (4-amino-phenyl) -3-butoxy-benzamide [3- (4-amino-phenylcarbamoyl) -phenoxy] -ethyl acetate Ester Pyridine-2-carboxylic acid (4-amino-phenyl) -amide Quinoline-4-carboxylic acid (4-amino-phenyl) -amide 5-Methyl-furan-2-carboxylic acid (4-amino-phenyl) -amide 5-difluoromethyl-furan-2-carboxylic acid (4-amino-phenyl) -amide 1H-indole-2-carboxylic acid (4-amino-phenyl) -amide 4-methyl- [1,2,3] thiadiazole- 5-carboxylic acid (4-amino-phenyl) -amide thiophen-3-carboxylic acid (4-amino-phenyl) -amide 5-chloro-furan-2-carboxylic acid (4-amino-phenyl) -amide 5-nitro -Furan-2-carboxylic acid (4-amino-phenyl) -amide N- (4-amino-phenyl) -2-thiophene-2 -Yl-acetamide 3-methyl-furan-2-carboxylic acid (4-amino-phenyl) -amide 5-bromo-furan-2-carboxylic acid (4-amino-phenyl) -amide 4-bromo-furan-2- Carboxylic acid (4-amino-phenyl) -amide N- (4-amino-phenyl) -nicotinamide N- (4-aminophenyl) -3-furan-carboxamide 4-phenyl- [1,2,3] thiadiazole- 5-carboxylic acid (4-amino-phenyl) -amide acetic acid 3- (4-amino-phenylcarbamoyl) -phenyl ester benzo [1,3] dioxole-4-carboxylic acid (4-amino-phenyl) -amide N- (4-amino-phenyl) -3- (2-dimethylamino-ethoxy) -benzamide N- (4-amino-phenyl) -3-trifluoromethoxy-benzamide N- (4-amino-phenyl) -3- ( 2-morpholin-4-yl-ethoxy) -benzamide (4-amino-phenyl) -carbamic acid hexyl furan-2-carboxylic acid (4 -Amino-phenyl) -amide (4-amino-phenyl) -carbamic acid phenyl ester hexanoic acid (4-amino-phenyl) -amide N- (4-amino-phenyl) -acrylamide N- (4-amino-phenyl) 2-Methoxy-acetamide 4-furan-3-yl- [1,2,3] thiadiazole-5-carboxylic acid (4-amino-phenyl)
-Amide 5-tert-butyl-furan-2-carboxylic acid (4-amino-phenyl) -amide 3-chloro-4-methanesulfinyl-phenylamine 5-methyl- [1,2,3] thiadiazole-4-carboxylic acid Acid (4-amino-phenyl) -amide 2- (4-amino-2-chloro-phenyl) -ethanol (4-amino-2-chloro-phenyl) -carbamic acid 2-piperidin-1-yl-ethyl ester 5 -Chloro-N, N-dimethyl-benzene-1,3-diamine 3- (2-methyl-butyl) -5-trifluoromethyl-phenylamine 3-isobutyl-5-trifluoromethyl-phenylamine furan-2- Carboxylic acid (4-aminomethyl-phenyl) -amide N- (4-aminomethyl-phenyl) -2-fluoro-benzamide [1,2,3] thiadiazole-4-carboxylic acid (4-aminomethyl-phenyl)- Amide N- (4-aminomethyl-phenyl) -2,6-difluoro-benzamide oxazole-4-carboxylic acid (4-amino-phenyl ) -Amide N- (4-amino-phenyl) -3-chloro-benzamide N- (4-amino-phenyl) -4-chloro-benzamide acetic acid 4- (4-amino-phenylcarbamoyl) -phenyl ester N- ( 4-amino-phenyl) -4-dimethylamino-benzamide 1- (4-amino-phenyl) -3- (3,5-bis-trifluoromethyl-phenyl) -thiourea N- (4-amino-phenyl)- 2-Iodo-benzamide N- (4-amino-phenyl) -3-trifluoromethyl-benzamide Example 16 (Method 3B) 1- (4-amino-2-chloro-phenyl) -ethanol of tetrabutylammonium fluoride A 1M solution (in 5.7 mL of tetrahydrofuran) was added to [3-chloro-4- (1-hydroxy-ethyl) -phenyl] -carbamic acid 2-trimethylsilanyl-ethyl ester (0.5 g) and the mixture was allowed to stand for about 3.5 hours. Stir at room temperature. The solution is then concentrated under reduced pressure, dissolved in a 1: 1 mixture of ethyl acetate and hexane, washed successively with water, then with saturated aqueous sodium chloride and dried over anhydrous magnesium sulfate. Removal of the solvent under reduced pressure followed by chromatography on silica gel (using 40% ethyl acetate in hexane as eluent) gives the product as an amber oil.

Example 17 (Method 3C) N- (4-Amino-3-cyanophenyl) -2-fluoro-benzamide N- [3-cyano-4- (2,2,2-trifluoroacetyl-amino) -Phenyl] -2-fluoro
-Potassium carbonate (5.0 g) is added to a solution of benzamide (2.5 g) (270 mL of methanol and 16 mL of water) and the mixture is refluxed overnight. After removing the solvent under reduced pressure, the residue is suspended in water and extracted with dichloromethane. The organic extracts are pooled, washed with water, then with saturated aqueous sodium chloride, dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure to give the desired compound as a white solid.

Using the above procedures and the appropriate starting materials, the following compounds were prepared.

N- (4-amino-phenyl) -2-methanesulfinyl-benzamide N- (4-amino-3-cyano-phenyl) -2-fluoro-benzamide furan-2-carboxylic acid (4-amino-3 -Cyano-phenyl) -amide N- (4-amino-3-cyano-phenyl) -acetamido furan-2-carboxylic acid (4-amino-3-trifluoromethyl-phenyl) -amide N- (4-amino- 3-methoxy-phenyl) -acetamide N- (4-amino-3-methoxy-phenyl) -2-fluoro-benzamide furan-2-carboxylic acid (4-amino-3-methoxy-phenyl) -amide Example 17 ( Method 4A) 2-Chloro-1-cyclohexyloxy-4-nitro-benzene Cyclohexanol (2.9 g) in 20 mL of dimethyl sulfoxide was washed three times with potassium hydride (0.90 g, hexane) under an argon atmosphere. Solution), and slowly stir the solution at room temperature for about 1 hour. To. 3-chloro-4-fluoro-
A solution of nitrobenzene (1 g) (in 10 mL of dimethyl sulfoxide) was added, then
The resulting dark red solution is heated to about 100 degrees for 3 hours. The reaction mixture is then cooled, diluted with diethyl ether (300 mL) and washed successively with aqueous saturated ammonium chloride, water three times and then with aqueous saturated sodium chloride. The organic layer is then dried over anhydrous magnesium sulfate, the solvent is removed under reduced pressure and the resulting oil is chromatographed on silica gel (using 5% ethyl acetate in hexane as eluent) to give the desired oil. The product is obtained as an orange solid.

Example 18 (Method 4C) (2-chloro-4-nitro-phenyl) -methyl- (1-methyl-pyrrolidin-3-yl) -amine 3-chloro-4-fluoronitrobenzene (1.0 g) and Combine N, N'-dimethyl-3-aminopyrrolidine (1.72 g) and stir for about 24 hours. The mixture is then diluted with ethyl acetate, washed twice with water and once with saturated sodium chloride and dried over anhydrous sodium sulfate. After removal of the solvent under reduced pressure, the residue is chromatographed on silica gel (using pure ethyl acetate and then pure methanol as eluent)
To give the desired product as a yellow oil.

Using the above procedures and the appropriate starting materials, the following compounds were prepared.

(2-chloro-4-nitro-phenyl) -dipropyl-amine 1- (2-chloro-4-nitro-phenyl) -piperidine 1- (2-chloro-4-nitro-phenyl) -pyrrolidine (2 -Chloro-4-nitro-phenyl) -cyclohexyl-methyl-amine benzyl- (2-chloro-4-nitro-phenyl) -amine (2-chloro-4-nitro-phenyl) -methyl- (1-methyl-piperidine -4-yl) -amine (2-chloro-4-nitro-phenyl) -cyclohexyl-ethyl-amine (2-chloro-4-nitro-phenyl) -cyclohexyl-amine (2-chloro-4-nitro-phenyl) -Methyl- (1-methyl-pyrrolidin-3-yl) -amine (1-benzyl-pyrrolidin-3-yl)-(2-chloro-4-nitro-phenyl) -methyl-amine (2-chloro-4- Nitro-phenyl) -cyclopentyl-methyl-amine 1- (2-chloro-4-nitro-phenyl) -decahydro-quinoline allyl- (2-chloro-4-nitro-phenyl) -cyclo Xyl-amine 2-[(2-chloro-4-nitro-phenyl)-(2-hydroxy-ethyl) -amino] -ethanol (2-chloro-4-nitro-phenyl) -isobutyl-methyl-amine (2- Chloro-4-nitro-phenyl) -hexyl-methyl-amine 2-[(2-chloro-4-nitro-phenyl) -methyl-amino] -ethanol N- (2-chloro-4-nitro-phenyl) -N , N ', N'-Trimethyl-ethane-1,2-diamine N- (2-chloro-4-nitro-phenyl) -N, N', N'-trimethyl-propane-1,3-diamine (1- Benzyl-piperidin-4-yl)-(2-chloro-4-nitro-phenyl) -amine N- (2-chloro-4-nitro-phenyl) -N ', N'-dimethyl-ethane-1,2- Diamine N- (2-chloro-4-nitro-phenyl) -N ', N'-dimethyl-propane-1,3-diamine (2-chloro-4-nitro-phenyl)-(2-methoxy-ethyl)- Methyl-amine (1-benzyl-pyrrolidin-3-yl)-(2-chloro-4-nitro-phenyl) -amine 4-piperidine -1-yl-3-trifluoromethyl-benzonitrile 4-dimethylamino-3-trifluoromethyl-benzonitrile 4- (4-methyl-piperazin-1-yl) -3-trifluoromethyl-benzonitrile 19 (Method 4E) Butyl- (2-chloro-4-nitro-phenyl) -thioether A solution of 3-chloro-4-fluoro-nitrobenzene (5.0 g) and sodium sulfide (2.5 g) (30 mL of N, N-dimethyl (In formamide) for 1 hour at room temperature and then treated with 1-iodobutane (12.6 g). The solvent is then removed under reduced pressure and the residue obtained is treated with ethyl acetate and hexane to precipitate inorganic salts. The solids are removed by filtration and the filtrate is reduced under reduced pressure. The resulting residue is then passed through hydrous magnesium silicate using dichloromethane as eluent to give the desired compound as a yellow solid.

Using the above procedures and the appropriate starting materials, the following compounds were prepared.

1-butylsulfanyl-2-chloro-4-nitro-benzene 2-chloro-1-cyclohexylsulfanyl-4-nitro-benzene 2-chloro-1-ethylsulfanyl-4-nitro-benzene Example 20 (Method 4F) A solution of (4-chloro-5-methoxy-2-nitro-phenyl) -dimethyl-amine trifluoro-methanesulfonic acid 4-chloro-5-methoxy-2-nitro-phenyl ester (1.0 g) (2.0 mL) In tetrahydrofuran), dimethylamine (4.0 mL of a 40% aqueous solution) was added and the mixture was stirred for about 15 hours at room temperature. Then the solution is concentrated under reduced pressure, the residue is dissolved in ethyl acetate and then washed with water. The aqueous layer was extracted once with ethyl acetate, and the combined organic layers were washed with aqueous saturated sodium chloride,
Dry over anhydrous sodium sulfate. The solvent is removed by evaporation under reduced pressure and the residue is triturated with hexane to give the desired product as a colorless solid.

Using the above procedures and the appropriate starting materials, the following compounds were prepared.

(4-chloro-2-nitro-phenyl) -dimethyl-amine 4- (4-chloro-5-methoxy-2-nitro-phenyl) -morpholine (4-chloro-5-methoxy-2-nitro- (Phenyl) -dimethyl-amine 1- (4-chloro-5-methoxy-2-nitro-phenyl) -piperidine 1- (4-chloro-5-methoxy-2-nitro-phenyl) -pyrrolidine benzyl- (4-chloro -5-Methoxy-2-nitro-phenyl) -amine (2-chloro-6-nitro-phenyl) -dimethyl-amine Example 21 (Method 4G) (2-chloro-4-nitro-phenyl) -methyl-phenyl -Amine n-Butyllithium (12.3 mL of a 2.5 M solution in hexane) is added dropwise at 0 ° C. to a solution of N-methylaniline (3.0 g) in 75 mL of tetrahydrofuran. The mixture was allowed to warm slowly to room temperature, then recooled to 0 ° C and maintained at -78 ° C
A solution of -4-fluoronitrobenzene (4.9 g) in 35 mL of tetrahydrofuran is added by cannula. After the addition, the reaction mixture is allowed to warm to room temperature over 1 hour, then concentrated under reduced pressure, quenched by the addition of aqueous saturated ammonium chloride and extracted three times with ethyl acetate. The pooled organic layers are washed three times with aqueous 5% hydrochloric acid, once with water, once with aqueous saturated sodium bicarbonate, once with aqueous saturated sodium chloride and then dried over anhydrous magnesium sulfate. After removal of the solvent under reduced pressure, the residue is chromatographed on silica gel (using 5% diethyl ether in hexane as eluent) to give the desired product as a clear, colorless oil.

Example 22 (Method 4H) 2,6-Dichloro-4-nitrophenol 3,4,5-trichloronitrobenzene (14.86 g) was added to potassium phenoxide (8.66 g)
(In 66 mL of diethylene glycol) and the mixture is heated to 160 ° C. for about 15 hours. The resulting dark brown solution is cooled to room temperature, poured over 100 mL of cold water and extracted twice with diethyl ether. The pooled organic extracts are washed with water, aqueous 10% sodium hydroxide and then dried over anhydrous magnesium sulfate. After removal of the solvent under reduced pressure, the resulting oil is distilled in a Kugelrohr apparatus to give a yellow oil which solidifies on standing. Recrystallization from ethanol-water gives the desired product as a pale yellow solid.

Example 23 (Method 5A) (3,5-dichloro-4-ethoxy-phenyl) -carbamic acid tert-butyl ester (3,5-dichloro-4-hydroxy-phenyl) -carbamic acid tert-butyl ester (
1.0 g) and potassium carbonate (1.0 g) in 18 mL of acetone.
36 mL) and the mixture is stirred at room temperature for about 15 hours. The solution is then filtered, concentrated under reduced pressure, and partitioned between ethyl acetate and water. The separated aqueous layer is extracted twice more with ethyl acetate, and the pooled organic extracts are washed successively with aqueous 10% sodium hydroxide, water, and then dried over anhydrous sodium sulfate. Evaporation of the solvent under reduced pressure gives the desired product as a tan solid.

Using the above procedure and the appropriate starting materials, the following compounds were prepared.

(3,5-Dichloro-4-ethoxy-phenyl) -carbamic acid tert-butyl ester (4-butoxy-3,5-dichloro-phenyl) -carbamic acid tert-butyl ester (4-benzyloxy-3 , 5-Dichloro-phenyl) -carbamic acid tert-butyl ester (4-carbamoylmethoxy-3,5-dichloro-phenyl) -carbamic acid tert-butyl ester [3,5-dichloro-4- (2-nitrilo-ethoxy) ) -Phenyl] -carbamic acid tert-butyl ester (4-tert-butoxycarbonylamino-2,6-dichloro-phenoxy) -acetic acid methyl ester 3-butoxy-benzoic acid methyl ester 3-tert-butoxycarbonylmethoxy-benzoic acid Methyl ester 3-carbamoylmethoxy-benzoic acid methyl ester [4- (3-carbamoylmethoxy-benzoylamino) -phenyl] -carbamic acid te
rt-butyl ester {4- [3- (2-chloro-ethoxy) -benzoylamino] -phenyl} -carbamic acid ter
t-butyl ester Example 24 (method 5C) (2,6-dichloro-4-nitro-phenoxy) -acetic acid tert-butyl ester 2,6-dichloro-4-nitrophenol (2.5 g) and potassium carbonate (3.3 g) ) Solution (50 mL
Dimethyl-formamide), tert-butyl-bromoacetate (10 mL) was added,
Then the mixture is stirred at room temperature for 2 days. The solution is then poured into 500 mL of water, extracted three times with hexane, and the pooled organic extracts are washed with aqueous saturated ammonium chloride and dried over anhydrous magnesium sulfate. Following removal of the solvent under reduced pressure, the resulting oil is triturated with hexane to give the desired product as a white solid.

Using the above procedures and starting materials, the following compounds were prepared: 3-Dimethylamino-1- (4-nitro-phenyl) -propenone 2-chloro-1-isopropoxy-4-nitro-benzene 1,3-dichloro-2-methoxy-4-methyl-5-nitro-benzene 1-chloro-4-ethoxy-2-methoxy-5-nitro-benzene 1-butoxy-4-chloro-5-methoxy-2- Nitro-benzene 1-chloro-2-methoxy-5-nitro-4- (phenylmethoxy) benzene (CA name) 1-chloro-4-methoxy-5-nitro-2- (phenylmethoxy) benzene (CA name) ( 2,6-Dichloro-4-nitro-phenoxy) -acetic acid tert-butyl ester (2,6-dichloro-4-nitro-phenoxy) -acetonitrile 1-chloro-4-methoxy-2-methyl-5-nitro-benzene 2- (4-chloro-5-methoxy-2-nitro-phenoxy) -acetamide 2- (2-chloro-5-methoxy-4-nitro-phenoxy) -acetamide (4-chloro -5-methoxy-2-nitro-phenoxy) -acetonitrile (2-chloro-5-methoxy-4-nitro-phenoxy) -acetonitrile 4- (2-chloro-5-methoxy-4-nitro-phenoxy) -butyronitrile 2 -(4-chloro-5-methoxy-2-nitro-phenoxy) -ethanol 2- (2-chloro-5-methoxy-4-nitro-phenoxy) -ethanol (2-chloro-5-methoxy-4-nitro- Phenoxy) -acetic acid tert-butyl ester (2-chloro-5-methoxy-4-nitro-phenoxy) -acetic acid methyl ester (4-chloro-5-methoxy-2-nitro-phenoxy) -acetic acid methyl ester (4-chloro -5-methoxy-2-nitro-phenoxy) -acetic acid tert-butyl ester (2-chloro-4-nitro-phenoxy) -acetonitrile 1-butoxy-2-chloro-4-nitro-benzene 2-chloro-4-nitro -1- (2,2,2-trifluoro-ethoxy) -benzene 2-chloro-4-nitro-1-propoxy-benzene 2-chloro-1 -Ethoxy-4-nitro-benzene 1,3-diiodo-2,4-dimethoxy-5-nitro-benzene 1,3-dibromo-2,4-dimethoxy-5-nitro-benzene 3-chloro-2,4- Dimethoxy-nitrobenzene Example 25 (Method 5E) [3,5-dichloro-4- (2-hydroxy-ethoxy) -phenyl] -carbamic acid tert-butyl ester (3,5-dichloro-4-hydroxy-phenyl)- Carbamic acid tert-butyl ester
(1.0 g) and potassium carbonate (0.55 g) in a solution (in 20 mL of toluene) of ethylene carbonate (1.
6 g) are added and the mixture is heated to reflux for 3 hours. 2.5M to the cooled reaction mixture
Aqueous sodium hydroxide (50 mL) is added and the separated organic layer is washed successively with water, then with aqueous saturated sodium chloride, and then dried over anhydrous sodium sulfate. The solvent is then removed by evaporation under reduced pressure and the resulting residue is chromatographed on silica gel (using 30% ethyl acetate in hexane as eluent) to give the desired product as a white foam.

Example 26 (Method 6) 3- (2-Chloro-4-nitro-phenoxy) -1-methyl-pyrrolidine A solution of 2-chloro-4-nitrophenol (2.0 g) (in 60 mL of tetrahydrofuran) 1
-Methyl-3-pyrrolidinol (2.3 g), triphenylphosphine (6.0 g) and diethylazodicarboxylate (3.6 mL) are added, and the mixture is stirred at room temperature under an argon atmosphere for 1.5 hours. The solution is then concentrated under reduced pressure, diluted with ethyl acetate,
Wash sequentially with aqueous sodium hydroxide, water, saturated aqueous sodium chloride,
And dried over anhydrous magnesium sulfate. The solvent is removed by evaporation under reduced pressure and the residue is chromatographed on silica gel (using ethyl acetate then 10% methanol in dichloromethane) as eluent. The pooled product fractions are then recrystallized from hexane to give the desired product as a yellow solid. Using the above procedure and appropriate starting materials, the following compound was prepared: 4- (2-chloro-4-nitro-phenoxy) -1-methyl-piperidine 3- (2-chloro-4-nitro-phenoxy) ) -1-Methyl-pyrrolidine [2- (2-chloro-4-nitro-phenoxy) -ethyl] -dimethyl-amine [3- (2-chloro-4-nitro-phenoxy) -propyl] -dimethyl-amine Example 27 (method 7A) containing 2-chloro-3-methoxy-6-nitro-phenol and 2,4-dichloro-3-methoxy-6-nitro-phenol 3-methoxy-6-nitro-phenol (0.5 g) Aqueous sodium hypochlorite (5.25% aqueous solution, 21 mL) is added to the resulting flask, and the mixture is stirred at room temperature for about 24 hours. The mixture is then cooled in an ice bath and acidified by adding concentrated hydrochloric acid,
Then extract twice with ethyl acetate. The organic extract was dried over anhydrous magnesium sulfate, the solvent was removed by evaporation under reduced pressure, and the residue was chromatographed on silica gel (using 15% acetone in hexane as eluent).
Both the mono- and di-chlorinated products are obtained as yellow solids.

Using the above procedure and the appropriate starting materials, the following compound was prepared: 3-Chloro-2-hydroxy-4-methoxy-nitrobenzene 3,5-dichloro-2-hydroxy-4-methoxy-nitrobenzene Example 28 (Method 7B) 2,4-Dichloro-3-methyl-6-nitro-phenol A solution of 3-methyl-4-nitro-phenol (5.0 g) (in 150 mL of water) was added with aqueous sodium hypochlorite ( A 5.25% aqueous solution, 230 mL) is added and the mixture is stirred at room temperature for about 15 hours. Additional aqueous sodium hypochlorite (5.25% aqueous solution, 230 mL) is added and the mixture is stirred at room temperature for 2.5 days. The mixture is cooled in an ice bath, acidified by adding concentrated hydrochloric acid and then extracted twice with ethyl acetate. The organic extract is dried over anhydrous magnesium sulfate, the solvent is removed by evaporation under reduced pressure and the residue is chromatographed on silica gel (using ethyl acetate as eluent) to give the desired product as a yellow solid obtain. An analytically pure sample is obtained in a single recrystallization from chloroform.

Example 29 (Method 7C) 1-Bromo-2,4-dimethoxy-5-nitro-benzene A solution of 2,4-dimethoxy-nitrobenzene (0.50 g) in 3 mL of chloroform was treated with bromine.
(0.23 g) solution (in 1 mL of chloroform) is added dropwise and the mixture is stirred at room temperature for about 15 hours. Additional bromine (0.15 g) solution (in 1 mL of chloroform) is added and the reaction is stirred for another 4 hours. The mixture is then poured into 5% aqueous sodium bisulfite and then extracted with chloroform. The pooled organic extracts are washed successively with 5% aqueous sodium bisulfite, then with saturated sodium chloride and dried over anhydrous sodium sulfate. The solvent is removed under reduced pressure and recrystallization of the residue from toluene gives the desired product as a yellow solid.

Example 30 (Method 7D) A solution of 2,4-dibromo-3-methoxy-6-nitro-phenol 5-methoxy-2-nitro-phenol (0.25 g) and silver trifluoroacetate (0.49 g) ( To 3 mL of glacial acetic acid), a solution of bromine (1.42 g) in 3 mL of glacial acetic acid is added dropwise and the mixture is stirred at room temperature for about 24 hours. The solution was then partitioned between ethyl acetate and water, and the organic layer was successively three times with 5% aqueous sodium bisulfite, three times with aqueous saturated sodium bicarbonate, and once with aqueous saturated sodium chloride. Wash. The organic layer is then dried over anhydrous magnesium sulfate and the solvent is removed under reduced pressure. The residue is chromatographed on silica gel (using 20% ethyl acetate in hexane as eluent) and then recrystallized from chloroform to give the desired dibrominated product as an orange solid.

Example 31 (Method 7E) 1-Iodo-2,4-dimethoxy-5-nitro-benzene A solution of 2,4-dimethoxy-nitrobenzene (1.0 g) in 30 mL of glacial acetic acid was treated with iodine dichloride. Benzyl trimethyammonium acid (1.90 g) and anhydrous zinc chloride (1.0 g) were added,
The mixture is then stirred at room temperature under an argon atmosphere. Further benzyltrimethyammonium diiodate dichloride (0.4 g) is added after 5 hours and again after 24 hours. Further zinc chloride (0.5 g) and glacial acetic acid (15 mL) are added after 24 hours. The mixture is stirred at room temperature for 3 days and filtered, diluted with 5% aqueous sodium bisulfite and extracted three times with ethyl acetate. The pooled organic extracts are washed successively with 5% aqueous sodium bisulfite, aqueous saturated sodium chloride and then dried over anhydrous magnesium sulfate. After removal of the solvent under reduced pressure, the residue is triturated with hexane to give the desired product as a pale yellow solid.

Example 32 (Method 7F) 2,4-diiodo-3-methoxy-6-nitro-phenol A solution of 5-methoxy-2-nitro-phenol (0.25 g) (15 mL of dichloromethane and 6
(in mL of methanol), add benzyltrimethyammonium diiodate iodate (1.08 g) and sodium bicarbonate (0.85 g) and stir the mixture at room temperature for 24 hours.
The solution is then filtered, the filtrate is concentrated under reduced pressure, the residue is dissolved in ethyl acetate and then washed successively with 5% aqueous sodium bicarbonate, 5% aqueous sodium bisulfite, and aqueous saturated sodium chloride I do. After drying over anhydrous magnesium sulfate, the solvent is removed by evaporation under reduced pressure, and the residue is recrystallized from toluene to give the desired product as yellow needles.

Example 33 (Method 7G) 1-Fluoro-2,4-dimethoxy-5-nitro-benzene A solution of 2,4-dimethoxy-nitrobenzene (1.0 g) in 10 mL of tetrachloroethane
To the solution is added 3,5-dichloro-1-fluoro-pyridinium triflate (85%, 5.07 g) and the mixture is heated at 120 ° C. for 5 hours. Further 3,5-dichloro-1-fluoro-pyridinium triflate (85%, 0.25 g) is added and heating is continued for 1 hour.
The solution is then cooled to room temperature and passed through a column of silica gel (using hexane and then 30% ethyl acetate in hexane as eluent). The fractions containing the product are combined, evaporated under reduced pressure and the residue is crystallized from hexane to give the desired product as a tan solid.

Example 34 (Method 8) 3-chloro-4-trifluoromethyl-nitrobenzene 3-chloro-4-iodo-nitrobenzene (2.26 g), trimethyl (trifluoromethyl) silane (5.68 g), copper iodide (I) (2.28 g) and potassium fluoride (0.56 g) solution (8 mL
In N, N-dimethylformamide) in a sealed tube at 80 ° C. for 40 hours. The solution is then cooled, diluted with diethyl ether, filtered through diatomaceous earth and the filtrate is washed successively with water, aqueous saturated sodium chloride and dried over anhydrous sodium sulphate. The solvent was removed under reduced pressure and the residue was chromatographed on silica gel (1% diethyl ether in hexane as eluent, then 10%).
% Ethyl acetate in hexane) to give the desired product as a colorless oil.

Example 35 (Method 9) (3-chloro-4-methanesulfinyl-phenyl) -carbamic acid tert-butyl ester (3-chloro-4-thiomethyl-phenyl) -carbamic acid tert-butyl ester (0.8
To a solution of 9 g) (in 15 mL of dichloromethane) at 0 ° C. is added a solution of dimethyldioxirane (〜0.11 M in acetone, 34 mL) and the mixture is stirred at 0 ° C. for 1 hour. The solvent is removed under reduced pressure and the residue is dissolved in dichloromethane, washed with saturated aqueous sodium chloride and then dried over anhydrous magnesium sulfate. The solvent is removed under reduced pressure to give the desired product as an orange foam.

Example 36 (Method 9B) [4- (2-Methylsulfinyl-benzoylamino) -phenyl] -carbamic acid tert-butyl ester 2-methylsulfanyl-N- [4- (2,2,2-tri Fluoro-acetylamino) -phenyl
To a solution of] -benzamide (234 mg) is added a saturated solution of sodium periodate (5 mL) and the mixture is stirred for 12 hours. Pour the purple mixture into water, extract with ethyl acetate, dry over anhydrous potassium carbonate and evaporate to give a red solid, 101 mg.

Using the above procedure and the appropriate starting materials, the following compounds were prepared: [4- (2-methanesulfinyl-benzoylamino) -phenyl] -carbamic acid tert
-Butyl ester 2-methanesulfinyl-N- [4- (2,2,2-trifluoro-acetylamino) -phenyl
] -Benzamide Example 37 (Method 10) (3-chloro-4-methanesulfonyl-phenyl) -carbamic acid tert-butyl ester (3-chloro-4-thiomethyl-phenyl) -carbamic acid tert-butyl ester (0.9
To a solution of 0 g) (in 30 mL of dichloromethane) at 0 ° C. is added a solution of dimethyldioxirane (〜0.11 M in acetone, 80 mL) and the mixture is stirred at 0 ° C. for 1 hour. The solvent is removed under reduced pressure and the residue is dissolved in dichloromethane, washed with saturated aqueous sodium chloride and then dried over anhydrous magnesium sulfate. The solvent is removed under reduced pressure to give the desired product as an orange foam.

Example 38 (Method 11) 3-chloro-4-vinyl-phenylamine 3-chloro-4-iodoaniline (6.95 g), triphenylarsine (0.67 g) and tris (dibenzylideneacetone) palladium (0 ) (0.50 g) in a deoxygenated solution (in 120 mL of tetrahydrofuran) at 50 ° C. is added tributylvinyltin (10 g) and the mixture is stirred at 50 ° C. under an argon atmosphere for about 15 hours. The reaction is cooled, filtered through diatomaceous earth and the filtrate is evaporated to dryness under reduced pressure. The residue is dissolved in hexane and extracted three times with 5% aqueous hydrochloric acid. The aqueous acidic extract is made basic with solid potassium carbonate and extracted three times with ethyl acetate. Wash such pooled extracts with aqueous saturated sodium chloride, dry over anhydrous magnesium sulfate, and remove the solvent under reduced pressure. The resulting residue is chromatographed on silica gel (hexane as eluent, then 10% ethyl acetate in hexane)
To obtain the desired product as an amber oil.

Example 39 (Method 12) [3-chloro-4- (1-hydroxy-ethyl) -phenyl] -carbamic acid 2-trimethylsilanyl-ethyl ester (3-chloro-4-vinyl-phenyl)- 2-trimethylsilanyl-ethyl carbamic acid
Ester (2.6 g) was added to mercury acetate (3.48 g) in 7 mL of water and tetrahydrofuran (5.
25 mL) and the mixture is stirred for about 15 hours. 3 N aqueous sodium hydroxide (8.7 mL) and 0.5 M sodium borohydride solution (in 8.7 mL 3 N aqueous sodium hydroxide) are added and stirring is continued for 6 hours. The solution is then saturated with sodium chloride and extracted with ethyl acetate. The organic extract is washed with aqueous saturated sodium chloride and dried over anhydrous sodium sulfate. After removal of the solvent under reduced pressure, the residue is chromatographed on silica gel (using 20% ethyl acetate in hexane as eluent) to give the desired product as a white solid.

Example 40 (Method 13) [3-Chloro-4- (2-hydroxy-ethyl) -phenyl] -carbamic acid tert-butyl ester stirred suspension of sodium borohydride (0.45 g) (13 mL In tetrahydrofuran),
At 0 ° C. glacial acetic acid (0.75 mL) is added and the mixture is stirred at 0 ° C. for 1 hour. The solution is then warmed to room temperature and (3-chloro-4-vinyl-phenyl) -carbamic acid 2-trimethylsilanyl-ethyl ester (1.0 g) is added. The reaction was stirred at room temperature for about 15 hours,
Then, heat and reflux for about 20 hours. The mixture is then cooled and a solution of 5N aqueous sodium hydroxide (0.80 mL) and 30% aqueous hydrogen peroxide (0.56 mL) is added. After stirring for a further 15 hours, the layers are separated, the aqueous layer is extracted three times with diethyl ether, and such organic extracts are dried over anhydrous magnesium sulfate. After removal of the solvent under reduced pressure, the residue is chromatographed on silica gel (using 40% ethyl acetate in hexane as eluent) to give the desired product as an amber oil.

Example 41 (Method 14) [4- (1-azido-ethyl) -3-chloro-phenyl] -carbamic acid 2-trimethylsilanyl-ethyl ester [3-chloro-4- (1-hydroxy- Ethyl) -phenyl] -carbamic acid 2-trimethylsilanyl-ethyl ester (1.25 g) in 20 mL of tetrahydrofuran
Triphenyl under an atmosphere of argon at ° C. - phosphine (2.6 g), approximately 2.5 molar equivalents of hydrazoic acid (in dichloromethane, Fieser and Fieser, Reagents for Organic Synthe sis, Vol.1, pg446; Wiley (Wiley), New York And diethyl azodicarboxylate (1.72 g). After about 10 minutes, the solvent is removed under reduced pressure and the residue is chromatographed on silica gel (using 5% ethyl acetate in hexane as eluent) to give the desired product as a colorless oil.

Example 42 (Method 15) [3-Chloro-4- (3-dimethylamino-prop-1-ynyl) -phenyl] -carbamic acid tert-butyl ester (3-chloro-4-iodo-phenyl) -Carbamic acid tert-butyl ester (10.0g)
To a deoxygenation solution (in 120 mL of triethylamine)
(2.82 g), bis (triphenyl-phosphine) palladium (II) chloride (0.4 g),
And cuprous iodide (0.054 g). The mixture is allowed to stand at room temperature under argon atmosphere for about 6 hours.
Stir for an hour and then heat briefly (about 10 minutes) at 60 ° C. The reaction mixture is then cooled, filtered through kieselguhr and the solvent is removed by evaporation under reduced pressure. The residue is dissolved in ethyl acetate, washed three times with water, once with aqueous saturated sodium chloride and dried over anhydrous magnesium sulfate. The solvent is removed by evaporation under reduced pressure and the residue is chromatographed on silica gel (using 80% ethyl acetate in hexane as eluent) and the purified product solidifies on standing with an amber colored Obtain as oil.

Using the above procedure and the appropriate starting materials, the following compounds were prepared: [3-Chloro-4- (3-dimethylamino-prop-1-ynyl) -phenyl] -carbamic acid
tert-butyl ester [3- (4-methoxy-phenyl) -prop-2-ynyl] -dimethyl-amine 4- (3-dimethylamino-prop-1-ynyl) -benzonitrile dimethyl- [3- (4- Nitro-phenyl) -prop-2-ynyl] -amine Example 43 (method 16) [3-Chloro-4- (3-dimethylamino-acryloyl) -phenyl] -carbamic acid tert-butyl ester [3-chloro- 4- (3-dimethylamino-prop-1-ynyl) -phenyl] -carbamic acid
An ice-cold solution of tert-butyl ester (4.0 g) in 30 mL of dichloromethane was added in small portions.
3-Chloroperoxybenzoic acid (2.34 g) is added. After stirring the reaction at 0 ° C. for 20 minutes, the mixture was mixed with 20 weight equivalents of basic alumina (Brockmann grade I).
, 150 mesh) and the N-oxide is eluted using a 5% methanol solution in dichloromethane. All fractions containing the desired amine N-oxide were combined and evaporated under reduced pressure to near dryness. Residue in methanol (about 50 ml
) In three successive small portions, followed by evaporation under reduced pressure to near dryness,
Then, the volume of the solution is adjusted to 250 mL by adding methanol. The methanolic solution of the N-oxide is heated at reflux for about 15 hours, then cooled and the solvent is evaporated to dryness under reduced pressure. The residue is purified by chromatography on silica gel (using 80% ethyl acetate in hexane as eluent) to give the desired product as a pale yellow solid.

Example 44 (Method 17) tert-butyl (3-chloro-4-isoxazol-5-yl-phenyl) -carbamate [3-chloro-4- (3-dimethylamino-acryloyl) -phenyl] -Carbamic acid ter
A solution of t-butyl ester (270 mg) in 3 ml of dioxane is treated with hydroxylamine hydrochloride (122 mg) and the mixture is stirred at room temperature for 10 days. The mixture is diluted with ethyl acetate, washed successively with water, 5% aqueous sodium bicarbonate, aqueous saturated sodium chloride, and then dried over anhydrous magnesium sulfate. The solvent is removed by evaporation under reduced pressure and the resulting residue is chromatographed on silica gel (using 33% ethyl acetate in hexane as eluent) to give the desired product as a colorless solid.

Example 45 (Method 18) [3-Chloro-4- (1H-pyrazol-3-yl) -phenyl] -carbamic acid tert-butyl ester [3-chloro-4- (3-dimethylamino-acryloyl) ) -Phenyl] -carbamic acid ter
A solution of t-butyl ester (250 mg) in 1.25 ml of ethanol was added to hydrazine hydrate.
(0.25 ml) and the mixture is stirred at room temperature for 3 hours. The mixture is diluted with 30 mL of diethyl ether, washed three times with water, once with aqueous saturated sodium chloride, and then dried over anhydrous magnesium sulfate. The solvent is removed by evaporation under reduced pressure and the resulting residue is chromatographed on silica gel (using 67% ethyl acetate in hexane as eluent) to give the desired product as an oil.

Example 46 (Method 19A) N- (2-chloro-4-nitrophenyl) -2-thiomorpholino-4-yl-acetamide N- (chloroacetyl) -2-chloro-4-nitroaniline (3.80 To a solution of g) (in 50 mL of tetrahydrofuran) is added thiomorpholine (10 mL) and the solution is left for 1 hour. The reaction mixture is poured into water, the pale yellow solid is collected and then recrystallized from hot 2-propanol to give a pale yellow crystalline solid.

Using the above procedure and the appropriate starting materials, the following compounds were prepared: (4- {2- [bis- (2-hydroxy-ethyl) -amino] -acetylamino} -phenyl) -carbamine Acid tert-butyl ester [4- (2-dimethylamino-acetylamino) -phenyl] -carbamic acid tert-butyl ester {4- [3- (2-dimethylamino-ethoxy) -benzoylamino] -phenyl} -carbamine Acid tert-butyl ester {4- [3- (2-morpholin-4-yl-ethoxy) -benzoylamino] -phenyl} -carbamic acid tert-butyl ester N- (2-chloro-4-nitro-phenyl)- 2-dimethylamino-acetamido N- (2-chloro-4-nitro-phenyl) -2-piperidin-1-yl-acetamido N- (2-chloro-4-nitro-phenyl) -2-morpholin-4-yl -Acetamide N- (2-chloro-4-nitro-phenyl) -2-dipropylamino-acetamide N- (2-chloro-4-nit -Phenyl) -2-thiomorpholin-4-yl-acetamide N- (2-chloro-4-nitro-phenyl) -2-diethylamino-acetamide N- (2-chloro-4-nitro-phenyl) -2-pyrrolidine 1-yl-acetamide 2-azepan-1-yl-N- (2-chloro-4-nitro-phenyl) -acetamide N- (2-chloro-4-nitro-phenyl) -2- (2-methyl- Piperidin-1-yl) -acetamido N- (2-chloro-4-nitro-phenyl) -2- (3-methyl-piperidin-1-yl) -acetamido N- (2-chloro-4-nitro-phenyl) -2- (4-Methyl-piperidin-1-yl) -acetamide Example 47 (Method 19B) N- (2-chloro-4-nitrophenyl) -2- (2-dimethylaminoethylsulfanyl) acetamide N- ( (Chloroacetyl) -2-chloro-4-nitroaniline (3.01 g) solution (100 mL of N, N-
To dimethylformamide) is added powdered sodium carbonate (6.0 g) and 2-dimethylaminoethanethiol hydrochloride (6.0 g). The mixture is stirred at 25 ° C. for 1 hour, poured into water and extracted into ethyl acetate. The ethyl acetate solution is dried over anhydrous potassium carbonate and concentrated under reduced pressure to give an oil. The oil is crystallized from toluene-hexane (3: 1) to give a pale yellow crystalline solid.

Example 48 (Method 20) (4-tert-butoxycarbonylamino-2-chloro-phenyl) -carbamic acid 2-piperidin-1-yl-ethyl ester 1,1-carbonyl-di- (1,2 A solution of (4-amino-3-chloro-4-phenyl) -carbamic acid tert-butyl ester (5.0 g) in a suspension of (4,4) -triazole (4.0 g) in dichloromethane (40 mL) (In dichloromethane) dropwise over 20 minutes. The reaction is stirred at room temperature for 30 minutes, at which time a precipitate forms. To this mixture is added piperidine ethanol (6.6 mL) and tetra-hydrofuran (20 mL) to maintain homogeneity. After heating at reflux overnight, the reaction is cooled and then poured into water, the organic layer is separated and then washed with aqueous saturated sodium chloride. The solution was dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure to give a crude oil, which was purified by chromatography on silica gel (using 5% methanol in dichloromethane as eluent). The desired product is obtained as a white foam.

Example 49 A solution of 5-phenyl- [1,2,3] thiadiazole-4-carboxylic acid methyl ester ethyl benzoyl acetate (1.1 g) in 10 mL of acetonitrile was added to 4-
Treat with methylbenzenesulfonyl azide (1.3 g) and triethylamine (1.6 g). After stirring at room temperature overnight, the reaction is concentrated under reduced pressure, and the resulting crude is dissolved in ethyl acetate and washed with 1N sodium hydroxide. The organic layer is then dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure to give a yellow oil. Take up the oil in dichloromethane, filter through a pad of hydrous magnesium silicate and elute with dichloromethane to obtain the partially purified diazoketone as a colorless oil. A sample of the diazoketone (1.2 g) from above was added to toluene (25
mL) and treated with 2,4-bis (4-methoxyphenyl) -1,3-dithia-2,4-diphosphetane-2,4-disulfide (2.8 g) and the reaction was heated to reflux I do. After 3 hours, the reaction is cooled to room temperature, applied to a pad of silica gel and eluted with dichloromethane. After removal of the solvent under reduced pressure, the resulting oil is purified by chromatography on silica gel (using 30% diethyl ether in petroleum ether as eluent) and then recrystallized from hexane to give the desired product As pale yellow needles.

Using the above procedure and the appropriate starting materials, the following compounds were prepared: 5-phenyl- [1,2,3] thiadiazole-4-carboxylic acid ethyl ester 5-methyl- [1,2, 3] Thiadiazole-4-carboxylic acid methyl ester Example 50 Ethyl-benzoyl acetate semicarbazide Ethyl benzoyl acetate (5.0 g) was dissolved in methanol (10 mL) and quickly dissolved in a hot solution of semicarbazide hydrochloride (29 g) in 130 mL of water ). To this was added pyridine (4.1 g) and after heating at reflux for 5 minutes, the reaction mixture was allowed to stand overnight.
Cool to -20 ° C. The resulting solid semicarbazone is collected by filtration, washed with water and then with diethyl ether to give the desired compound as white crystals.

Using the above procedure and the appropriate starting materials, the following compounds were prepared: Ethyl (Z) -3-[(aminocarbonyl) hydrazono] -4,4,4-trifluorobutanoate 3- [ Ethyl (Z) -2- (aminocarbonyl) hydrazono] -3-phenylpropanoate Ethyl 3-[(E) -2- (aminocarbonyl) hydrazono] -3- (3-furyl) propanoate
Ester Example 51 5-Phenyl- [1,2,3] thiadiazole-5-carboxylic acid ethyl ester ethyl benzoyl acetate A solution of 2.5 g of semicarbazone (in 5 mL of neat thionyl chloride) at 0 ° C. for 1 hour Stir for hours. Then dichloromethane (25 mL)
And the excess thionyl chloride is slowly destroyed with aqueous saturated sodium bicarbonate. The precipitate formed on cooling is removed by filtration, and the filtrate is extracted with dichloromethane. The pooled organic extracts are dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure. Chromatography on silica gel (50 as eluent)
% Hexane in dichloromethane) gives the desired product as a colorless oil.

Using the above procedure and the appropriate starting materials, the following compounds were prepared: 4-methyl- [1,2,3] thiadiazole-5-carboxylic acid methyl ester 4-phenyl- [1,2, 3] Thiadiazole-5-carboxylic acid ethyl ester 4-furan-3-yl- [1,2,3] thiadiazole-5-carboxylic acid ethyl ester Example 52 4-Methyl- [1,2,3] thiadiazole-5 -Carboxylic acid 4-methyl- [1,2,3] thiadiazole-5-carboxylic acid methyl ester (1.7 g) is dissolved in methanol (15 mL) and treated with 1 N sodium hydroxide (16 mL). After stirring at room temperature for 1 hour, the reaction is treated with concentrated hydrochloric acid (1.5 mL) and concentrated under reduced pressure. The resulting cloudy aqueous layer is extracted twice with diethyl ether, and the pooled organic layers are dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure to give the desired compound as a white powder.

Using the above procedure and the appropriate starting materials, the following compounds were prepared: 3-Furoxy-3-methoxy-benzoic acid 5-furan-3-yl- [1,2,3] thiadiazole-4-carboxylic acid Acid Thiazole-4-carboxylic acid 4-Methyl- [1,2,3] thiadiazole-5-carboxylic acid 5-Methyl- [1,2,3] thiadiazole-4-carboxylic acid Example 53 (Method 25) Trifluoro -Methanesulfonic acid 4-chloro-5-methoxy-2-nitro-phenyl ester To a solution of 4-chloro-5-methoxy-2-nitro-phenol (6.5 g) in dichloromethane (150 mL) under an argon atmosphere At 0 ° C. triethylamine (10 g) is added, and then a solution of trifluoro-methanesulfonic anhydride (13.5 g) in 30 mL of dichloromethane. The solution is stirred at 0 ° C. for 10 minutes and then diluted with dichloromethane and washed successively with aqueous saturated sodium bicarbonate and aqueous saturated sodium chloride. After drying over anhydrous sodium sulfate, the solvent is removed by evaporation under reduced pressure, and the residue is dissolved in a 20% dichloromethane solution (in hexane) and passed through a short column of hydrous magnesium silicate (20% as eluent). Use dichloromethane (in hexane)). The fractions containing the product are pooled and the solvent is removed by evaporation under reduced pressure to give the desired product as a yellow oil.

Using the above procedure and the appropriate starting materials, the following compounds were prepared: trifluoro-methanesulfonic acid 4-chloro-5-methoxy-2-nitro-phenyl ester trifluoro-methanesulfonic acid 4- Chloro-2-nitro-phenyl ester trifluoro-methanesulfonic acid 2-chloro-6-nitro-phenyl ester Example 54 (Method 26) [4- (3-dimethylamino-benzoylamino) -phenyl] -carbamic acid -Butyl ester [4- (3-amino-benzoylamino) -phenyl] -carbamic acid t-butyl ester (505 mg), sodium cyanoborohydride (250 mg), acetic acid (3 drops) and 40% aqueous formaldehyde (4 mL) ) In 1: 2 tetrahydrofuran-methanol (15 mL)
Is stirred for 15 minutes and poured into aqueous saturated sodium bicarbonate and extracted with ethyl acetate. The ethyl acetate solution is dried over anhydrous potassium carbonate and concentrated under reduced pressure to give a solid, which is recrystallized from acetonitrile to give a pale pink crystalline solid.

Using the above procedures and the appropriate starting materials, the following compounds were prepared: [4- (3-Dimethylamino-benzoylamino) -phenyl] -carbamic acid tert-butyl ester (3-bromo-5 -Trifluoromethyl-phenyl) -dimethyl-amine N- (3-chloro-5-dimethylamino-phenyl) -acetamide Example 55 (Method 27) N- (4-aminophenyl) -2-hydroxybenzamide 2- ( To a solution of 4-aminophenylcarbamoyl) phenyl acetate (580 mg) in 10 mL of methanol is added saturated sodium bicarbonate (2 mL) and water (3 mL). The mixture is heated at 80 ° C. for 30 minutes and poured into aqueous half-saturated sodium chloride and extracted with ethyl acetate. The ethyl acetate solution is dried over anhydrous sodium sulfate and concentrated under reduced pressure to give an oil, which is triturated with diethyl ether to give the desired product as a white solid.

Example 56 (Method 28) [4- (3-Hydroxybenzoylamino) phenyl} carbamic acid t-butyl ester 3- (4-aminophenylcarbamoyl) phenyl acetate (4.34 mg) solution (75 mL)
0.1 M aqueous sodium hydroxide (25 mL) and tetrahydrofuran (25 mL). The solution is heated at 40 ° C. for 30 minutes and cooled, poured into 1M hydrochloric acid and extracted with ethyl acetate. The ethyl acetate solution is dried over anhydrous sodium sulfate and concentrated under reduced pressure to give a white solid, which is further purified by trituration with diethyl ether.

Example 57 (Method 29) N- (4-Aminophenyl) -2-hydroxymethylbenzamide Lithium borohydride in a solution of N- (4-aminophenyl) phthalimide (332 mg) in 4 mL of tetrahydrofuran (1.0 g) is added and the mixture is stirred at 25 ° C. for 1 hour. The mixture is poured into water and extracted with ethyl acetate. The ethyl acetate solution is dried over anhydrous sodium sulfate and concentrated under reduced pressure to give a white foam, which is triturated with diethyl ether to give the desired product as a white powder.

Example 58 (Method 30) (3-chloro-5-dimethylamino-phenyl) -carbamic acid tert-butyl ester (3-amino-5-chloro-phenyl) -carbamic acid tert-butyl ester (0.32 g ) (In 10 mL of toluene) is added aqueous formaldehyde (37%, 15 mL) followed by 10% palladium on carbon (0.50 g) and the mixture is stirred under an atmosphere of hydrogen for about 15 hours. The solution is then filtered through kieselguhr and the filtrate is concentrated under reduced pressure. The residue is chromatographed on silica gel (using 50% dichloromethane in hexane as eluent) to give the desired product as a white solid.

Example 59 (Method 35) N- (4- {3- [3,5-dichloro-4- (2-hydroxy-ethoxy) -phenyl] -thioureido} -phenyl) -acetamidoacetic acid 2- {4 -[3- (4-acetylamino-phenyl) -thioureido] -2,6-dichlorophenoxy} -ethyl ester (0.16 g) solution (1 of tetrahydrofuran and methanol)
: 1 mixture in 2.5 mL), 1 N aqueous sodium hydroxide (1 mL) is added and the mixture is stirred at room temperature for about 2 hours. This solution is added to 2M aqueous hydrochloric acid (3 mL), extracted into ethyl acetate, and the extract is dried over anhydrous sodium sulfate. The solvent is removed by evaporation under reduced pressure and the residue is triturated with diethyl ether to give the desired product as a white solid.

Example 60 (Method 36) {4- [3- (4-Acetylamino-phenyl) -thioureido] -2,6-dichlorophenoxy} -acetic acid {4- [3- (4-acetylamino-phenyl) ) -Thioureido] -2,6-dichlorophenoxy
} -Acetate ethyl ester (0.29 g) solution (1: 1 tetrahydrofuran and methanol)
(In 4 mL), 1N aqueous sodium hydroxide (2 mL) is added and the mixture is stirred at room temperature for about 2 hours. Pour this solution into 2M aqueous hydrochloric acid (5 mL), extract into ethyl acetate, and dry the extract over anhydrous sodium sulfate. The solvent is removed by evaporation under reduced pressure and the residue is triturated with diethyl ether to give the desired product as a white solid.

Using the above procedure and the appropriate starting materials, the following compounds were prepared: {4- [3- (4-acetylamino-phenyl) -thioureido] -2,6-dichlorophenoxy
} -Acetic acid {2- [3- (4-acetylamino-phenyl) -thioureido] -4-chloro-5-methoxy-phenoxy} -acetic acid {4- [3- (4-acetylamino-phenyl) -thioureido] 2-Chloro-5-methoxy-phenoxy} -acetic acid Example 61 (method 37) Benzoic acid 2- {4- [3- (4-acetylamino-phenyl) -thioureido] -2,6-dichloro-phenoxy} -Ethyl ester N- (4- {3- [3,5-dichloro-4- (2-hydroxy-ethoxy) -phenyl] -thioureido
To an ice-cold solution of} -phenyl) -acetamide (0.20 g) in 2 mL of pyridine and 0.5 mL of tetrahydrofuran is added benzoyl chloride (0.08 g) and the mixture is stirred at 0 ° C. for 1.5 hours. The mixture is then diluted with ethyl acetate, washed successively twice with 2% aqueous hydrochloric acid, once with aqueous saturated sodium chloride and then dried over anhydrous sodium sulfate. After removal of the solvent under reduced pressure, the residue is chromatographed on silica gel (5% methanol in dichloromethane as eluent)
And the fractions containing the product are combined, evaporated under reduced pressure, and the residue is recrystallized from acetone-hexane to give the desired product as a white powder.

Example 62 (Method 38) Methanesulfonic acid 2- {4- [3- (4-acetylamino-phenyl) -thioureido] -2,6-dichlorophenoxy} -ethyl ester N- (4- {3 -[3,5-Dichloro-4- (2-hydroxy-ethoxy) -phenyl] -thioureido
To an ice-cooled solution of} -phenyl) -acetamide (0.20 g) in 2 mL of pyridine and 0.5 mL of tetrahydrofuran is added methanesulfonyl chloride (0.11 g) and the solution is stirred at 0 ° C. for 45 minutes. The reaction mixture was then diluted with ethyl acetate and 2%
Twice with aqueous hydrochloric acid and once with aqueous saturated sodium chloride, and then dried over anhydrous magnesium sulfate. After removing the solvent by evaporation under reduced pressure,
The resulting residue is recrystallized from acetone-hexane to give the desired product as a white powder.

Example 63 (Method 39) N- (4- {3- [3,5-dichloro-4- (2-dimethylamino-ethoxy) -phenyl] -thioureido} -phenyl) -acetamide methanesulfonic acid 2 -{4- [3- (4-acetylamino-phenyl) -thioureido] -2,6
To a solution of -dichlorophenoxy} -ethyl ester (0.33 g) in 6 mL of tetrahydrofuran was added aqueous dimethyl-amine (8.8 M, 0.5 mL) and the mixture was added at room temperature for 5 minutes.
Stir for days. The reaction mixture is then diluted with ethyl acetate, then washed with aqueous saturated sodium chloride and dried over anhydrous magnesium sulfate. After removal of the solvent under reduced pressure, the residue is chromatographed on silica gel (using pure methanol as eluent). The fractions containing the pooled product are evaporated under reduced pressure and the residue is recrystallized from acetonitrile to give the desired product as a white powder.

Using the above procedures and the appropriate starting materials, the following compounds were prepared: N- (4- {3- [3,5-dichloro-4- (2-dimethylamino-ethoxy) -phenyl] -Thioureido} -phenyl) -acetamide benzoic acid 2- {4- [3- (4-acetylamino-phenyl) -thioureido] -2,6-dichloro-phenoxy} -ethyl ester Example 64 (Method 40) furan- 2-Carboxylic acid (4- {3- [4- (1-amino-ethyl) -3-chloro-phenyl] -thioureido} -phenyl) -amide Tin (II) chloride dihydrate (0.25 g) solution In 2.5 mL of methanol, furan-2-carboxylic acid (4- {3- [4- (1-azido-ethyl) -3-chloro-phenyl] -thioureido} -phenyl) -amide (0.22 g) And the solution is stirred at room temperature for about 15 hours. The solution is then diluted with ethyl acetate, washed successively with aqueous saturated sodium bicarbonate and then with aqueous saturated sodium chloride, and then dried over anhydrous sodium sulfate.
After removal of the solvent by evaporation under reduced pressure, the residue is chromatographed on silica gel (using 8% methanol (in dichloromethane containing 1% triethylamine) as eluent) to give the desired product as a yellow solid. obtain.

Example 65 (Method 41) [1,2,3] -Thiadiazole-4-carboxylic acid (4-isothiocyanato-phenyl) -amide Ice-cooled solution of 1,1'-thiocarbonyldiimidazole (7.28 g) [1,2,3] -Thiadiazole-4-carboxylic acid (4-amino-phenyl) -amide (9.0 g) (in 100 mL of tetrahydrofuran) is added (in 50 mL of tetrahydrofuran). After about 1 hour, the solution is removed by evaporation and the residue is dissolved in ethyl acetate. The crude product is precipitated by addition of diethyl ether, which is collected by filtration, dissolved in dichloromethane and passed through a plug of hydrous magnesium silicate. After removal of the solvent, the residue is recrystallized from ethyl acetate-hexane to give the desired product as a slightly yellow solid.

Using the above procedure and the appropriate starting materials, the following compounds were prepared: 2-Fluoro-N- (4-isothiocyanato-phenyl) -benzamide furan-2-carboxylic acid (4-isothiocyanato-phenyl) -Amido [1,2,3] thiadiazole-4-carboxylic acid (4-isothiocyanato-phenyl) -amide Thiazole-4-carboxylic acid (4-isothiocyanato-phenyl) -amide Example 66 (Method 42) N, N, -Dimethyl-5-trifluoromethyl-benzene-1,3-diamine 3-amino-5-bromo-benzotrifluoride (1.0 g) solution (degassed (argon)
Bis- (tri- o -tolylphosphino) palladium in 2 mL of tetrahydrofuran)
(0.15 g), a solution of dimethylamine (2 M in tetrahydrofuran, 4.2 mL), and a solution of lithium bis (trimethylsilyl) amide (1 M in tetrahydrofuran)
, 10.4 mL). The reaction mixture is heated to 100 ° C. for about 2.5 hours in a closed vessel to complete the reaction. The mixture is cooled to room temperature, cooled by adding water and diluted with ethyl acetate. The product is extracted three times into 5% aqueous hydrochloric acid and the pooled acidic extracts are cooled to basic by the addition of 5N aqueous sodium hydroxide. The basic solution is extracted with ethyl acetate and the organic extracts thus pooled are washed with aqueous saturated sodium chloride, dried over anhydrous magnesium sulfate and evaporated to dryness under reduced pressure. The resulting residue is chromatographed on silica gel (
Use 20-30% ethyl acetate (in hexane) as eluent) to give the desired product as a slightly colored solid.

Using the above procedure and the appropriate starting materials, the following compound was prepared: 3- (4-methyl-piperazin-1-yl) -5-trifluoromethyl-phenylamine 3-morpholine-4- Yl-5-trifluoromethyl-phenylamine 3-piperidin-1-yl-5-trifluoromethyl-phenylamine 3-pyrrolidin-1-yl-5-trifluoromethyl-phenylamine N, N-dimethyl-5- Trifluoromethyl-benzene-1,3-diamine N-isobutyl-N-methyl-5-trifluoromethyl-benzene-1,3-diamine N-butyl-N-methyl-5-trifluoromethyl-benzene-1, 3-Diamine Example 67 (method 43) (3-isobutyl-5-trifluoromethyl-phenyl) -carbamic acid tert-butyl ester tetrahydrofuran (5 mL) capped with a rubber stopper and cooled in a dry ice-acetone bath ) Bubble isobutylene for about 5 minutes. 9-
Borabicyclo [3.3.1] nonane solution (0.5 M in tetrahydrofuran, 11 mL) was added,
Seal the container with a Teflon cap, slowly warm to room temperature, and maintain at room temperature for about 2.5 hours. The mixture is then re-cooled in a dry ice-acetone bath, the Teflon cap is replaced with a rubber stopper, and the mixture is vented with argon to evacuate excess isobutylene. A solution of (3-bromo-5-trifluoromethyl-phenyl) -carbamic acid tert-butyl ester (1.7 g) in 12 mL of tetrahydrofuran, followed by [1,1'-bis (diphenylphosphino) -ferrocene ] Add palladium (II) chloride-dichloromethane complex (0.12g) and then 3N aqueous sodium hydroxide. The container is again sealed with a Teflon cap and then heated to 65 ° C. for about 15 hours. The mixture is cooled to room temperature, diluted with hexane, washed with water, aqueous saturated sodium chloride, dried over anhydrous magnesium sulfate and evaporated under reduced pressure. The resulting oil is chromatographed on silica gel (using 5% ethyl acetate in hexane as eluent) to give the desired product as a white powder.

Using the above procedure and the appropriate starting materials, the following compounds were prepared: [3- (2-Methyl-butyl) -5-trifluoromethyl-phenyl] -tert-carbamic acid
Butyl ester (3-isobutyl-5-trifluoromethyl-phenyl) -tert-butyl carbamate
Ester Example 68 (Method 44) 2- (3,5-Dichloro-phenylsulfanyl) -ethylamine 0.61 mL of a solution of (3,5-dichlorophenylthio) acetonitrile (1.2 g) in 3.0 mL of ethylene glycol dimethyl ether. Of a 10M borane dimethyl sulfide complex is added and the mixture is heated at reflux for 0.5 hour. The reaction was cooled in an ice bath and
Add mL water and 2.0 mL concentrated hydrochloric acid. The mixture is heated at reflux for 0.5 hours. The clear solution is then cooled and made basic with 5N sodium hydroxide and extracted with ether. The ether extract is dried over potassium carbonate, filtered, and concentrated to give 1.0 g of a colorless oil.

Using the above procedure and the appropriate starting materials, the following compound was prepared: 2- (3-bromo-phenylsulfanyl) -ethylamine 2- (4-bromo-phenoxy) -ethylamine 2- (4- Iodo-phenoxy) -ethylamine 2- (3,4-dichloro-phenoxy) -ethylamine 2- (3-chloro-phenylsulfanyl) -ethylamine 2- (3,4-dichloro-phenylsulfanyl) -ethylamine 3- (4- Bromo-phenyl) -propylamine 2- (2-fluoro-phenoxy) -ethylamine 2- (2-chloro-phenoxy) -ethylamine 2- (3-bromo-phenoxy) -ethylamine 2- (3-fluoro-phenoxy)- Ethylamine 2- (3-iodo-phenoxy) -ethylamine 2- (3,5-dichloro-phenylsulfanyl) -ethylamine 2-phenylsulfanyl-ethylamine 1- (2-chloro-phenyl) -ethylamine Example 69 (Method 45) N- (1- Futaren 2-yl - ethyl) - formamide 2-acetyl naphthalene (3.0 g), a mixture of ammonium formate (11.0 g), formic acid (3.3 mL) and formamide (3.5 mL), heated for 3 hours at 190 ° C.. The mixture is cooled, poured into water and extracted with ether. The ether extracts are dried over anhydrous potassium carbonate, filtered and concentrated to give a yellow oil, which crystallizes from toluene-hexane to give 1.97 g of a white solid.

Using the above procedure and the appropriate starting materials, the following compounds were prepared: N- [1- (4-fluoro-phenyl) -2-methyl-propyl] -formamide N- (1-naphthalene- Example 70 (Method 46) 1- (2-Naphthyl) ethylamine N- (1-naphthalen-2-yl-ethyl) -formamide (1.12 g), ethanol (10 mL) and 5N water Heat a mixture of sodium oxide (10 mL) at reflux for 1 hour. The solution is cooled, poured into water and extracted with ether. The ether solution is dried over anhydrous potassium carbonate, filtered, and concentrated to give the product (0.95 g) as a pale yellow oil.

Using the above procedure and the appropriate starting materials, the following compounds were prepared: 1- (3-trifluoromethyl-phenyl) -ethylamine 1- (4-fluoro-phenyl) -2-methyl-propyl Amine [3- (1-Amino-ethyl) -phenyl] -dimethyl-amine 3- (1-amino-ethyl) -benzonitrile Example 71 (Method 47) 1- (3-trifluoromethyl-phenyl) -ethanone O-Methyl-oxime methoxylamine hydrochloride (2.33 g) is added to a solution of 3 '-(trifluoromethyl) -acetophenone (1.5 g) in 20 mL of ethanol and 2 mL of pyridine. The solution is heated at reflux for 45 minutes. The reaction mixture is cooled, concentrated under reduced pressure, and partitioned between water and ethyl acetate. Extract the aqueous layer with ethyl acetate. Wash the combined organic layers with aqueous saturated sodium chloride, dry over anhydrous magnesium sulfate,
It is then concentrated under reduced pressure to give the desired product as a colorless oil (1.61g).

Using the above procedure and the appropriate starting materials, the following compounds were prepared: 3,5-bis-trifluoromethyl-benzaldehyde oxime 1- (4-fluoro-phenyl) -propan-1-one O -Methyl-oxime 1- (2-chloro-phenyl) -ethanone O-methyl-oxime 1- (3-bromo-phenyl) -ethanone O-methyl-oxime 1- (3-chloro-phenyl) -ethanone O-methyl -Oxime 1-p-tolyl-ethanone O-methyl-oxime 1- (4-fluoro-phenyl) -pentan-1-one O-methyl-oxime 1- (4-fluoro-phenyl) -2-phenyl-ethanone O -Methyl-oxime 1-o-tolyl-ethanone O-methyl-oxime 1-m-tolyl-ethanone O-methyl-oxime 1- (2-fluoro-phenyl) -ethanone O-methyl-oxime 3- (1-methoxy Imino-ethyl) -benzonitrile 4- (1-methoxyimino-ethyl) -benzonitrile 1- (4-methoxy -Phenyl) -ethanone O-methyl-oxime 1- (2-methoxy-phenyl) -ethanone O-methyl-oxime 1- (4-dimethylamino-phenyl) -ethanone O-methyl-oxime 1- (2-trifluoro Methyl-phenyl) -ethanone O-methyl-oxime 1- (3-methoxy-phenyl) -ethanone O-methyl-oxime 1- (3-trifluoromethyl-phenyl) -ethanone O-methyl-oxime 1- (4- (Trifluoromethyl-phenyl) -ethanone O-methyl-oxime 1-furan-2-yl-ethanone O-methyl-oxime 1-pyridin-4-yl-ethanone O-methyl-oxime 1- (1-methyl-1H- Pyrrol-2-yl) -ethanone O-methyl-oxime 1-thiophen-3-yl-ethanone O-methyl-oxime (4-fluoro-phenyl) -phenyl-methanone O-methyl-oxime 1- (4-methoxyphenyl ) Ethanone O-methyloxime 1- (3-chloro-4-methoxy-phenyl) -ethanone O-meth 4-oxime 4- (1-methoxyimino-ethyl) -benzenesulfonamide 4- (1-methoxyimino-ethyl) -N, N-dimethyl-benzenesulfonamide 1- [4- (piperidine-1-sulfonyl)- Phenyl] -ethanone O-methyl-oxime 4- (1-methoxyimino-ethyl) -N, N-dipropyl-benzenesulfonamide 2-fluoro-N- [4- (1-methoxyimino-ethyl) -phenyl]- Benzamide 1- (3,5-bis-trifluoromethyl-phenyl) -ethanone O-methyl-oxime 1- [4- (1H-imidazoli-1-yl) phenyl] -1-ethanone, O-methyloxime 1- [4- (trifluoromethyl-) phenyl] -1-ethanone, O-methyloxime 1- [1,1'-biphenyl] -4-yl-1-ethanone, O-methyloxime 1- (4-methylphenyl ) -1-Ethanone, O-methyl oxime 1- [4-fluoro-3- (trifluoromethyl) phenyl] ethanone O-methyl oxime 1- [3,5-bis (trifluoromethyl L) phenyl] ethanone O-benzyloxime 1- [4-chloro-3- (trifluoromethyl) phenyl] ethanone O-methyloxime 1- [3-fluoro-5- (trifluoromethyl) phenyl] ethanone O-methyl Oxime 1- [2-Fluoro-4- (trifluoromethyl) phenyl] ethanone O-methyloxime 1- [2-Fluoro-5- (trifluoromethyl) phenyl] ethanone O-methyloxime 1- (2,4- Dichlorophenyl) ethanone O-methyloxime 1- (2,4-dimethylphenyl) ethanone O-methyloxime 1- [2,4-bis (trifluoromethyl) phenyl] ethanone O-methyloxime 1- (3-bromophenyl) Ethanone O-methyloxime 1- (3-methylphenyl) ethanone O-methyloxime 1- [4- (4-morpholinyl) phenyl] ethanone O-methyloxime 1- (2-chloro-4-fluorophenyl) ethanone O- Methyl oxime 1- (4-bromo-2-fluorophene E) Ethanone O-methyloxime 1- (3,4-difluorophenyl) ethanone O-methyloxime 1- [3- (trifluoromethyl) phenyl] ethanone O-methyloxime 1- [2- (trifluoromethyl) phenyl ] Ethanone O-methyloxime 1- (2,4-difluorophenyl) ethanone O-methyloxime 1- [3-fluoro-4- (trifluoromethyl) phenyl] ethanone O-methyloxime 1- (3,4-dichlorophenyl ) Ethanone O-methyloxime 1- [4-fluoro-2- (trifluoromethyl) phenyl] ethanone O-methyloxime 1- (3-chloro-4-fluorophenyl) ethanone O-methyloxime 1- (4-chloro -3-fluorophenyl) ethanone O-methyloxime 1- (2,5-difluorophenyl) ethanone O-methyloxime 1- (2-bromo-4-fluorophenyl) ethanone O-methyloxime 1- (3,4- Dibromophenyl) ethanone O-methyloxime 1- (2-Bromophenyl) ethanone O-methyloxime Example 72 (Method 48) 1- (2-Trifluoromethyl-phenyl) -ethylamine Sodium borohydride (1.17 g) was added to zirconium tetrachloride (1.8 g). Slowly add to the flask containing (in 27 mL of tetrahydrofuran). 1- (2-trifluoromethyl
-Phenyl) -ethanone A solution of O-methyl-oxime (1.34 g) in 7.7 mL of tetrahydrofuran is added and the resulting solution is stirred at 25 ° C. for 12 hours. Reaction mixture
Cool to ° C. and slowly add water (16 mL). Excess ammonium hydroxide is added and the solution is extracted twice with ethyl acetate. The organic portion is washed twice with 1N hydrochloric acid. The aqueous (acid) layer is made basic with sodium hydroxide and extracted with ethyl acetate.
Extract twice. The organic layer is then washed with aqueous saturated sodium chloride and dried over anhydrous magnesium sulfate. The solvent was removed under reduced pressure to give the desired product as a yellow oil.
(0.20 g).

Using the above procedure and the appropriate starting materials, the following compounds were prepared: 1- (3-methoxy-phenyl) -ethylamine 1- (4-fluoro-phenyl) -propylamine 1-naphthalene-2 -Yl-ethylamine 4- (1-amino-ethyl) -benzonitrile 1- (4-trifluoromethyl-phenyl) -ethylamine 1- (4-methoxy-phenyl) -ethylamine 1-prop-2-ynyl-pyrrolidine 1 -(2-methoxy-phenyl) -ethylamine 1-m-tolyl-ethylamine 1- (2-bromo-phenyl) -ethylamine 1-o-tolyl-ethylamine C- (4-fluoro-phenyl) -C-phenyl-methyl Amine 1- (4-fluoro-phenyl) -pentylamine 1- (4-fluoro-phenyl) -2-phenyl-ethylamine 1- (2-trifluoromethyl-phenyl) -ethylamine 1- (3-bromo-phenyl) -Ethylamine 1- (3-chloro-phenyl) -ethylamine [4- (1-amino -Ethyl) -phenyl] -dimethyl-amine 1- (1-methyl-1H-pyrrolyl-2-yl) -ethylamine 1-thiophen-3-yl-ethylamine 1- [3,5-bis (trifluoromethyl) phenyl ] Propylamine 1- [3,5-bis (trifluoromethyl) phenyl] -1-butanamine or 1- [3,5-bis (trifluoromethyl) phenyl] butylamine 1- [3,5-bis (trifluoro Methyl) phenyl] -1-pentanamine 1- (4-methylphenyl) ethanamine 1- [3- (trifluoromethyl) phenyl] ethylamine 1- [4- (trifluoromethyl) phenyl] ethylamine 1- (3-methyl (Phenyl) -ethanamine 1- (3,4-dichlorophenyl) ethanamine 1- (2-bromo-phenyl) -ethylamine 1- (2-trifluoromethyl-phenyl) -ethylamine 1- (3-bromo-phenyl) -ethylamine 1 -(3-chloro-4-methoxy-phenyl) -ethylamine 4- (1-amino-ethyl) -N, N-dimethyl-benzenesulfonamide 1- [4- (piperidin-1-sulfonyl) -phenyl] -ethylamine 1-quinolin-6-yl-ethylamine 1- (3,5-bis-trifluoromethyl-phenyl) -ethylamine 4-[(1S) -1-aminoethyl] benzonitrile (S) -alpha-methyl-3,5-bis (trifluoromethyl) -benzenemethanamine (
S) -Alpha-methyl-3,5-bis (trifluoromethyl) -benzenemethanamine 1-biphenyl-4-yl-ethylamine 1- (4-fluoro-phenyl) -ethylamine 1- [4-fluoro-3- (Trifluoromethyl) phenyl] ethanamine 1- [4-chloro-3- (trifluoromethyl) phenyl] ethanamine N- {4-[(1R) -1-aminoethyl] phenyl} -1,2,3-thiadiazole -4-carboxamide N- {4-[(1S) -1-aminoethyl] phenyl} -1,2,3-thiadiazole-4-carboxamide 1- [3-fluoro-5- (trifluoromethyl) phenyl] ethylamine 1- [2-fluoro-4- (trifluoromethyl) phenyl] ethylamine 1- [2-fluoro-5- (trifluoromethyl) phenyl] ethylamine 1- (2,4-dichlorophenyl) ethylamine 1- (2,4 -Dimethylphenyl) ethylamine 1- [2,4-bis (trifluoromethyl) phenyl] ethylamine 1- (2-chloro-4-fluorophenyl (Enyl) ethylamine 1- (3,4-difluorophenyl) ethylamine 1- (4-bromo-2-fluorophenyl) ethylamine 1- (3-fluorophenyl) ethylamine 1- (2,4-difluorophenyl) ethylamine 1- [ 3-fluoro-4- (trifluoromethyl) phenyl] ethylamine 1- [4-fluoro-2- (trifluoromethyl) phenyl] ethylamine 1- (3-chloro-4-fluorophenyl) ethylamine 1- (4-chloro -3-Fluorophenyl) ethylamine 1- (3,4-dibromophenyl) ethylamine 1- (2-bromo-4-fluorophenyl) ethanamine 1- (2-bromo-4-fluorophenyl) ethylamine Example 73 (method 49 ) (2-Fluoro-5-trifluoromethyl-phenoxy) -acetonitrile A solution of 2-fluoro-5-trifluoromethylphenol (25 g) in 0.55 liter of reagent grade acetone was added to solid potassium carbonate (7.7 g). ), There is added as quickly bromoacetonitrile (10 mL) with. The homogeneous mixture is stirred vigorously for about 20 hours, it is poured into water and extracted into diethyl ether. The combined ether extracts are washed with saturated sodium chloride and dried over anhydrous potassium carbonate.
Filter and concentrate under reduced pressure to give a pale orange solid, which is subjected to column chromatography on silica gel, eluting with dichloromethane to give the desired product as a white solid (28.3g).

Using the above procedure and appropriate starting materials, the following compound was prepared: (3-bromo-phenylsulfanyl) -acetonitrile (3-chloro-phenylsulfanyl) -acetonitrile (4-iodo-phenoxy)- Acetonitrile (3-trifluoromethyl-phenylsulfanyl) -acetonitrile (3,5-dichloro-phenylsulfanyl) -acetonitrile (3,4-dichloro-phenylsulfanyl) -acetonitrile (3,4-dichloro-phenoxy) -acetonitrile (2 -Fluoro-phenoxy) -acetonitrile (3-fluoro-phenoxy) -acetonitrile (2-chloro-phenoxy) -acetonitrile (3-bromo-phenoxy) -acetonitrile (2-fluoro-5-trifluoromethyl-phenoxy) -acetonitrile ( 3-Iodo-phenoxy) -acetonitrile (4-bromo-phenoxy) -acetonitrile 74 (method 50) 3-fluoro-5-trifluoromethylphenethylamine tosylate 2.5 g of 3-fluoro-5-trifluoromethylphenylacetonitrile and 2.34 g
(12.3 mmol) in p-toluenesulfonic acid solution (in 75 mL of ethylene glycol monomethyl ether) is hydrogenated using 200 mg of 10% palladium on carbon catalyst at 40 psi at room temperature for 3 hours. The catalyst is filtered off and the solvent is evaporated to half the volume. 3-fluoro-5-trifluoromethylphenethylamine desired by standing
P-toluenesulfonate crystallizes out. 4.26 g (91%) of white crystals are collected by filtration.

Using the above procedure and the appropriate starting materials, the following compound was prepared: 2- (3,5-difluoro-phenyl) -ethylamine 2- (4-trifluoromethyl-phenyl) -ethylamine 2- (3,4-difluoro-phenyl) -ethylamine 2- (2-fluoro-phenyl) -ethylamine 2- (3-fluoro-5-trifluoromethyl-phenyl) -ethylamine 2- (2-fluoro-3-trifluoro Methyl-phenyl) -ethylamine 2- (2,4-bis-trifluoromethyl-phenyl) -ethylamine 2- (4-fluoro-3-trifluoromethyl-phenyl) -ethylamine Example 75 (Method 51) Aminomethyl-2-trifluoromethyl-phenyl) -dimethyl-amine A solution of 4-dimethylamino-3-trifluoromethylbenzonitrile (0.35 g) (2 mL
In tetrahydrofuran) with a suspension of lithium aluminum hydride (0.1 g) (2 m
(In L of tetrahydrofuran) at 0 ° C. slowly and stir under argon for 2 hours. Water (0.1 mL) is added slowly at 0 ° C., followed by 5% sodium hydroxide (0.1 mL) and water (0.3 mL). The gray solid formed is filtered and washed with tetrahydrofuran. The filtrate is collected and concentrated under reduced pressure and the resulting oil is chromatographed on silica gel (as eluent).
Use 15% methanol in methylene chloride) to give the desired product as a pale orange oil (0.164 g).

Using the above procedure and the appropriate starting materials, the following compound was prepared: 4-Piperidin-1-yl-3-trifluoromethyl-benzylamine (4-aminomethyl-2-trifluoromethyl- (Phenyl) -dimethyl-amine 4- (4-methyl-piperazin-1-yl) -3-trifluoromethyl-benzylamine (3-aminomethyl-5-trifluoromethyl-phenyl) -dimethyl-amine [3- ( 2-amino-ethyl) -5-trifluoromethyl-phenyl] -dimethyl-amine [4- (2-amino-ethyl) -2-methyl-phenyl] -dimethyl-amine Example 76 (method 52) 3-dimethyl Amino-5-trifluoromethyl-benzaldehyde Diisobutylaluminum hydride (10 mL of a 1 M solution in methylene chloride) is added to a solution of 3-dimethylamino-5-trifluoromethylbenzonitrile (1.06 g) in 25 mL of methylene chloride. Drop at ℃, and the mixture Is stirred for 2 hours. While at 0 ° C., a saturated aqueous solution of potassium sodium tartrate (8 mL) is slowly added, and the solution is added for 1.5 min.
Stir for hours. The reaction mixture is then extracted with ethyl acetate, dried over anhydrous magnesium sulfate and concentrated under reduced pressure to give the desired product as a yellow solid (0.97g).

Using the above procedure and the appropriate starting materials, the following compounds were prepared: 3-dimethylamino-5-trifluoromethyl-benzaldehyde 4-dimethylamino-3-methyl-benzaldehyde Example 77 (Method 53) ) Dimethyl- [3- (2-nitro-vinyl) -5-trifluoromethyl-phenyl] amine Nitromethane (0.473 g) was added to 3-dimethylamino-5-trifluoromethylbenzaldehyde (0.885 g) and aluminum acetate (0.339 g). g) (in 3.4 mL of acetic acid) and the solution is heated at 110 ° C. for 6 hours. The reaction mixture is cooled to 0 ° C. and a solid forms, which is filtered and washed with 1: 1 water-acetic acid. This solid is recrystallized from ethanol to give the desired product as a red solid (0.39g).

Using the above procedure and the appropriate starting materials, the following compounds were prepared: dimethyl- [3- (2-nitro-vinyl) -5-trifluoromethyl-phenyl] -amine dimethyl- [2- Methyl-4- (2-nitro-vinyl) -phenyl] -amine Example 78 (method 54) 3- (4-Bromo-phenyl) -propionitrile diethyl azodicarboxylate (5.2 g) was added to 4-bromo -Phenethyl alcohol (
2.01 g) and triphenylphosphine (7.9 g) in 16 mL of diethyl ether
At 0 ° C. The reaction mixture is stirred for 10 minutes and a solution of acetone cyanohydrin (2.6 g) in 10 mL of diethyl ether is added. The clear orange solution is stirred at 0 ° C. for 5 minutes and then at 25 ° C. for 12 hours. The reaction mixture is filtered and washed with diethyl ether. The filtrate is concentrated under reduced pressure and subjected to column chromatography on silica gel (using 10% ethyl acetate-hexane as eluent) to give the desired product as a pale yellow oil (2.04 g).

Example 79 (method 55) N, N-dimethyl-formamide dimethyl acetal in a solution of 3-dimethylamino-2-isocyano-acrylic acid ethyl ester ethyl isocyanoacetate (5.0 g) in ethanol (100 mL) (6.5 g) is added dropwise over 10 minutes with stirring. The reaction is stirred for 24 hours and the ethanol is evaporated. The resulting oil is passed through magnesium silicate using 50% ethyl acetate-hexane as eluent. The solvent was removed and the resulting oil was crystallized from ethyl acetate-hexane to give yellow needles (3.0 g).

Example 80 (Method 56) A solution of 4-carbethoxythiazole 3-dimethylamino-2-isocyano-acrylic acid ethyl ester (1.0 g) and triethylamine (3.0 g) in 30 mL of tetrahydrofuran Treat with gaseous hydrogen sulfide until the starting material is consumed. The mixture is concentrated to an oil and purified by column chromatography using silica and 25% ethyl acetate-hexane as eluent. The purified material (0.61 g) is isolated as an oil.

Example 81 (Method 34) N- {4- [3- (5-Chloro-2,4-dimethoxy-phenyl) -ureido] -phenyl} -2-fluoro-benzamide N- (4-amino- Phenyl) -2-fluoro-benzamide (0.43 g) suspension (4 mL
(In setonitrile), 5-chloro-2,4-dimethoxyphenylisocyanate (0.40 g)
To process. The mixture goes into solution and stands for 12 hours. A white solid forms,
And collected by filtration (0.79 g). [M + H] 444. Using the above procedure and appropriate starting materials, the following compounds were prepared:number M + H Compound name 81 445 N- {4- [3- (5-chloro-2,4-dimethoxy-phenyl) -ureido] -phenyl} -2-fluoro-benzamide 82 441 N- {4- [3- (5-chloro- 2,4-dimethoxy-phenyl) -ureido] -phenyl} -2-methyl-benzamide 83 435 [1,2,3] thiadiazole-4-carboxylic acid {4- [3- (5-chloro-2,4- Dimethoxy-phenyl) -ureido] -phenyl} -amide 84 443 [1,2,3] thiadiazole-4-carboxylic acid {4- [3- (4-chloro-3-trifluoromethyl-phenyl) -ureido]- Phenyl} -amide 85 453 N- {4- [3- (4-Chloro-3-trifluoromethyl-phenyl) -ureido] -phenyl} -2-fluoro-benzamide 86 409 [1,2,3] thiadiazole- 4-carboxylic acid {4- [3- (3,5-dichloro-phenyl) -ureido] -phenyl} -amide 87 486 N- {4- [3- (3,5-bis-trifluoromethyl-phenyl) -Ureido] -phenyl} -2-fluoro-benzamide 88 458 furan-2-carboxylic acid {4- [3- (3,5-bis -Trifluoro-methyl-phenyl) -ureido] -phenyl} -amide 89 476 [1,2,3] thiadiazole-4-carboxylic acid {4- [3- (3,5-bis-trifluoromethyl-phenyl) -Ureido] -phenyl} -amide 90 423 [1,2,3] thiadiazole-4-carboxylic acid {4- [3- (3,4-dichloro-benzyl) -ureido] -phenyl} -amide Example 91 ( Method 31) [1,2,3] -thiadiazole-4-carboxylic acid {4- [3- (3,5-bis-trifluoromethylphenyl) -thioureido] -phenyl} amide [1,2,3]- Of thiadiazole-4-carboxylic acid (4-amino-phenyl) amide (2.0 g)
1-isothiocyanato-3,5-bis-trifluoro in solution (in 50 mL of acetonitrile)
Methylmethyl-benzene (2.5 g) (in 50 mL of acetonitrile) is added dropwise
Add dropwise quickly and stir the reaction at room temperature. After 90 minutes, the solvent was removed under reduced pressure to produce
The brown solid is recrystallized from ethyl acetate / hexane to give pure product. [M + H] 492. Using the above procedure and the appropriate starting materials, the following compounds were prepared:number M + H Compound name 92 506 [3-chloro-5- (3- {4- [1, 2, 3] Thiadiazole-4-carbonyl) -amino] -phenyl} -thioureido) -phenyl] -carbamic acid tert-butyl ester 93 409 1- (5-chloro-2, 4-dimethoxy-phenyl) -3- (4-morpholin-4-yl) -thiourea 94 370 1- (5-chloro-2, 4-dimethoxy-phenyl) -3- (4-methylsulfanyl-phenyl) -thiourea 95 338 1- (5-chloro-2, 4-dimethoxy-phenyl) -3-p-tolyl-thiourea 96 414 (4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -phenylsulfanyl} -acetic acid 97 384 1- (5-chloro-2, 4-dimethoxy-phenyl) -3- [4- (2-hydroxy-ethoxy) -phenyl] -thiourea 98 340 1- (5-chloro-2, 4-dimethoxy-phenyl) -3- (4-hydroxy-phenyl) -thiourea 99 395 N- {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -phenyl} -N-methylacetamide 100 381 N- {3- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -phenyl} -acetamide 101 411 {4- [3- (5-chloro-2, 4-Dimethoxy-phenyl) -thioureido] -phenyl} -carbamic acid ethyl ester 102 319 1- (2, 4-dimethoxy-phenyl) -3- (4-methoxy-phenyl) -thiourea 103 346 N- {4- [3- (2, 4-dimethoxy-phenyl) -thioureido] -phenyl} -acetamide 104 316 N- {4- [3- (4-methoxy-phenyl) -thioureido] -phenyl} -acetamide 105 316 N- {4- [3- ( 2-methoxy-phenyl) -thioureido] -phenyl} -acetamide 106 351 N- {4- [3- (3-chloro-4-methoxy-phenyl) -thioureido] -phenyl} -acetamide 107 351 N- {4- [3- (5-chloro-2-methoxy-phenyl) -thioureido] -phenyl} -acetamide 108 371 N- {4- [3- (3, 5-dichloro-4-hydroxy-phenyl) -thioureido] -phenyl} -acetamide 109 385 N- {4- [3- (3, 5-dichloro-4-methoxy-phenyl) -thioureido] -phenyl} -acetamide 110 381 N- {4- [3- (4-chloro-2, 5-dimethoxy-phenyl) -thioureido] -phenyl} -acetamide 111 389 N- {4- [3- (2-chloro-5-trifluoromethyl-phenyl) -thioureido] -phenyl} -acetamide 112 389 N- { 4- [3- (4-chloro-3-trifluoromethyl-phenyl) -thioureido] -phenyl} -acetamide 113 422 Benzoic acid 4- [3- (4-acetylamino-phenyl) -thioureido] -3-hydroxy -Phenyl ester 114 457 N- {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -phenyl} -2-methyl-benzamide 115 501 acetic acid 2- {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -phenyl-carbamoyl} -phenyl ester 116 461 N- {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -phenyl} -4-fluoro-benzamide 117 461 N- {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -phenyl} -3-fluoro-benzamide 118 461 N- {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -phenyl} -2-fluoro-benzamide 119 473 N- {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -phenyl} -2-methoxy-benzamide 120 473 N- {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -phenyl} -3-methoxy-benzamide 121 473 N- {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -phenyl} -4-methoxy-benzamide 122 443 N- {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -phenyl} -benzamide 123 417 N- {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -phenyl} -methanesulfonamide 124 331 N- {4- [3- (3-nitro-phenyl) -thioureido] -phenyl} -acetamide 125 339 1- (3-chloro- 4-methoxy-phenyl) -3- (3-nitro-phenyl) -thiourea 126 337 N- {4- [3- (5-chloro-2-hydroxy-phenyl) -thioureido] -phenyl} -acetamide 127 439 { 4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -phenyl} -carbamic acid tert-butyl ester 128 351 N- {4- [3- (3-chloro-4-hydroxy-5-methyl-phenyl) -thioureido] -phenyl} -Acetamide 129 385 N- {4- [3- (3, 5-dichloro-4-hydroxy-2-methyl-phenyl) -thioureido] -phenyl} -acetamide 130 318 N- {4- [3- (2, 4-dihydroxy-phenyl) -thioureido] -phenyl} -acetamide 131 414 N- {4- [3- (2, 4-methoxy-5-trifluoromethyl-phenyl) -thioureido] -phenyl} -acetamide 132 332 N- {4- [3- (2-hydroxy-4-methoxy-phenyl) -thioureido] -phenyl} -acetamide 133 465 N- {4- [3- (3, 5-Dichloro-4-methoxy-phenyl) -thioureido] -phenyl} -4-fluoro-benzamide 134 500 3-acetylamino-N- {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -phenyl} -benzamide 135 488 N- {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -phenyl} -3-nitro-benzamide 136 486 N- {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -phenyl} -3-dimethylamino-benzamide 137 536 N- {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -phenyl} -3-methanesulfonyl-amino-benzamide 138 511 N- {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -phenyl} -2-trifluoromethyl-benzamide 139 459 N- {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -phenyl} -2-hydroxy-benzamide 140 479 N- {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -phenyl} -2, 6-difluoro-benzamide 141 477 2-chloro-N- {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -phenyl} -benzamide 142 522 2-bromo-N- {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -phenyl} -benzamide 143 488 N- {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -phenyl} -2-nitro-benzamide 144 445 pyrazine-2-carboxylic acid {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -phenyl} -amide 145 463 5-methyl-thiophen-2-carboxylic acid {4- [3- (5-chloro-2,4- 4-dimethoxy-phenyl) -thioureido] -phenyl} -amide 146 494 quinoline-8-carboxylic acid {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -phenyl} -amide 147 446 1-methyl-1H-pyrrole-2-carboxylic acid {4- [3- (5-chloro-2,4- 4-dimethoxy-phenyl) -thioureido] -phenyl} -amide 148 369 1- (5-chloro-2, 4-dimethoxy-phenyl) -3- (2-nitro-phenyl) -thiourea 149 369 1- (5-chloro-2, 4-dimethoxy-phenyl) -3- (4-nitro-phenyl) -thiourea 150 425 N- {4- [3- (5-bromo-2, 4-dimethoxy-phenyl) -thioureido] -phenyl} -acetamide 151 376 N- {4- [3- (3, Four, 5-trimethoxy-phenyl) -thioureido] -phenyl} -acetamide 152 399 N- {4- [3- (3, 5-dichloro-2-methoxy-4-methyl-phenyl) -thioureido] -phenyl} -acetamide 153 499 benzo [b] thiophen-2-carboxylic acid {4- [3- (5-chloro-2,4- 4-dimethoxy-phenyl) -thioureido] -phenyl} -amide 154 483 benzofuran-2-carboxylic acid {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -phenyl} -amide 155 444 N- {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -phenyl} -isonicotinamide 156 493 naphthalene-2-carboxylic acid {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -phenyl} -amide 157 493 naphthalene-1-carboxylic acid {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -phenyl} -amide 158 494 isoquinoline-1-carboxylic acid {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -phenyl} -amide 159 494 Quinoline-2-carboxylic acid {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -phenyl} -amide 160 444 N- {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -phenyl} -nicotinamide 161 478 5-nitro-furan-2-carboxylic acid {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -phenyl} -amidocarbamic acid phenyl ester 162 459 {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -phenyl} -163 467 5-chloro-furan-2-carboxylic acid {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -phenyl} -amide 164 439 {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -phenyl} -carbamic acid isobutyl ester 165 397 {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -phenyl} -carbamic acid methyl ester 166 433 furan-3-carboxylic acid {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -phenyl} -amide 167 447 3-methyl-furan-2-carboxylic acid {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -phenyl} -amide 168 512 5-bromo-furan-2-carboxylic acid {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -phenyl} -amide 169 512 4-bromo-furan-2-carboxylic acid {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -phenyl} -amide 170 433 furan-2-carboxylic acid {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -phenyl} -amide 171 467 {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -phenyl} -carbamic acid hexyl ester 172 494 isoquinoline-4-carboxylic acid {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -phenyl} -amide 173 451 [1, 2, 3] thiadiazole-4-carboxylic acid {4- [3- (5-chloro-2,3 4-dimethoxy-phenyl) -thioureido] -phenyl} -amide 174 434 1H- [1, 2, 3] triazole-4-carboxylic acid {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -phenyl} -amide 175 528 3-bromo-thiophen-2-carboxylic acid {4- [3- (5-chloro-2,2- 4-dimethoxy-phenyl) -thioureido] -phenyl} -amide 176 399 N- {4- [3- (3, 5-dichloro-4-ethoxy-phenyl) -thioureido] -phenyl} -acetamide 177 427 N- {4- [3- (4-butoxy-3, 5-dichloro-phenyl) -thioureido] -phenyl} -acetamide 178 461 N- {4- [3- (4-benzyloxy-3, 5-dichloro-phenyl) -thioureido] -phenyl} -acetamide 179 381 N- {4- [3- (3-chloro-2, 4-dimethoxy-phenyl) -thioureido] -phenyl} -acetamide 180 530 (3- {4- [3- (5-chloro-2, 4-Dimethoxy-phenyl) -thioureido] -phenylcarbamoyl} -phenyl) -carbamic acid ethyl ester 181 458 2-amino-N- {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -phenyl} -benzamide 182 519 biphenyl-2-carboxylic acid {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -phenyl} -amide 183 469 1- (5-chloro-2, 4-dimethoxy-phenyl) -3- [4- (1, 3-dioxo-1, 3-dihydro-isoindolin-2-yl) -phenyl] -thiourea 184 487 N- {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -phenyl} -phthalamic acid 185 473 N- {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -phenyl} -2-hydroxy-methyl-benzamide 186 479 N- {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -phenyl} -2, 3-difluoro-benzamide 187 479 N- {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -phenyl} -2, 5-difluoro-benzamide 188 479 N- {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -phenyl} -2, 4-difluoro-benzamide 189 500 2-acetylamino-N- {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -phenyl} -benzamide 190 441 1- (5-chloro-2, 4-dimethoxy-phenyl) -3- (6-oxo-5, 6-dihydro-phenanthridin-2-yl) -thiourea 191 536 N- {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -phenyl} -2-methanesulfonylamino-benzamide 192 497 N- {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -phenyl} -2, 3, 4-trifluoro-benzamide 193 533 N- {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -phenyl} -2, 3, Four, Five, 6-pentafluoro-benzamide 194 489 N- {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -phenyl} -2-methylsulfanyl-benzamide 195 431 5-methyl-furan-2-carboxylic acid {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -ureido] -phenyl} -amide 196 467 5-difluoromethyl-furan-2-carboxylic acid {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -ureido] -phenyl} -amide 197 472 N- {4- [3- (5-iodo-2, 4-dimethoxy-phenyl) -thioureido] -phenyl} -acetamide 198 364 N- {4- [3- (5-fluoro-2, 4-dimethoxy-phenyl) -thioureido] -phenyl} -acetamide 199 365 N- {4- [3- (5-chloro-2-methoxy-4-methyl-phenyl) -thioureido] -phenyl} -acetamide 200 459 [ 1, 2, 3] Thiadiazole-4-carboxylic acid {4- [3- (4-chloro-3-trifluoromethyl-phenyl) -thioureido] -phenyl} -amide 201 455 [1, 2, 3] thiadiazole-4-carboxylic acid {4- [3- (3, 5-dichloro-4-methoxy-phenyl) -thioureido] -phenyl} -amide 202 392 N- {4- [3- (3-chloro-4-diethylamino-phenyl) -thioureido] -phenyl} -acetamide 203 432 N -(4- {3- [3-chloro-4- (cyclohexyl-methyl-amino) -phenyl] -thioureido} -phenyl) -acetamide 204 506 1-hydroxy-naphthalene-2-carboxylic acid {4- [3- (4-acetylamino-phenyl) -thioureido] -2-chloro-phenyl} -amide 205 406 N- {4- [3- (3-chloro-4-morpholin-4-yl-phenyl) -thioureido] -phenyl } -Acetamide 206 443 1- (5-chloro-2, 4-dimethoxy-phenyl) -3- (3-chloro-4-morpholin-4-yl-phenyl) -thiourea 207 372 1- (5-chloro-2, 4-dimethoxy-phenyl) -3- (5-chloro-2-methyl-phenyl) -thiourea 208 501 N- {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -phenyl} -isophthalamic acid methyl ester 209 487 N- {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -phenyl} -isophthalamic acid 210 549 3-benzyloxy-N- {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -phenyl} -benzamide 211 434 N- (4- {3- [5-chloro-2-methoxy-4- (4-nitrilo-butoxy) -phenyl] -thioureido} -phenyl ) -Acetamide 212 406 N- (4- {3- [5-chloro-2-methoxy-4- (2-nitrilo-ethoxy) -phenyl] -thioureido} -phenyl) -acetamide 213 406 N- (4- { 3- [5-chloro-4-methoxy-2- (2-nitrilo-ethoxy) -phenyl] -thioureido} -phenyl) -acetamide 214 411 N- (4- {3- [5-chloro-2- (2 -Hydroxy-ethoxy) -4-methoxy-phenyl] -thioureido} -phenyl) -acetamide 215 411 N- (4- {3- [5-chloro-4- (2-hydroxy-ethoxy) -2-methoxy-phenyl) ] -Thioureido} -phenyl) -acetamide 216 481 {4- [3- (4-acetylamino-phenyl) -thioureido] -2-chloro-5-methoxy-phenoxy} -acetic acid tert-butyl ester 217 439 {4- [3- (4-acetyl Mino-phenyl) -thioureido]-2-chloro-5-methoxy-phenoxy} -acetic acid methyl ester 218 481 {2- [3- (4-acetylamino-phenyl) -thioureido] -4- 4-chloro-5-methoxy- Phenoxy} -acetic acid tert-butyl ester 219 515 3-butoxy N- {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -phenyl} -benzamide 220 505 N- {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -phenyl} -2-methanesulfinyl-benzamide 221 545 (3- {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -phenylcarbamoyl} -phenoxy) -acetic acid ethyl ester 222 517 (3- {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -phenylcarbamoyl} -phenoxy) -acetic acid 223 367 N- {4- [3- (5-chloro-4-hydroxy-2-methoxy-phenyl) -thioureido] -phenyl}- Acetamide 224 444 pyridine-2-carboxylic acid {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -phenyl} -amide 225 494 quinoline-4-carboxylic acid {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -phenyl} -amide 226 436 N- {4- [3- (5-chloro-4-methoxy-2-morpholin-4-yl-phenyl) -thioureido] -phenyl}- Acetamide 227 394 N- {4- [3- (5-Chloro-2-dimethylamino-4-methoxy-phenyl) -thioureido] -phenyl} -acetamide 228 420 N- {4- [3- (5-chloro- 4-methoxy-2-pyrrolidin-1-yl-phenyl) -thioureido] -phenyl} -acetamido 229 434 N- {4- [3- (5-chloro-4-methoxy-2-piperidin-1-yl-phenyl) ) -Thioureido] -phenyl} -acetamide 230 405 [1, 2, 3] Thiadiazole-4-carboxylic acid {4- [3- (3-chloro-4-methyl-phenyl) -thioureido] -phenyl} -amide 231 415 N- {4- [3- (3-chloro-4- Methyl-phenyl) -thioureido] -phenyl} -2-fluoro-benzamide 232 427 N- {4- [3- (3-chloro-4-methyl-phenyl) -thioureido] -phenyl} -3-methoxy-benzamide 233 387 Furan-2-carboxylic acid {4- [3- (3-chloro-4-methyl-phenyl) -thioureido] -phenyl} -amide 234 411 N- {4- [3- (3-chloro-4-methyl -Phenyl) -thioureido] -phenyl} -2-methyl-benzamide 235 433 N- {4- [3- (3-chloro-4-methyl-phenyl) -thioureido] -phenyl} -2, 6-difluoro-benzamide 236 398 pyridine-2-carboxylic acid {4- [3- (3-chloro-4-methyl-phenyl) -thioureido] -phenyl} -amide 237 502 [1, 2, 3] Thiadiazole-4-carboxylic acid (4- {3- [3-chloro-4- (cyclohexyl-methyl-amino) -phenyl] thioureido} -phenyl) -amide 238 512 N- (4- {3- [3 -Chloro-4- (cyclohexyl-methyl-amino) -phenyl] -thioureido] -phenyl) -2-fluoro-benzamide 239 404 N- {4- [3- (3-chloro-4-piperidin-1-yl- Phenyl) -thioureido] -phenyl} -acetamide 240 364 N- {4- [3- (3-chloro-4-dimethylamino-phenyl) -thioureido] -phenyl} -acetamide 241 426 N- {4- [3- (4-benzylamino-3-chloro-phenyl) -thioureido] -phenyl} -acetamide 242 390 N- {4- [3- (3-chloro-4-pyrrolidin-1-yl-phenyl) -thioureido] -phenyl } -Acetamide 243 419 N- (4- {3- [3-chloro-4- (4-methyl-piperazin-1-yl) -phenyl) -thioureido} -phenyl) -acetamide 244 469 N- {4- [ 3- (4-chloro-3-trifluoro) Methyl-phenyl) -thioureido] -phenyl} -2-fluorobenzamide 245 422 N- {4- [3- (2-benzylamino-4-methoxy-phenyl) -thioureido] -phenyl} -acetamide 246 484 furan-2 -Carboxylic acid (4- {3- [3-chloro-4- (cyclohexyl-methyl-amino) -phenyl] -thioureido} -phenyl) -amide 247 508 N- (4- {3- [3-chloro-4 -(Cyclohexyl-methyl-amino) -phenyl] -thioureido} -phenyl) -2-methyl-benzamide 248 530 N- (4- {3- [3-chloro-4- (cyclohexyl-methyl-amino) -phenyl] -Thioureido} -phenyl) -2, 6-difluoro-benzamide 249 495 pyridine-2-carboxylic acid (4- {3- [3-chloro-4- (cyclohexyl-methyl-amino) -phenyl] -thioureido} -phenyl) -amide 250 524 N- (4 -{3- [3-chloro-4- (cyclohexyl-methyl-amino) -phenyl] -thioureido} -phenyl) -3-methoxy-benzamide 251 376 N- (4- {3- [3-chloro-4- (2-Nitro-ethoxy) -phenyl] -thioureido} -phenyl) -acetamide 252 393 N- {4- [3- (4-sec-butoxy-3-chloro-phenyl) -thioureido] -phenyl} -acetamide 253 501 Acetic acid 3- {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -phenylcarbamoyl} -phenyl ester 254 459 N- {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -phenyl} -3-hydroxy-benzamide 255 487 benzo [1, 3] dioxole-4-carboxylic acid {4- [3- (5-chloro-2, 4-dimethoxy-phenyl] thioureido] -phenyl} -amide 256 527 N- {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -phenyl} -3-trifluoromethoxy-benzamide 257 530 N- {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -phenyl} -3- (2-dimethylamino-ethoxy) -benzamide 258 572 N- {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -phenyl} -3- (2-morpholin-4-yl-ethoxy) -benzamide 259 406 N- {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -2-cyano-phenyl} -acetamide 260 521 N- {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -2, 5-dimethoxy-phenyl} -2-fluoro-benzamide 261 441 N- {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -2, 5-dimethoxy-phenyl} -acetamide 262 527 2- {4- [3- (4-acetylamino-phenyl) -thioureido] -2-chloro-phenoxy} -5-chloro-benzenesulfonic acid 263 562 2- {4 -[3- (4-acetylamino-phenyl) -thioureido] -2-chloro-phenoxy} -4, 5-dichloro-benzenesulfonic acid 264 527 4-phenyl- [1, 2, 3] thiadiazole-5-carboxylic acid {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -phenyl} -amide 265 381 N- (4- {3- [3-chloro-4- (2-hydroxy-ethoxy) -phenyl] thioureido} -phenyl) -acetamide 266 393 N- {4- [3- (4-butoxy-3-chloro-phenyl) -thioureido] -phenyl} -acetamide 267 446 N- (4- {3- [3-chloro-4- (cyclohexyl-ethyl-amino) ) -Phenyl] -thioureido} -phenyl) -acetamide 268 365 N- {4- [3- (3-chloro-4-ethoxy-phenyl] -thioureido] -phenyl} -acetamide 269 427 N- {4- [3 Tert-butyl-(4-benzyloxy-3-chloro-phenyl] -thioureido] -phenyl} -acetamide 270 317 {4-[(3-methyl-furan-2-carbonyl) -amino] -phenyl} -carbamic acid Ester 271 456 N- {4- [3- (2-benzylamino-5-chloro-4-methoxy-phenyl) -thioureido] -phenyl} -acetamide 272 420 N- {4- [3- (3-chloro- 4-Zipro 273 458 N- (4- {3- [4-allyl-cyclohexyl-amino) -3-chloro-phenyl] -thioureido} -phenyl) -acetamide 274 411 N- {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -2-methoxy-phenyl} -acetamide 275 415 N- {2-chloro-4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -phenyl} -acetamide 276 493 furan-2-carboxylic acid {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -2, 5-dimethoxy-phenyl} -amide 277 486 N- {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -2-cyano-phenyl} -2-fluoro-benzamide 278 495 N- {2-chloro-4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -phenyl} -2-fluoro-benzamide 279 465 5-methyl- [1, 2, 3] thiadiazole-4-carboxylic acid {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) thioureido] -phenyl-amide 280 517 5-furan-3-yl- [1, 2, 3] thiadiazole-4-carboxylic acid {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) thioureido] -phenyl} -amide 281 527 5-phenyl- [1, 2, 3] thiadiazole-4-carboxylic acid {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) thioureido] -phenyl} -amide 282 458 N- (4- {3- [3-chloro-4- (octahydro-quinolin-1-yl) -phenyl] -thioureido} -phenyl) -acetamide 283 458 N- [5-[[[(5-chloro-2, 4-dimethoxy-phenyl) amino] thioxomethyl] amino] -2-pyridinyl] -2-methylbenzamide 284 434 furan-2-carboxylic acid {5- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -pyridin-2-yl} -amide 285 425 N- {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -2-methoxy-5-methyl-phenyl} -acetamide 286 505 N- {4- [3- (5-chloro-2, 4-Dimethoxy-phenyl) -thioureido] -2-methoxy-5-methyl-phenyl} -2-fluoro-benzamide 287 477 Furan-2-carboxylic acid {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -2-methoxy-5-methyl-phenyl} -amide 288 517 4-furan-3-yl- [1, 2, 3] thiadiazole-5-carboxylic acid {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) thioureido] -phenyl} -amide 289 462 N- {5- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -pyridin-2-yl} -fluoro-benzamide 290 384 N- {4- [3- (4-methoxy-3-trifluoromethyl-phenyl) -thioureido] -phenyl} -Acetamide 291 394 N- [4- (3- {3-chloro-4-[(2-hydroxy-ethyl) -methyl-amino] -phenyl} -thioureido) -phenyl] acetamide 292 485 N- {2- Benzoyl-4- [3- (5-chloro-2, 4-dimethoxy-phenyl) thioureido] -phenyl} -2-acetamide 293 565 N- {2-benzoyl-4- [3- (5-chloro-2, 4-Dimethoxy-phenyl) thioureido] -phenyl} -2-fluoro-benzamide 294 537 {2-benzoyl-4- [3- (5-chloro-2,2-furan-2-carboxylate) 4-dimethoxy-phenyl) -thioureido] -phenyl} -amide 295 475 N- {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -3-methyl-phenyl} -2-fluoro-benzamide 296 447 furan-2-carboxylic acid {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -3-methyl-phenyl} -amide 297 395 N- {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -3-methyl-phenyl} -acetamide 298 435 N- [4- (3- {3-chloro-4-[(3-dimethylamino-propyl) -methyl-amino] ] -Phenyl} -thioureido) -phenyl] acetamide 299 418 N- {4- [3- (3-chloro-4-cyclohexylamino-phenyl) -thioureido) -phenyl} acetamide 300 421 N- [4- (3- {3-chloro-4-[(2-dimethylamino-ethyl) -methyl-amino] -phenyl} -thioureido) -phenyl] acetamide 301 580 5-[[[(5-chloro-2, 4-dimethoxyphenyl) amino] thioxomethyl] amino] -2-[(2-fluorobenzoyl) amino] -N-phenyl-benzamide 302 552 furan-2-carboxylic acid {4- [3- (5-chloro- 2, 4-dimethoxy-phenyl) -thioureido] -2-phenylcarbamoyl-phenyl} -amide 303 491 N- {4- [3- (5-chloro-2, 4-dimethoxy-phenyl-thioureido] -2-methoxy-phenyl} -2-fluoro-benzamide 304 463 furan-2-carboxylic acid {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -2-methoxy-phenyl} -amide 305 449 N- {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -2-trifluoromethyl-phenyl} -acetamide 306 458 furan-2-carboxylic acid {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -2-cyano-phenyl} -amide 307 467 furan-2-carboxylic acid {2-chloro-4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -phenyl} -amide 308 501 furan-2-carboxylic acid {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -2-trifluoromethyl-phenyl} -amide 309 395 N- {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -2-methyl-phenyl} -acetamide 310 475 N- {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -2-methyl-phenyl} -2-fluoro-benzamide 311 447 furan-2-carboxylic acid {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -2-methyl-phenyl} -amide 312 378 N- {4- [3- (4-acetylamino-phenyl) -thioureido] -2-chloro-phenyl} -acetamide 313 408 {4- [3- (4-acetylamino-phenyl) -thioureido] -2-chloro-phenyl} -carbamic acid ethyl ester 314 382 N- {5- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -pyridin-2-yl} -acetamide 315 509 N- (4- {3- [4- (1-benzyl-piperidin-4-ylamino) -3-chloro-phenyl ] -Thioureido} -phenyl) -acetamide 316 407 N- (4- {3- [3-chloro-4- (2-dimethylamino-ethylamino) -phenyl] -thioureido} -phenyl) -acetamide 317 408 N- [4- (3- {3-chloro-4-[(2-methoxy-ethyl) -methyl-amino] -phenyl} -thioureido) -phenyl] -acetamide 318 421 N- (4- {3- [3- Chloro-4- (3-dimethylamino-propylamino) -phenyl] -thioureido} -phenyl) -acetamide 319 495 N- (4- {3- [4- (1-benzyl-pyrrolidin-3-ylamino) -3] -Chloro-phenyl] -thioureido} -phenyl} -acetamide 320 483 Furan-2-carboxylic acid {5-chloro-4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -2-hydroxy-phenyl} -amide 321 431 N- {5-chloro-4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -2-hydroxy-phenyl} -acetamide 322 511 (5H, 11H-benzo [e] pyrrolo [1, 2-a] [1, 4] Diazepin-10-yl)-(2-chloro-4-imidazoli-1-yl-phenyl) -methanone 323 451 [1, 2, 3] thiadiazole-5-carboxylic acid {4- [3- (5-chloro-2,3 4-dimethoxy-phenyl) thioureido] -phenyl} -amide 324 483 furan-2-carboxylic acid {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -naphthalen-1-yl} -amide 325 511 N- {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -naphthalen-1-yl} -2-fluoro-benzamide 326 429 N- {5-chloro-4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -2-methyl-phenyl} -acetamide 327 509 N- {5-chloro-4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -2-methyl-phenyl} -2-fluoro-benzamide 328 481 furan-2-carboxylic acid {5-chloro-4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -2-methyl-phenyl} -amide 329 431 N- {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -naphthalen-1-yl} -acetamide 330 416 Furan-2-carboxylic acid {4- [3- (3-chloro-4-dimethylamino-phenyl) -thioureido] -phenyl } -Amide 331 561 Furan-2-carboxylic acid [4- (3- {4-[(1-benzyl-pyrrolidin-3-yl) -methyl-amino] -3-chloro-phenyl) -thioureido) -phenyl] -Amido 332 513 N- [4- (3- {3-chloro-4- [methyl- (1-methyl-pyrrolidin-3-yl) -amino] -phenyl} -thioureido) -phenyl] -2-fluoro- Benzamide 333 463 N- {4- [3- (5-chloro-2-methoxy-4-methyl-phenyl) -thioureido] -phenyl} -2, 6-difluoro-benzamide 334 420 N- (4- {3- [3-chloro-4- (1-methyl-pyrrolidin-3-yloxy) -phenyl] -thioureido} -phenyl) -acetamide 335 434 N- ( 4- {3- [3-chloro-4- (1-methyl-piperidin-4-yloxy) -phenyl] -thioureido} -phenyl) -acetamide 336 422 N- (4- {3- [3-chloro- 4- (3-dimethylamino-propoxy) -phenyl] -thioureido} -phenyl) -acetamide 337 425 2-acetylamino-5- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -benzoic acid 338 505 5- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -2- (2-fluoro-benzoylamino) -benzoic acid 339 477 5- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -2-[(furan-2-carbonyl) amino] -benzoic acid 340 545 N- [4- (3- {3-chloro-4- [methyl- (1-methyl- Piperidin-4-yl) -amino] -phenyl} -thioureido) -phenyl} -2, 6-difluoro-benzamide 341 503 [1, 2, 3] Thiadiazole-4-carboxylic acid [4- (3- {3-chloro-4- [methyl- (1-methyl-pyrrolidin-3-yl) -amino] -phenyl} -thioureido) -phenyl] -amide 342 443 N- {4- [3- (3-chloro-4-methylsulfanyl-phenyl) -thioureido] -phenyl} -2-methyl-benzamide 343 408 N- (4- {3- [3-chloro-4- (2-Dimethylamino-ethoxy) -phenyl] -thioureido} -phenyl) -acetamide 344 499 furan-2-carboxylic acid [4- (3- {3-chloro-4- [methyl- (1-methyl-piperidine- 4-yl) -amino] -phenyl} -thioureido) -phenyl] -amide 345 419 N- {4- [3- (3-chloro-4-cyclohexyloxy-phenyl) -thioureido] -phenyl} -acetamide 346 440 N- {4- [3- (3-chloro-4-dimethylamino-phenyl) -thioureido] -phenyl} -2-methyl-benzamide 347 493 N- {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -3-methyl-phenyl} -2, 6-difluoro-benzamide 348 462 N- {4- [3- (3-chloro-4-dimethylamino-phenyl) -thioureido] -phenyl} -2, 6-difluoro-benzamide 349 531 N- [4- (3- {3-chloro-4- [methyl- (1-methyl-pyrrolidin-3-yl) -amino] -phenyl} -thioureido) -phenyl] -2 , 6-difluoro-benzamide 350 427 pyridine-2-carboxylic acid {4- [3- (3-chloro-4-dimethylamino-phenyl) -thioureido] -phenyl} -amide 351 430 pyridine-2-carboxylic acid {4- [3- (3-Chloro-4-methylsulfanyl-phenyl) -thioureido] -phenyl} -amide 352 428 pyridine-2-carboxylic acid {4- [3- (5-chloro-2-methoxy-4-methyl- Phenyl) -thioureido] -phenyl} -amide 353 417 furan-2-carboxylic acid {4- [3- (5-chloro-2-methoxy-4-methyl-phenyl) -thioureido] -phenyl} -amide 354 496 pyridine 2-carboxylic acid [4- (3- {3-chloro-4- [methyl (1-methyl-pyrrolidin-3-yl) amino] -phenyl} -thioureido) -phenyl] -amide 355 495 N- {3 -Chloro-4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -phenyl} -2-fluoro-benzamide 356 467 furan-2-carboxylic acid {3-chloro-4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -phenyl} -amide 357 515 N- {4- [3- (3-chloro-4-cyclohexylsulfanyl-phenyl) -thioureido] -phenyl} -2-fluoro-benzamide 358 449 N- {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -3-trifluoromethyl-phenyl} -acetamide 359 529 N- {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -3-trifluoromethyl-phenyl} -2-fluoro-benzamide 360 421 N- {4- [3- (4-acetylamino-phenyl) -thioureido] -2-chloro -Phenyl} -2-dimethyl-amino-acetamide 361 473 Furan-2-carboxylic acid (4- {3- [3-chloro-4- (2-dimethylamino-acetylamino) -phenyl] -thioureido} -phenyl) -Amide 362 501 N- (4- {3- [3-chloro-4- (2-dimethylamino-acetylamino) -phenyl] -thioureido} -phenyl) -2-fluoro-benz-amide 363 461 N- { 4- [3- (4-acetylamino-phenyl) -thioureido] -2-chloro-phenyl} -2-piperidin-1-yl-acetamide 364 541 N- (4- {3- [3-chloro-4- (2-Piperidin-1-yl-acetylamino) -phenyl] -thioureido} -phenyl) -2-fluoro-benz-amide 365 513 furan-2-carboxylic acid (4- {3- [3-chloro-4- (2-piperidine-1- -Acetylamino) -phenyl] -thioureido} -phenyl) -amide 366 463 N- {4- [3- (4-acetylamino-phenyl) -thioureido] -2-chloro-phenyl} -2-morpholine-4 -Yl-acetamide 367 543 N- (4- {3- [3-chloro-4- (2-morpholin-4-yl-acetylamino) -phenyl] -thioureido} -phenyl) -2-fluoro-benzamide 368 515 Furan-2-carboxylic acid (4- {3- [3-chloro-4- (2-morpholin-4-yl-acetylamino) -phenyl] -thioureido} -phenyl) -amide 369 414 N- {4- [ 3- (3-chloro-4-methanesulfonylamino-phenyl) -thioureido] -phenyl} -acetamide 370 494 N- {4- [3- (3-chloro-4-methanesulfonylamino-phenyl) -thioureido]- Phenyl} -2-fluoro-benzamide 371 466 furan-2-carboxylic acid {4- [3- (3-chloro-4-methane-sulfonylamino-phenyl) -thioureido] -phenyl} -amido 372 481 N- {4- [3- (4-acetylamino-phenyl) -thioureido] -2-chloro-phenyl} -2- (2-dimethylamino-ethyl-sulfanyl) -acetamide 373 561 N- [4- (3- {3-chloro-4- [2- (2-dimethylamino-ethyl-sulfanyl) -acetylamino] -phenyl} -thioureido) -phenyl] -2-fluoro-benzamide 374 585 N- [4- (3- {4-[(1-benzyl-pyrrolidin-3-yl) -methyl-amino] -3-chloro-phenyl} -thioureido) -phenyl] -2-methyl-benzamide 375 523 N- [4- ( 3- {3-chloro-4- [methyl (1-methyl-piperidin-4-yl) -amino] -phenyl} -thioureido) -phenyl] -2-methyl-benzamide 376 510 pyridine-2-carboxylic acid [4 -(3- {3-chloro-4- [methyl (1-methyl-piperidin-4-yl) amino] -phenyl} -thioureido) -phenyl] -amide 377 347 N- {4- [3- (3- Chloro-4-vinyl-phenyl) -thioureido] -phenyl} -ace Toamide 378 441 Furan-2-carboxylic acid {4- [3- (4-chloro-3-trifluoromethyl-phenyl) -thioureido] -phenyl} -amide 379 452 Pyridine-2-carboxylic acid {4- [3- (4-Chloro-3-trifluoromethyl-phenyl) -thioureido] -phenyl} -amide 380 487 N- {4- [3- (4-Chloro-3-trifluoromethyl-phenyl) -thioureido] -phenyl } -2, 6-difluoro-benzamide 381 486 N- {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -3-cyano-phenyl} -2-fluoro-benzamide 382 458 furan-2-carboxylic acid {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -3-cyano-phenyl} -amide 383 406 N- {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -3-cyano-phenyl} -acetamide 384 395 N- {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -2-methylisothioureido] -phenyl} -acetamide 385 396 N- {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -2-methylisothioureido] -phenyl} -acetamide 386 461 N- {4- [3- (3-chloro-4-ethylsulfanyl-phenyl) -thioureido] -phenyl} -2-fluoro- Benzamide 387 489 N- {4- [3- (4-butylsulfanyl-3-chloro-phenyl) -thioureido] -phenyl} -2-fluoro-benzamide 388 411 N- {4- [3- (5-chloro- 2, 4-dimethoxy-phenyl) -thioureido] -3-methoxy-phenyl} -acetamide 389 491 N- {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -3-methoxy-phenyl} -2-fluoro-benzamide 390 463 furan-2-carboxylic acid {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -3-methoxy-phenyl} -amide 391 531 [1, 2, 3] Thiadiazole-4-carboxylic acid (4- {3- [3-chloro-4- (2-piperidin-1-yl-acetyl-amino) -phenyl] -thioureido} -phenyl) -amide 392 481 N- { 4- [3- (3-chloro-4-methanesulfinyl-phenyl) -thioureido] -phenyl} -2, 6-difluoro-benzamide 393 497 N- {4- [3- (3-chloro-4-methanesulfonyl-phenyl) -thioureido] -phenyl} -2, 6-difluoro-benzamide 394 459 N- {4- [3- (5-chloro-2-methoxy-phenyl) -thioureido] -2-methyl-phenyl} -2-fluoro-benzamide 395 429 N- {4- [ 3- (3-chloro-4-methyl-phenyl) -thioureido] -2-methyl-phenyl} -2-fluoro-benzamide 396 533 furan-2-carboxylic acid [4- (3- {3-chloro-4- [2- (2-Dimethylamino-ethylsulfanyl) -acetylamino] -phenyl} -thioureido) -phenyl] -amide 397 458 N- {4- [3- (4-acetylamino-3-chloro-phenyl)-] Thioureido] -phenyl} -2-fluoro-benzamide 398 460 [2-chloro-4- (3- {4-[(furan-2-carbonyl) -amino] -phenyl} -thioureido) -phenyl] -carbamic acid Ethyl ester 399 488 (2-Chloro-4- {3- [4- (2-fluoro-benzoylamino) -phenyl] -thioureido} -phenyl) -carbamic acid ethyl ester 400 440 N- {4- [3- ( 4-acetyl Amino-phenyl) -thioureido]-2-chloro-phenyl} -benzamide 401 520 N- {4-[({[4- (benzoylamino) -3-chloro-phenyl] -amino} -thioxomethyl) -amino]- Phenyl} -2-fluoro-benzamide 402 529 N- {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -2-trifluoromethyl-phenyl} -2-fluoro-benzamide 403 492 furan-2-carboxylic acid {4- [3- (4-benzoylamino-3-chloro- Phenyl) -thioureido] -phenyl} -amide 404 416 N- {4- [3- (4-amino-3-chloro-phenyl) -thioureido] -phenyl} -2-fluoro-benzamide 405 479 N- {4- [3- (4-acetylamino-phenyl) -thioureido] -2-chloro-phenyl} -2-thiomorpholin-4-yl-acetamide 406 531 furan-2-carboxylic acid (4- {3- [3-chloro -4- (2-thiomorpholin-4-yl-acetylamino) -phenyl] -thioureido} -phenyl) -amide 407 559 N- (4- {3- [3-chloro-4- (2-thiomorpholine- 4-yl-acetylamino) -phenyl] -thioureido} -phenyl) -2-fluoro-benzamide 408 461 N- {4- [3- (3-chloro-4-methylsulfanyl-phenyl) -thioureido] -2- Met -Phenyl} -2-fluoro-benzamide 409 430 Furan-2-carboxylic acid {4- [3- (4-acetylamino-3-chloro-phenyl) -thioureido] -phenyl} -amide 410 477 N- {4- [3- (4-acetylamino-phenyl) -thioureido] -2-chloro-phenyl} -2-dipropylamino-acetamide 411 529 furan-2-carboxylic acid (4- {3- [3-chloro-4- (2-dipropylamino-acetylamino) -phenyl] -thioureido} -phenyl) -amide 412 449 N- {4- [3- (4-acetylamino-phenyl) -thioureido] -2-chloro-phenyl} -2 -Diethylamino-acetamide 413 501 furan-2-carboxylic acid (4- {3- [3-chloro-4- (2-diethylamino-acetylamino) -phenyl] -thioureido} -phenyl) -amide 414 529 N- ( 4- {3- [3-chloro-4- (2-diethylamino-acetylamino) -phenyl] -thioureido} -phenyl) -2-fluoro-benzamide 415 447 N- {4- [3- (4-acet Tylamino-phenyl) -thioureido]-2-chloro-phenyl} -2-pyrrolidin-1-yl-acetamide 416 499 furan-2-carboxylic acid (4- {3- [3-chloro-4- (2-pyrrolidine- 1-yl-acetylamino) -phenyl] -thioureido} -phenyl) -amide 417 527 N- (4- {3- [3-chloro-4- (2-pyrrolidin-1-yl-acetylamino) -phenyl] -Thioureido} -phenyl) -2-fluoro-benzamide 418 475 N- {4- [3- (5-chloro-2-methoxy-4-methyl-phenyl) -thioureido] -3-methoxy-phenyl} -2- Fluoro-benzamide 419 445 N- {4- [3- (3-chloro-4-methyl-phenyl) -thioureido] -3-methoxy-phenyl} -2-fluoro-benzamide 420 477 N- {4- [3- (3-chloro-4-methylsulfanyl-phenyl) -thioureido] -3-methoxy-phenyl} -2-fluoro-benzamide 421 388 furan-2-carboxylic acid {4- [3- (4-amino-3-chloro) -Phenyl) -thiou Id] -Phenyl} -amide 422 527 Furan-2-carboxylic acid (4- {3- [4- (2-azepan-1-yl-acetylamino) -3-chloro-phenyl] -thioureido} -phenyl)- Amide 423 555 N- (4- {3- [4- (2-azepan-1-yl-acetylamino) -3-chloro-phenyl] -thioureido} -phenyl) -2-fluoro-benzamide 424 527 furan-2 -Carboxylic acid [4- (3- {3-chloro-4- [2- (2-methyl-piperidin-1-yl) -acetylamino] -phenyl} -thioureido) -phenyl] -amide 425 555 N- [ 4- (3- {3-chloro-4- [2- (2-methyl-piperidin-1-yl) -acetylamino] -phenyl} -thioureido) -phenyl] -2-fluoro-benzamide 426 339 furan-2 -Carboxylic acid [4- (3-pyridin-2-yl-thioureido) -phenyl] -amide 427 339 Furan-2-carboxylic acid [4- (3-pyridin-4-yl-thioureido) -phenyl] -amide 428 367 2-Fluoro-N- [4- (3-pyridin-3-yl-thiou Id) -Phenyl] -benzamide 429 339 Furan-2-carboxylic acid [4- (3-pyridin-3-yl-thioureido) -phenyl] -amide 430 353 Furan-2-carboxylic acid {4- [3- (3 -Amino-phenyl) -thioureido] -phenyl} -amide 431 406 Furan-2-carboxylic acid {4- [3- (3-trifluoromethyl-phenyl) -thioureido] -phenyl} -amide 432 380 2-fluoro- N- [4- (3-m-tolyl-thioureido) -phenyl] -benzamide 433 434 2-fluoro-N- {4- [3- (3-trifluoromethyl-phenyl) -thioureido] -phenyl} benzamide 434 381 N- {4- [3- (3-Amino-phenyl) -thioureido] -phenyl} -2-fluoro-benzamide 435 388 Furan-2-carboxylic acid {4- [3- (3-amino-5-chloro) -Phenyl) -thioureido] -phenyl} -amide 436 352 Furan-2-carboxylic acid [4- (3-m-tolyl-thioureido) -phenyl] -amide 437 416 N- {4- [3- (2-amino -5-chloro- Enyl) -thioureido] -phenyl} -2-fluoro-benzamide 438 571 (2-chloro-4- {3- [4- (2-fluoro-benzoylamino) -phenyl] -thioureido} -phenyl} -carbamic acid 2 -Piperidin-1-yl-ethyl ester 439 543 [2-chloro-4- (3- {4-[(furan-2-carbonyl) -amino] -phenyl} -thioureido) -phenyl] -carbamic acid 2-piperidine -1-yl-ethyl ester 440 388 furan-2-carboxylic acid {4- [3- (2-amino-5-chloro-phenyl) -thioureido] -phenyl} -amide 441 363 furan-2-carboxylic acid {4 -[3- (3-Cyano-phenyl) -thioureido] -phenyl} -amide 442 416 N- {4- [3- (3-amino-5-chloro-phenyl) -thioureido] -phenyl} -2-fluoro -Benzamide 443 367 2-Fluoro-N- [4- (3-pyridin-2-yl-thioureido) -phenyl] -benzamide 444 367 2-Fluoro-N- [4- (3-pyridin-4-yl-thioureido) ) -Phenyl] -benzamide 445 374 furan-2-carboxylic acid {4- [3- (6-chloro-pyridin-3-yl) -thioureido] -phenyl} -amide 446 388 furan-2-carboxylic acid {4- [ 3- (2-amino-3-chloro-phenyl) thioureido] -phenyl} -amide 447 396 Furan-2-carboxylic acid {4- [3- (3-hydrazinocarbonyl-phenyl) thioureido] -phenyl} -amide 448 410 2-Fluoro-N- (4- {3- [3- (1-hydroxy-ethyl) -phenyl] -thioureido} -phenyl) -benzamide 449 414 [1, 2, 3] Thiadiazole-4-carboxylic acid {4- [3- (3-hydrazinocarbonyl-phenyl) thioureido] -phenyl} -amide 450 399 [1, 2, 3] Thiadiazole-4-carboxylic acid {4- [3- (3-isopropyl-phenyl) thioureido] -phenyl} -amide 451 380 Furan-2-carboxylic acid {4- [3- (3-isopropyl-phenyl)- Thioureido] -phenyl} -amide 452 409 2-Fluoro-N- {4- [3- (3-isopropyl-phenyl) -thioureido] -phenyl} -benzamide 453 381 [1, 2, 3] Thiadiazole-4-carboxylic acid {4- [3- (3-cyano-phenyl) -thioureido] -phenyl} -amide 454 410 N- {4- [3- (3-dimethylamino-phenyl) -thioureido] -Phenyl} -2-fluoro-benzamide 455 381 furan-2-carboxylic acid {4- [3- (3-dimethylamino-phenyl) -thioureido] -phenyl} -amide 456 370 [1, 2, 3] Thiadiazole-4-carboxylic acid [4- (3-m-tolyl- -thioureido) -phenyl] -amide 457 424 [1, 2, 3] Thiadiazole-4-carboxylic acid {4- [3- (3-trifluoromethyl-phenyl) -thioureido] -phenyl} -amide 458 479 N- {3-chloro-4- [3- (5-chloro-2 -Methoxy-4-methyl-phenyl) -thioureido] -phenyl} -2-fluoro-benzamide 459 449 N- {3-chloro-4- [3- (3-chloro-4-methyl-phenyl) -thioureido ] -Phenyl} -2-fluoro-benzamide 460 481 N- {3-chloro-4- [3- (3-chloro-4-methylsulfanyl-phenyl) -thioureido] -phenyl} -2-fluoro-benzamide 461 391 N- {4- [3- (3-cyano-phenyl) -thioureido] -phenyl} -2-fluoro-benzamide 462 395 furan-2-carboxylic acid {4- [3- (3-acetylamino-phenyl)- Thioureido] -phenyl} -amide 463 424 2-Fluoro-N- {4- [3- (3-hydrazinecarbonyl-phenyl) -thioureido] -phenyl} -benzamide 464 400 [1, 2, 3] Thiadiazole-4-carboxylic acid (4- {3- [3- (1-hydroxy-ethyl) -phenyl] -thioureido} -phenyl) -amide 465 434 N- {4- [3- (2-amino- 3-chloro-phenyl) -thioureido] -phenyl} -2, 6-difluoro-benzamide 466 406 [1, 2, 3] Thiadiazole-4-carboxylic acid {4- [3- (3-amino-5-chloro-phenyl) -thioureido] -phenyl} -amide 467 398 furan-2-carboxylic acid {4- [3- (3, 5-dimethoxy-phenyl) -thioureido] -phenyl} -amide 468 416 [1, 2, 3] thiadiazole-4-carboxylic acid {4- [3- (3, 5-dimethoxy-phenyl) -thioureido] -phenyl} -amide 469 454 5- (3- {4-[(furan-2-carbonyl) -amino] -phenyl} -thioureido) -isophthalic acid dimethyl ester 470 434 isoxazole -5-carboxylic acid {4- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -phenyl} -amide 471 392 [1, 2, 3] Thiadiazole-4-carboxylic acid {4- [3- (6-chloro-pyridin-3-yl) -thioureido] -phenyl} -amide 472 382 furan-2-carboxylic acid (4- {3- [3- (1-Hydroxy-ethyl) -phenyl] -thioureido} -phenyl) -amide 473 368 Furan-2-carboxylic acid {4- [3- (3-methoxy-phenyl) -thioureido] -phenyl) -amide 474 354 Furan-2-carboxylic acid {4- [3- (3-hydroxy-phenyl) -thioureido] -phenyl} -amide 475 382 2-fluoro-N- {4- [3- (3-hydroxy-phenyl) -thiouree Id] -phenyl} -benzamide 476 396 2-fluoro-N- {4- [3- (3-hydroxymethyl-phenyl) -thioureido] -phenyl} -benzamide 477 423 N- {4- [3- (3- Acetylamino-phenyl) -thioureido] -phenyl} -2-fluoro-benzamide 478 413 [1, 2, 3] Thiadiazole-4-carboxylic acid {4- [3- (3-acetylamino-phenyl) -thioureido] -phenyl} -amide 479 400 [1, 2, 3] Thiadiazole-4-carboxylic acid {4- [3- (3-dimethylamino-phenyl) -thioureido] -phenyl} -amide 480 340 Furan-2-carboxylic acid [4- (3-pyrimidin-4-yl-) Thioureido) -phenyl] -amide 481 378 Furan-2-carboxylic acid {4- [3- (1H-indazoli-5-yl) -thioureido] -phenyl} -amide 482 395 Furan-2-carboxylic acid [4- (3-benzothiazoli-5-yl-thioureido) -phenyl] -amide 483 406 2-fluoro-N- {4- [3- (1H-indazoli-5-yl) -thioureido] -phenyl} -benzamide 484 424 N -[4- (3-Benzothiazoly-5-yl-thioureido) -phenyl] -2-fluoro-benzamide 485 473 5- (3- {4-[([1, 2, 3] Thiadiazole-4-carbonyl) -amino] -phenyl} -thioureido) -isophthalic acid dimethyl ester 486 442 furan-2-carboxylic acid (4- {3- [4- (1-azido-ethyl) -3-chloro) -Phenyl] -thioureido} -phenyl) -amide 487 396 2-Fluoro-N- {4- [3- (3-methoxy-phenyl) -thioureido] -phenyl} -benzamide 488 368 furan-2-carboxylic acid { 4- [3- (3-hydroxymethyl-phenyl) -thioureido] -phenyl} -amide 489 416 Furan-2-carboxylic acid {4- [3- (5-chloro-2-dimethylamino-phenyl) -thioureide ] -Phenyl} -amide 490 444 N- {4- [3- (5-chloro-2-dimethylamino-phenyl) -thioureido] -phenyl} -2-fluoro-benzamide 491 506 [3-chloro-5- ( 3- {4-[([1, 2, 3] Thiadiazole-4-carbonyl) -amino] -phenyl} -thioureido) -phenyl] -carbamic acid tert-butyl ester 492 470 N- (4- {3- [4- (1-azido-ethyl) -3- Chloro-phenyl] -thioureido} -phenyl) -2-fluoro-benzamide 493 337 furan-2-carboxylic acid [4- (1H-thiazolo [5, 4-b] pyridine-2-ylideneamino) -phenyl] -amide 494 378 furan-2-carboxylic acid {4- [3- (1H-benzimidazoli-5-yl) -thioureido] -phenyl} -amide 495 392 Furan-2-carboxylic acid {4- [3- (2-methyl-1H-benzoimidazoli-5-yl) -thioureido] -phenyl} -amide 496 406 N- {4- [3- (1H-benzimidazolyl) -5-yl) -thioureido] -phenyl} -2-fluoro-benzamide 497 420 2-fluoro-N- {4- [3- (2-methyl-1H-benzimidazoli-5-yl) -thioureido]- Phenyl} -benzamide 498 452 [1, 2, 3] thiadiazole-4-carboxylic acid {5- [3- (5-chloro-2,3 4-dimethoxy-phenyl) -thioureido] -pyridin-2-yl} -amide 499 445 pyridine-2-carboxylic acid {5- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -pyridin-2-yl} -amide 500 434 [1, 2, 3] Thiadiazole-4-carboxylic acid {4- [3- (5-chloro-2-dimethylamino-phenyl) -thioureido] -phenyl} -amide 501 484 [1, 2, 3] Thiadiazole-4-carboxylic acid (4- {3- [4- (2-amino-pyrimidin-4-yl) -3-chloro-phenyl] -thioureido} -phenyl) -amide 502 494 N- (4- {3- [4- (2-Amino-pyrimidin-4-yl) -3-chloro-phenyl] -thioureido} -phenyl) -2-fluoro-benzamide 503 434 [1, 2, 3] Thiadiazole-4-carboxylic acid {4- [3- (3-chloro-2-dimethylamino-phenyl) -thioureido] -phenyl} -amide 504 462 N- {4- [3- (3-chloro-2 -Dimethylamino-phenyl) -thioureido] -phenyl} -2, 6-difluoro-benzamide 505 416 furan-2-carboxylic acid {4- [3- (3-chloro-2-dimethyl-amino-phenyl) -thioureido] -phenyl} -amide 506 445 pyridine-2-carboxylic acid {6 -[3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -pyridin-3-yl} -amide 507 462 N- {6- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -pyridin-3-yl} -2-fluoro-benzamide 508 482 [1, 2, 3] Thiadiazole-4-carboxylic acid {4- [3- (3-iodo-phenyl) -thioureido] -phenyl} -amide 509 413 [1, 2, 3] Thiadiazole-4-carboxylic acid {4- [3- (3-tert-butyl-phenyl) -thioureido] -phenyl} -amide 510 387 Furan-2-carboxylic acid {4- [3- (3-chloro- Benzyl) -thioureido] -phenyl} -amide 511 415 N- {4- [3- (3-chloro-benzyl) -thioureido] -phenyl} -2-fluoro-benzamide 512 434 furan-2-carboxylic acid {6- [3- (5-chloro-2, 4-dimethoxy-phenyl) -thioureido] -pyridin-3-yl} -amide 513 435 [1, 2, 3] Thiadiazole-4-carboxylic acid {4- [3- (3-bromo-phenyl) -thioureido] -phenyl} -amide 514 452 [1, 2, 3] thiadiazole-4-carboxylic acid {6- [3- (5-chloro-2,3 4-dimethoxy-phenyl) -thioureido] -pyridin-3-yl} -amide 515 426 [1, 2, 3] thiadiazole-4-carboxylic acid {5- [3- (3, 5-dichloro-phenyl) -thioureido] -pyridin-2-yl} -amide 516 474 furan-2-carboxylic acid {4- [3- (3, 5-bis-trifluoromethyl-phenyl) -thioureido] -phenyl} -amide 517 502 N- {4- [3- (3, 5-bis-trifluoromethyl-phenyl) -thioureido] -phenyl} -2-fluoro-benzamide 518 450 N- {4- [3- (4-amino-3, 5-dichloro-phenyl) -thioureido] -phenyl} -2-fluoro-benzamide 519 539 N- {4- [3- (4-amino-3, 5-dibromo-phenyl) -thioureido] -phenyl} -2-fluoro-benzamide 520 392 [1, 2, 3] Thiadiazole-4-carboxylic acid {4- [3- (5-chloro-pyridin-3-yl) -thioureido] -phenyl} -amide 521 529 [1, 2, 3] thiadiazole-4-carboxylic acid {4- [3- (4-amino-3,3 5-dibromo-phenyl) -thioureido] -phenyl} -amide 522 434 [1, 2, 3] Thiadiazole-4-carboxylic acid {4- [3- (3-chloro-5-dimethylamino-phenyl) -thioureido] -phenyl} -amide 523 444 N- {4- [3- (3-chloro-5 -Dimethylamino-phenyl) -thioureido] -phenyl} -2-fluoro-benzamide 524 416 Furan-2-carboxylic acid {4- [3- (3-chloro-5-dimethyl-amino-phenyl) -thioureido]- Phenyl} -amide 525 436 [1, 2, 3] Thiadiazole-4-carboxylic acid {4- [3- (5-bromo-pyridin-3-yl) -thioureido] -phenyl} -amide 526 379 furan-2-carboxylic acid {4- [3- (1H- Benzotriazoli-5-yl) -thioureido] -phenyl} -amide 527 424 N- {4- [3- (1H-benzotriazoli-5-yl) -thioureido] -phenyl} -2, 6-difluoro-benzamide 528 388 N- [4-({[2- (3-chloro-phenyl) -hydrazino] -thioxo-methyl} -amino) -phenyl] -furan-2-carboxamide 529 416 N- [4 -({[2- (3-Chloro-phenyl) -hydrazino] -thioxo-methyl} -amino) -phenyl] -2-fluoro-benzamide 530 456 Furan-2-carboxylic acid {4- [3- (2- Amino-3-chloro-5-trifluoromethyl-phenyl) -thioureido] -phenyl} -amide 531 513 N- {4- [3- (3-bromo-5-trifluoromethyl-phenyl} -thioureido] -phenyl } -2-fluoro-benzamide 532 503 [1, 2, 3] Thiadiazole-4-carboxylic acid {4- [3- (3-bromo-5-trifluoromethyl-phenyl) -thioureido] -phenyl} -amide 533 374 {4-[(furan-2-carbonyl) -amino ] -Phenyl} -thiocarbamic acid O- (3-chloro-phenyl) ester 534 474 [1, 2, 3] Thiadiazole-4-carboxylic acid {4- [3- (2-amino-3-chloro-5-trifluoromethyl-phenyl) -thioureido] -phenyl} -amide 535 508 [1, 2, 3] Thiadiazole-4-carboxylic acid {4- [3- (3-piperidin-1-yl-5-trifluoromethyl-phenyl) -thioureido] -phenyl} -amide 536 380 N- [4- (3 -Benzyl-thioureido) -phenyl] -2-fluoro-benzamide 537 439 [1, 2, 3] thiadiazole-4-carboxylic acid {4- [3- (3, 4-dichloro-benzyl) -thioureido] -phenyl} -amide 538 449 N- {4- [3- (3, 4-dichloro-benzyl) -thioureido] -phenyl} -2-fluoro-benzamide 539 370 [1, 2, 3] Thiadiazole-4-carboxylic acid [4- (3-benzyl-thioureido) -phenyl] -amide 540 424 N- [4- (3-benzo [1, 3] Dioxoli-5-ylmethyl-thioureido) -phenyl] -2-fluoro-benzamide 541 414 [1, 2, 3] thiadiazole-4-carboxylic acid [4- (3-benzo [1, 3] dioxoli-5-ylmethyl-thioureido) -phenyl] -amide 542 506 [1, 2, 3] thiadiazole-4-carboxylic acid {4- [3- (3, 5-bis-trifluoromethyl-benzyl) -thioureido] -phenyl} -amide 543 516 N- {4- [3- (3, 5-bis-trifluoromethyl-benzyl) -thioureido] -phenyl} -2-fluoro-benzamide 544 352 furan-2-carboxylic acid [4- (3-benzyl-thioureido) -phenyl] -amide 545 421 furan-2 -Carboxylic acid {4- [3- (3, 4-dichloro-benzyl) -thioureido] -phenyl} -amide 546 396 furan-2-carboxylic acid [4- (3-benzo [1, 3] dioxoli-5-ylmethyl-thioureido) -phenyl] -amide 547 488 furan-2-carboxylic acid {4- [3- (3, 5-bis-trifluoromethyl-benzyl) -thioureido] -phenyl} -amide 548 503 [1, 2, 3] Thiadiazole-4-carboxylic acid {4- [3- (4-bromo-3-trifluoromethyl-phenyl) -thioureido] -phenyl} -amide 549 529 N- {4- [3- (3-bromo- 4-trifluoromethoxy-phenyl) -thioureido] -phenyl} -2-fluoro-benzamide 550 519 [1, 2, 3] Thiadiazole-4-carboxylic acid {4- [3- (3-bromo-4-trifluoromethoxy-phenyl) -thioureido] -phenyl} -amide 551 473 furan-2-carboxylic acid {4- [3- ( 3-chloro-4-trifluoro-methylsulfanyl-phenyl) -thioureido] -phenyl} -amide 552 412 2-fluoro-N- (4- {3- [2- (3-fluoro-phenyl) -ethyl]- Thioureido} -phenyl) -benzamide 553 412 2-Fluoro-N- (4- {3- [2- (4-fluoro-phenyl) -ethyl] -thioureido} -phenyl) -benzamide 554 402 [1, 2, 3] Thiadiazole-4-carboxylic acid (4- {3- [2- (3-fluoro-phenyl) -ethyl] -thioureido} -phenyl) -amide 555 402 [1, 2, 3] Thiadiazole-4-carboxylic acid (4- {3- [2- (4-fluoro-phenyl) -ethyl] -thioureido} -phenyl) -amide 556 495 [1, 2, 3] Thiadiazole-4-carboxylic acid (4- {3- [3- (2-methyl-butyl) -5-trifluoromethyl-phenyl] -thioureido} -phenyl) -amide 557 481 [1, 2, 3] Thiadiazole-4-carboxylic acid {4- [3- (3-isobutyl-5-trifluoromethyl-phenyl) -thioureido] -phenyl) -amide 558 523 [1, 2, 3] Thiadiazole-4-carboxylic acid (4- {3- [3- (4-methyl-piperazin-1-yl) -5-trifluoro-methyl-phenyl] -thioureido} -phenyl) -amide 559 510 [1 , 2, 3] Thiadiazole-4-carboxylic acid {4- [3- (3-morpholin-4-yl-5-trifluoromethyl-phenyl) -thioureido] -phenyl} -amide 560 494 [1, 2, 3] Thiadiazole-4-carboxylic acid {4- [3- (3-pyrrolidin-1-yl-5-trifluoromethyl-phenyl) -thioureido] -phenyl} -amide 561 384 Furan-2-carboxylic acid (4- {3- [2- (4-Fluoro-phenyl) -ethyl] thioureido} -phenyl} -amide 562 419 [1, 2, 3] Thiadiazole-4-carboxylic acid (4- {3- [2- (3-chloro-phenyl) -ethyl] -thioureido} -phenyl} -amide 563 429 N- (4- {3- [2- (3 -Chloro-phenyl) -ethyl] -thioureido} -phenyl) -2-fluoro-benzamide 564 401 furan-2-carboxylic acid (4- {3- [2- (3-chloro-phenyl) -ethyl] -thioureido} -Phenyl) -amide 565 402 [1, 2, 3] Thiadiazole-4-carboxylic acid (4- {3- [1- (4-fluoro-phenyl) -ethyl] -thioureido} -phenyl) -amide 566 504 2-fluoro-N- {4- [3- ( 3-pyrrolidin-1-yl-5-trifluoromethyl-phenyl) -thioureido] -phenyl} -benzamide 567 477 N- {4- [3- (3-dimethylamino-5-trifluoromethyl-phenyl) -thioureide ] -Phenyl} -2-fluoro-benzamide 568 520 2-Fluoro-N- {4- [3- (3-morpholin-4-yl-5-trifluoromethyl-phenyl) -thioureido] -phenyl} -benzamide 569 533 2-fluoro-N- (4- {3- [3- (4-methyl-piperazin-1-yl) -5-trifluoromethyl-phenyl] -thioureido} -phenyl) -benzamide 570 518 2-fluoro- N- {4- [3- (3-Piperidin-1-yl-5-trifluoromethyl-phenyl) -thioureido] -phenyl} -benzamide 571 468 [1, 2, 3] Thiadiazole-4-carboxylic acid {4- [3- (3-dimethylamino-5-trifluoromethyl-phenyl) -thioureido] -phenyl} -amide 572 405 [1, 2, 3] Thiadiazole-4-carboxylic acid {4- [3- (3-chloro-benzyl) -thioureido] -phenyl} -amide 573 384 Furan-2-carboxylic acid (4- {3- [2- (3-fluoro -Phenyl) -ethyl] -thioureido} -phenyl) -amide 574 366 Furan-2-carboxylic acid [4- (3-phenethyl-thioureido) -phenyl] -amide 575 384 [1, 2, 3] Thiadiazole-4-carboxylic acid [4- (3-phenethyl-thioureido) -phenyl] -amide 576 394 2-Fluoro-N- [4- (3-phenethyl-thioureido) -phenyl] -benzamide 577 505 2- Fluoro-N- (4- {3- [3- (2-methyl-butyl) -5-trifluoromethyl-phenyl] -thioureido} -phenyl) -benzamide 578 491 2-fluoro-N- {4- [3 -(3-isobutyl-5-trifluoro-methyl-phenyl) -thioureido] -phenyl} -benzamide 579 388 furan-2-carboxylic acid {4- [3- (3, 5-difluoro-benzyl) -thioureido] -phenyl} -amide 580 416 N- {4- [3- (3, 5-difluoro-benzyl) -thioureido] -phenyl} -2-fluoro-benzamide 581 406 [1, 2, 3] thiadiazole-4-carboxylic acid {4- [3- (3, 5-difluoro-benzyl) -thioureido] -phenyl} -amide 582 421 furan-2-carboxylic acid {4- [3- (3, 5-dichloro-benzyl) -thioureido] -phenyl} -amide 583 449 N- {4- [3- (3, 5-dichloro-benzyl) -thioureido] -phenyl} -2-fluoro-benzamide 584 439 [1, 2, 3] thiadiazole-4-carboxylic acid {4- [3- (3, 5-dichloro-benzyl) -thioureido] -phenyl} -amide 585 438 Furan-2-carboxylic acid {4- [3- (3-fluoro-5-trifluoromethyl-benzyl) -thioureido] -phenyl} -amide 586 466 2-Fluoro-N- {4- [3- (3-fluoro-5-trifluoro-methyl-benzyl) -thioureido] -phenyl} -benzamide 587 456 [1, 2, 3] Thiadiazole-4-carboxylic acid {4- [3- (3-fluoro-5-trifluoromethyl-benzyl) -thioureido] -phenyl} -amide 588 384 [1, 2, 3] Thiadiazole-4-carboxylic acid {4- [3- (1-phenyl-ethyl) -thioureido] -phenyl} -amide 589 394 2-fluoro-N- {4- [3- (1-phenyl-ethyl) -Thioureido] -phenyl} -benzamide 590 366 furan-2-carboxylic acid {4- [3- (1-phenyl-ethyl) -thioureido] -phenyl} -amide 591 412 2-fluoro-N- (4- {3 -[1- (4-Fluoro-phenyl) ethyl] -thioureido} -phenyl) -benzamide 592 384 Furan-2-carboxylic acid (4- {3- [1- (4-fluoro-phenyl) -ethyl] -thioureido } -Phenyl) -amide 593 413 N- {4- [3- (1-tert-butyl-1H-imidazoli-2-yl) -thioureido] -phenyl} -2-fluoro-benzamide 594 510 [1, 2, 3] Thiadiazole-4-carboxylic acid (4- {3- [3- (isobutyl-methyl-amino) -5-trifluoromethyl-phenyl] -thioureido} -phenyl) -amide 595 510 [1, 2, 3] Thiadiazole-4-carboxylic acid (4- {3- [3- (3-hydroxy-pyrrolidin-1-yl) -5-trifluoro-methyl-phenyl] -thioureido} -phenyl) -amide 596 520 2- Fluoro-N- (4- {3- [3- (isobutyl-methyl-amino) -5-trifluoromethyl-phenyl] -thioureido} -phenyl) -benzamide 597 510 [1, 2, 3] Thiadiazole-4-carboxylic acid (4- {3- [3- (butyl-methyl-amino) -5-trifluoromethyl-phenyl] -thioureido} -phenyl) -amide 598 520 N- (4- {3 -[3- (butyl-methyl-amino) -5-trifluoro-methyl-phenyl] -thioureido} -phenyl) -2-fluoro-benzamide 599 520 [1, 2, 3] thiadiazole-4-carboxylic acid (4- {3- [2- (3, 5-bis-trifluoromethyl-phenyl) -ethyl] -thioureido} -phenyl) -amide 600 442 [1, 2, 3] Thiadiazole-4-carboxylic acid {4- [3- (4-fluoro-3-trifluoromethyl-phenyl) -thioureido] -phenyl} -amide 601 522 [1, 2, 3] Thiadiazole-4-carboxylic acid {4- [3- (4-piperidin-1-yl-3-trifluoromethyl-benzyl) -thioureido] -phenyl} -amide 602 482 [1, 2, 3] Thiadiazole-4-carboxylic acid {4- [3- (4-dimethylamino-3-trifluoromethyl-benzyl) -thioureido] -phenyl} -amide 603 381 furan-2-carboxylic acid (4- {3- [2- (4-Amino-phenyl) -ethyl] -thioureido} -phenyl) -amide 604 445 Furan-2-carboxylic acid (4- {3- [2- (4-bromo-phenyl) -ethyl] -thioureido } -Phenyl) -amide 605 380 Furan-2-carboxylic acid {4- [3- (2-p-tolyl-ethyl) -thioureido] -phenyl} -amide 606 463 [1, 2, 3] Thiadiazole-4-carboxylic acid (4- {3- [2- (4-bromo-phenyl) -ethyl] thioureido} -phenyl) -amide 607 396 furan-2-carboxylic acid (4- {3- [2 -(3-Methoxy-phenyl) -ethyl] thioureido} -phenyl) -amide 608 403 [1, 2, 3] Thiadiazole-4-carboxylic acid {4- [3- (1-tert-butyl-1H-imidazoli-2-yl) -thioureido] -phenyl} -amide 609 384 Furan-2-carboxylic acid {4- [3 -(1-tert-butyl-1H-imidazoli-2-yl) -thioureido] -phenyl} -amide 610 492 N- {4- [3- (4-dimethylamino-3-trifluoromethyl-benzyl) -thioureido ] -Phenyl} -2-fluoro-benzamide 611 427 furan-2-carboxylic acid (4- {3- [2- (3, 4-dimethoxy-phenyl) -ethyl] thioureido} -phenyl) -amide 612 380 Furan-2-carboxylic acid {4- [3- (3-phenyl-propyl) -thioureido] -phenyl} -amide 613 399 [1, 2, 3] Thiadiazole-4-carboxylic acid {4- [3- (3-phenyl-propyl) -thioureido] -phenyl} -amide 614 502 furan-2-carboxylic acid (4- {3- [2- (3, 5-bis-trifluoro-methyl-phenyl) -ethyl] thioureido} -phenyl) -amide 615 550 [1, 2, 3] thiadiazole-4-carboxylic acid {4- [3- (4-iodo-3-trifluoromethyl-phenyl-thioureido] -phenyl} -amide 616 532 2-fluoro-N- {4- [3- (4 -Piperidin-1-yl-3-trifluoromethyl-benzyl) -thioureido] -phenyl} -amide 617 537 [1, 2, 3] Thiadiazole-4-carboxylic acid (4- {3- [4-methyl-piperazin-1-yl) -3-trifluoromethyl-benzyl] -thioureido} -phenyl) -amide 618 482 [1, 2, 3] Thiadiazole-4-carboxylic acid {4- [3- (3-dimethylamino-5-trifluoromethyl-benzyl) -thioureido] -phenyl} -amide 619 488 Furan-2-carboxylic acid {4- [3- (3, 5-bis-trifluoro-methyl-phenyl) -thioureido-methyl] -phenyl} -amide 620 421 furan-2-carboxylic acid {4- [3- (3, 5-dichloro-phenyl) -thioureidomethyl] -phenyl} -amide 621 421 furan-2-carboxylic acid {4- [3- (3, 4-dichloro-phenyl) -thioureidomethyl] -phenyl} -amide 622 455 furan-2-carboxylic acid {4- [3- (4-chloro-3-trifluoro-methyl-phenyl) -thioureido-methyl]- Phenyl} -amide 623 466 2-Fluoro-N- {4- [3- (4-fluoro-3-trifluoro-methyl-benzyl) -thioureido] -phenyl} -benzamide 624 456 [1, 2, 3] Thiadiazole-4-carboxylic acid {4- [3- (4-fluoro-3-trifluoromethyl-benzyl) -thioureido] -phenyl} -amide 625 410 2-fluoro-N- {4- [3- ( 2-phenoxy-ethyl) -thioureido] -phenyl} -benzamide 626 382 Furan-2-carboxylic acid {4- [3- (2-phenoxy-ethyl) -thioureido] -phenyl} -amide 627 400 [1, 2, 3] Thiadiazole-4-carboxylic acid {4- [3- (2-phenoxy-ethyl) -thioureido] -phenyl} -amide 628 409 2-Fluoro-N- {4- [3- (3-phenyl-propyl) -Thioureido] -phenyl} -benzamide 629 425 [1, 2, 3] Thiadiazole-4-carboxylic acid {4- [3- (5-trifluoromethyl-pyridin-3-yl) -thioureido] -phenyl} -amide 630 439 [1, 2, 3] thiadiazole-4-carboxylic acid {4- [3- (3, 4-dichloro-phenyl) -thioureido-methyl] -phenyl} -amide 631 473 [1, 2, 3] Thiadiazole-4-carboxylic acid {4- [3- (4-chloro-3-trifluoromethyl-phenyl) -thioureido-methyl] -phenyl} -amide 632 381 2-fluoro-N- [4- (3 -Pyridin-3-ylmethyl-thioureido) -phenyl] -benzamide 633 353 Furan-2-carboxylic acid [4- (3-pyridin-3-ylmethyl-thioureido) -phenyl] -amide 634 371 [1, 2, 3] Thiadiazole-4-carboxylic acid [4- (3-pyridin-3-ylmethyl-thioureido) -phenyl] -amide 635 439 [1, 2, 3] thiadiazole-4-carboxylic acid {4- [3- (3, 5-dichloro-phenyl) -thioureido-methyl] -phenyl} -amide 636 492 N- {4- [3- (3-dimethylamino-5-trifluoromethyl-benzyl) -thioureido] -phenyl} -2-fluoro -Benzamide 637 415 [1, 2, 3] Thiadiazole-4-carboxylic acid (4- {3- [2- (3-methoxy-phenyl) -ethyl] -thioureido} -phenyl) -amide 638 399 [1, 2, 3] Thiadiazole-4-carboxylic acid {4- [3- (2-p-tolyl-ethyl) -thioureido] -phenyl} -amide 639 445 [1, 2, 3] thiadiazole-4-carboxylic acid (4- {3- [2- (3, 4-dimethoxy-phenyl) -ethyl] -thioureido} -phenyl) -amide 640 506 [1, 2, 3] thiadiazole-4-carboxylic acid {4- [3- (3, 5-bis-trifluoromethyl-phenyl) -thioureidomethyl] -phenyl} -amide 641 516 N- {4- [3- (3, 5-bis-trifluoromethyl-phenyl) -thioureidomethyl] -phenyl} -2-fluoro-benzamide 642 449 N- {4- [3- (3, 5-dichloro-phenyl) -thioureido-methyl] -phenyl} -2-fluoro-benzamide 643 449 N- {4- [3- (3, 4-dichloro-phenyl) -thioureido-methyl] -phenyl} -2-fluoro-benzamide 644 448 [1, 2, 3] Thiadiazole-4-carboxylic acid {4- [3- (3-acetylamino-5-chloro-phenyl) -thioureido] -phenyl} -amide 645 453 [1, 2, 3] thiadiazole-4-carboxylic acid (4- {3- [2- (3, 4-dichloro-phenyl) -ethyl] -thioureido} -phenyl) -amide 646 413 [1, 2, 3] Thiadiazole-4-carboxylic acid {4- [3- (1-methyl-3-phenyl-propyl) -thioureido] phenyl} -amide 647 463 [1, 2, 3] Thiadiazole-4-carboxylic acid (4- {3- [1- (4-bromo-phenyl) -ethyl] -thioureido} -phenyl) -amide 648 413 [1, 2, 3] Thiadiazole-4-carboxylic acid {4- [3- (4-phenyl-butyl) -thioureido] phenyl} -amide 649 397 [1, 2, 3] Thiadiazole-4-carboxylic acid [4- (3-indan-1-yl-thioureido) -phenyl] -amide 650 400 [1, 2, 3] Thiadiazole-4-carboxylic acid {4- [3- (2-methoxy-benzyl) -thioureido] -phenyl} -amide 651 415 [1, 2, 3] Thiadiazole-4-carboxylic acid (4- {3- [2- (2-methoxy-phenyl) -ethyl] -thioureido} -phenyl) -amide 652 415 [1, 2, 3] Thiadiazole-4-carboxylic acid (4- {3- [2- (4-methoxy-phenyl) -ethyl] -thioureido} -phenyl) -amide 653 506 N- (4- {3- [2- (3 -Dimethylamino-5-trifluoromethyl-phenyl) -ethyl] -thioureido} -phenyl) -2-fluoro-benzamide 654 510 [1, 2, 3] Thiadiazole-4-carboxylic acid (4- {3- [3- (3-dimethylamino-propyl) -5-trifluoromethyl-phenyl] -thioureido} -phenyl) -amide 655 417 [1, 2, 3] Thiadiazole-4-carboxylic acid {4- [3- (2-phenylsulfanyl-ethyl) -thioureido] -phenyl} -amide 656 427 2-fluoro-N- {4- [3- (2-phenylsulfanyl- Ethyl) -thioureido] -phenyl} -benzamide 657 399 furan-2-carboxylic acid {4- [3- (2-phenylsulfanyl-ethyl) -thioureido] -phenyl} -amide 658 381 2-fluoro-N- [4 -(3-Pyridin-4-ylmethyl-thioureido) -phenyl] -benzamide 659 353 Furan-2-carboxylic acid [4- (3-pyridin-4-ylmethyl-thioureido) -phenyl] -amide 660 371 [1 , 2, 3] Thiadiazole-4-carboxylic acid [4- (3-pyridin-4-ylmethyl-thioureido) -phenyl] -amide 661 506 2-Fluoro-N- {4- [3- (3-iodo-benzyl) -thioureide ] -Phenyl} -benzamide 662 478 Furan-2-carboxylic acid {4- [3- (3-iodo-benzyl) -thioureido] -phenyl} -amide 663 496 [1, 2, 3] Thiadiazole-4-carboxylic acid {4- [3- (3-iodo-benzyl) -thioureido] -phenyl} -amide 664 479 N- (4- {3- [2- (3, 5-dichloro-phenoxy) -ethyl] -thioureido} -phenyl) -2-fluoro-benzamide 665 451 furan-2-carboxylic acid (4- {3- [2- (3, 5-dichloro-phenoxy) -ethyl] -thioureido} -phenyl) -amide 666 445 N- (4- {3- [2- (3-chloro-phenoxy) -ethyl] -thioureido} -phenyl) -2-fluoro -Benzamide 667 417 furan-2-carboxylic acid (4- {3- [2- (3-chloro-phenoxy) -ethyl] -thioureido} -phenyl) -amide 668 435 [1, 2, 3] Thiadiazole-4-carboxylic acid (4- {3- [2- (3-chloro-phenoxy) -ethyl] -thioureido} -phenyl) -amide 669 466 2-fluoro-N- {4- [3- ( 2-fluoro-5-trifluoro-methyl-benzyl) -thioureido] -phenyl} -benzamide 670 438 Furan-2-carboxylic acid {4- [3- (2-fluoro-5-trifluoromethyl-benzyl) -thioureide ] -Phenyl} -amide 671 456 [1, 2, 3] Thiadiazole-4-carboxylic acid {4- [3- (2-fluoro-5-trifluoromethyl-benzyl) -thioureido] -phenyl} -amide 672 416 N- {4- [3- (3, 4-difluoro-benzyl) -thioureido] -phenyl} -2-fluoro-benzamide 673 452 N- (4- {3- [2- (4-dimethylamino-3-methyl-phenyl) -ethyl] -thioureido}- (Phenyl) -2-fluoro-benzamide 674 496 [1, 2, 3] Thiadiazole-4-carboxylic acid (4- {3- [2- (3-dimethylamino-5-trifluoromethyl-phenyl) -ethyl] -thioureido} -phenyl) -amide 675 388 Furan-2-carboxylic acid {4- [3- (3, 4-difluoro-benzyl) -thioureido] -phenyl} -amide 676 406 [1, 2, 3] thiadiazole-4-carboxylic acid {4- [3- (3, 4-difluoro-benzyl) -thioureido] -phenyl} -amide 677 433 N- {4- [3- (3-chloro-4-fluoro-benzyl) -thioureido] -phenyl} -2-fluoro-benzamide 678 495 [ 1, 2, 3] Thiadiazole-4-carboxylic acid (4- {3- [2- (3-bromo-phenylsulfanyl) -ethyl] -thioureido} -phenyl) -amide 679 477 Furan-2-carboxylic acid (4- {3- [2- (3-bromo-phenyl-sulfanyl) -ethyl] -thioureido} -phenyl) -amide 680 505 N- (4- {3- [2- (3-bromo-phenylsulfanyl) -ethyl] -thioureide} -Phenyl) -2-fluoro-benzamide 681 493 [1, 2, 3] Thiadiazole-4-carboxylic acid (4- {3- [2- (3-bromo-4-methoxy-phenyl) -ethyl] -thioureido} -phenyl) -amide 682 493 [1, 2, 3] Thiadiazole-4-carboxylic acid (4- {3- [2- (5-bromo-2-methoxy-phenyl) -ethyl] -thioureido} -phenyl) -amide 683 419 [1, 2, 3] Thiadiazole-4-carboxylic acid (4- {3- [2- (2-chloro-phenyl) -ethyl] -thioureido} -phenyl) -amide 684 402 [1, 2, 3] Thiadiazole-4-carboxylic acid (4- {3- [2- (2-fluoro-phenyl) -ethyl] -thioureido} -phenyl) -amide 685 419 [1, 2, 3] Thiadiazole-4-carboxylic acid (4- {3- [2- (4-chloro-phenyl) -ethyl] -thioureido} -phenyl) -amide 686 475 [1, 2, 3] thiadiazole-4-carboxylic acid {4- [3- (3, 3-diphenyl-propyl) -thioureido] -phenyl} -amide 687 547 2-fluoro-N- (4- {3- [4- (4-methyl-piperazin-1-yl) -3-trifluoromethyl-benzyl ] -Thioureido} -phenyl) -benzamide 688 469 [1, 2, 3] thiadiazole-4-carboxylic acid (4- {3- [2- (3, 5-dichloro-phenoxy) -ethyl] -thioureido} -phenyl} -amide 689 423 [1, 2, 3] Thiadiazole-4-carboxylic acid {4- [3- (3-chloro-4-fluoro-benzyl) -thioureido] -phenyl} -amide 690 427 [1, 2, 3] Thiadiazole-4-carboxylic acid {4- [3- (4-tert-butyl-benzyl) -thioureido] -phenyl} -amide 691 399 [1, 2, 3] thiadiazole-4-carboxylic acid {4- [3- (3, 5-dimethyl-benzyl) -thioureido] -phenyl} -amide 692 442 [1, 2, 3] Thiadiazole-4-carboxylic acid (4- {3- [2- (4-dimethylamino-3-methyl-phenyl) -ethyl] -thioureido} -phenyl} -amide 693 479 [1, 2, 3] Thiadiazole-4-carboxylic acid (4- {3- [2- (4-bromo-phenoxy) -ethyl] -thioureido} -phenyl) -amide 694 526 [1, 2, 3] Thiadiazole-4-carboxylic acid (4- {3- [2- (4-iodo-phenoxy) -ethyl] -thioureido} -phenyl) -amide 695 489 N- (4- {3- [2- (4 -Bromo-phenoxy) -ethyl] -thioureido} -phenyl) -2-fluoro-benzamide 696 536 2-fluoro-N- (4- {3- [2- (4-iodo-phenoxy) -ethyl] -thioureido} -Phenyl) -benzamide 697 461 Furan-2-carboxylic acid (4- {3- [2- (4-bromo-phenoxy) -ethyl] -thioureido} -phenyl) -amide 698 508 Furan-2-carboxylic acid (4 -{3- [2- (4-Iodo-phenoxy) -ethyl] -thioureido} -phenyl) -amide 699 408 oxazole-4-carboxylic acid {4- [3- (3, 4-dichloro-phenyl) -thioureido] -phenyl} -amide 700 424 thiazole-4-carboxylic acid {4- [3- (3, 5-dichloro-phenyl) -thioureido] -phenyl} -amide 701 491 thiazole-4-carboxylic acid {4- [3- (3, 5-bis-trifluoromethyl-phenyl) -thioureido] -phenyl} -amide 702 408 oxazole-4-carboxylic acid {4- [3- (3, 5-dichloro-phenyl) -thioureido] -phenyl} -amide 703 469 [1, 2, 3] thiadiazole-4-carboxylic acid (4- {3- [2- (3, 4-dichloro-phenoxy) -ethyl] -thioureido} -phenyl) -amide 704 424 thiazole-4-carboxylic acid {4- [3- (3, 4-dichloro-phenyl) -thioureido] -phenyl} -amide 705 458 Thiazole-4-carboxylic acid {4- [3- (4-chloro-3-trifluoromethyl-phenyl) -thioureido] -phenyl} -amide 706 400 [1, 2, 3] Thiadiazole-4-carboxylic acid {4- [3- (2-phenylamino-ethyl) -thioureido] -phenyl} -amide 707 453 [1, 2, 3] thiadiazole-4-carboxylic acid (4- {3- [2- (2, 4-dichloro-phenyl) -ethyl] -thioureido} -phenyl} -amide 708 452 [1, 2, 3] Thiadiazole-4-carboxylic acid (4- {3- [2- (3-trifluoromethyl-phenyl) -ethyl] -thioureido} -phenyl) -amide 709 453 [1, 2, 3] thiadiazole-4-carboxylic acid (4- {3- [2- (2, 6-dichloro-phenyl) -ethyl] -thioureido} -phenyl) -amide 710 485 [1, 2, 3] thiadiazole-4-carboxylic acid (4- {3- [2- (3, 4-dichloro-phenylsulfanyl) -ethyl] -thioureido} -phenyl) -amide 711 503 [1, 2, 3] Thiadiazole-4-carboxylic acid (4- {3- [2- (2-fluoro-5-trifluoromethyl-phenyl-sulfanyl) -ethyl] -thioureido} -phenyl) -amide 712 668 N- (4- {3- [3-chloro-5- (3- {4-[([1, 2, 3] Thiadiazole-4-carbonyl) -amino] -phenyl} -thioureido) -phenyl] -thioureido} -phenyl)-[1, 2, 3] Thiadiazole-4-carboxamide 713 413 [1, 2, 3] Thiadiazole-4-carboxylic acid (4- {3- [2- (4-ethyl-phenyl) -ethyl] -thioureido} -phenyl) -amide 714 442 oxazole-4-carboxylic acid {4- [3- ( 4-chloro-3-trifluoromethyl-phenyl) -thioureido] -phenyl} -amide 715 475 oxazole-4-carboxylic acid {4- [3- (3, 5-bis-trifluoromethyl-phenyl) -thioureido] -phenyl} -amide 716 420 [1, 2, 3] thiadiazole-4-carboxylic acid (4- {3- [2- (3, 4-difluoro-phenyl) -ethyl] -thioureido} -phenyl) -amide 717 452 [1, 2, 3] Thiadiazole-4-carboxylic acid (4- {3- [2- (4-trifluoromethyl-phenyl) -ethyl] -thioureido} -phenyl) -amide 718 435 furan-2-carboxylic acid (4- {3 -[2- (3, 4-dichloro-phenyl) -ethyl] -thioureido} -phenyl) -amide 719 463 N- (4- {3- [2- (3, 4-dichloro-phenyl) -ethyl] -thioureido} -phenyl) -2-fluoro-benzamide 720 420 [1, 2, 3] thiadiazole-4-carboxylic acid (4- {3- [2- (3, 5-difluoro-phenyl) -ethyl] -thioureido} -phenyl) -amide 721 412 2-fluoro-N- (4- {3- [2- (2-fluoro-phenyl) -ethyl] -thioureido} -phenyl) -Benzamide 722 429 [1, 2, 3] Thiadiazole-4-carboxylic acid (4- {3- [2- (4-nitro-phenyl) -ethyl] -thioureido} -phenyl) -amide 723 399 [1, 2, 3] Thiadiazole-4-carboxylic acid {4- [3- (1-methyl-2-phenyl) -ethyl) -thioureido] -phenyl} -amide 724 437 N- {4- [3- (4-tert-butyl) -Benzyl) -thioureido] -phenyl} -2-fluoro-benzamide 725 409 N- {4- [3- (3, 5-dimethyl-benzyl) -thioureido] -phenyl} -2-fluoro-benzamide 726 400 [1, 2, 3] Thiadiazole-4-carboxylic acid {4- [3- (2-hydroxy-1-phenyl-ethyl) -thioureido] -phenyl} -amide 727 409 2-fluoro-N- {4- [3- (1 -Methyl-1-phenyl-ethyl) -thioureido] -phenyl} -benzamide 728 399 [1, 2, 3] Thiadiazole-4-carboxylic acid {4- [3- (1-methyl-1-phenyl-ethyl) -thioureido] -phenyl} -amide 729 405 [1, 2, 3] Thiadiazole-4-carboxylic acid {4- [3- (2-chloro-benzyl) -thioureido] -phenyl} -amide 730 388 [1, 2, 3] Thiadiazole-4-carboxylic acid {4- [3- (2-fluoro-benzyl) -thioureido] -phenyl} -amide 731 438 [1, 2, 3] Thiadiazole-4-carboxylic acid {4- [3- (3-trifluoromethyl-benzyl) -thioureido] -phenyl} -amide 732 388 [1, 2, 3] Thiadiazole-4-carboxylic acid {4- [3- (3-fluoro-benzyl) -thioureido] -phenyl} -amide 733 435 [1, 2, 3] Thiadiazole-4-carboxylic acid (4- {3- [2- (2-chloro-phenoxy) -ethyl] -thioureido} -phenyl) -amide 734 479 [1, 2, 3] Thiadiazole-4-carboxylic acid (4- {3- [2- (3-bromo-phenoxy) -ethyl] -thioureido} -phenyl) -amide 735 418 [1, 2, 3] Thiadiazole-4-carboxylic acid (4- {3- [2- (2-fluoro-phenoxy) -ethyl] -thioureido} -phenyl) -amide 736 418 [1, 2, 3] Thiadiazole-4-carboxylic acid (4- {3- [2- (3-fluoro-phenoxy) -ethyl] -thioureido} -phenyl) -amide 737 486 [1, 2, 3] Thiadiazole-4-carboxylic acid (4- {3- [2- (2-fluoro-5-trifluoromethyl-phenoxy) -ethyl] -thioureido} -phenyl) -amide 738 384 furan-2-carboxylic acid ( 4- {3- [2- (2-fluoro-phenyl) -ethyl] -thioureido} -phenyl) -amide 739 435 [1, 2, 3] Thiadiazole-4-carboxylic acid {4- [3- (4-bromo-phenyl) -thioureido] -phenyl} -amide 740 374 [1, 2, 3] Thiadiazole-4-carboxylic acid {4- [3- (4-fluoro-phenyl) -thioureido] -phenyl} -amide 741 388 [1, 2, 3] Thiadiazole-4-carboxylic acid {4- [3- (4-fluoro-benzyl) -thioureido] -phenyl} -amide 742 405 [1, 2, 3] Thiadiazole-4-carboxylic acid {4- [3- (4-chloro-benzyl) -thioureido] -phenyl} -amide 743 449 [1, 2, 3] Thiadiazole-4-carboxylic acid {4- [3- (4-bromo-benzyl) -thioureido] -phenyl} -amide 744 332 N- (4- {3- [1- (4-fluoro-phenyl)- Ethyl] -thioureido} -phenyl) -acetamide 745 438 thiazole-4-carboxylic acid {4- [3- (3, 4-dichloro-benzyl) -thioureido] -phenyl} -amide 746 455 thiazole-4-carboxylic acid {4- [3- (2-fluoro-5-trifluoromethyl-benzyl) -thioureido] -phenyl} -amide 747 426 Thiazole-4-carboxylic acid {4- [3- (4-tert-butyl-benzyl) -thioureido] -phenyl} -amide 748 374 [1, 2, 3] Thiadiazole-4-carboxylic acid {4- [3- (2-fluoro-phenyl) -thioureido] -phenyl} -amide 749 374 [1, 2, 3] Thiadiazole-4-carboxylic acid {4- [3- (3-fluoro-phenyl) -thioureido] -phenyl} -amide 750 526 [1, 2, 3] Thiadiazole-4-carboxylic acid (4- {3- [2- (3-iodo-phenoxy) -ethyl] -thioureido} -phenyl) -amide 751 409 N- (4- {3- [1- (4 -Fluoro-phenyl) -ethyl] -thioureido} -phenyl) -2-phenyl-acetamide 752 425 N- (4- {3- [1- (4-fluoro-phenyl) -ethyl] -thioureido} -phenyl) 2-methoxy-benzamide 753 425 N- (4- {3- [1- (4-fluoro-phenyl) -ethyl] -thioureido} -phenyl) -3-methoxy-benzamide 754 425 N- (4- { 3- [1- (4-fluoro-phenyl) -ethyl] -thioureido} -phenyl) -4-methoxy-benzamide 755 429 2-chloro-N- (4- {3- [1- (4-fluoro- Phenyl) -ethyl] -thioureido} -phenyl) -benzamide 756 429 4-chloro-N- (4- {3- [1- (4-fluoro-phenyl) -ethyl] -thioureido} -phenyl) -benzamide 757 453 4- (4- {3- [1- (4-fluoro-phenyl) -ethyl] -thioureido} -acetate Rucarbamoyl) -phenyl ester 758 394 N- (4- {3- [1- (4-fluoro-phenyl) -ethyl] -thioureido} -phenyl) -benzamide 759 395 N- (4- {3- [1- (4-fluoro-phenyl) -ethyl] -thioureido} -phenyl) -isonicotinamide 760 410 N- (4- {3- [1- (4-fluoro-phenyl) -ethyl] -thioureido} -phenyl ) -4-Hydroxy-benzamide 761 429 3-chloro-N- (4- {3- [1- (4-fluoro-phenyl) -ethyl] -thioureido} -phenyl) -benzamide 762 470 [1, 2, 3] Thiadiazole-4-carboxylic acid (4- {3- [2- (3-fluoro-5-trifluoromethyl-phenyl) -ethyl] -thioureido} -phenyl) -amide 763 520 [1, 2, 3] thiadiazole-4-carboxylic acid (4- {3- [2- (2, 4-bis-trifluoromethyl-phenyl) -ethyl] -thioureido} -phenyl) -amide 764 470 [1, 2, 3] Thiadiazole-4-carboxylic acid (4- {3- [2- (4-fluoro-3-trifluoromethyl-phenyl) -ethyl] -thioureido} -phenyl) -amide 765 438 4-dimethylamino-N- (4- {3- [1- (4-fluoro-phenyl) -ethyl] -thioureido} -phenyl) -benzamide 766 470 [1, 2, 3] Thiadiazole-4-carboxylic acid (4- {3- [2- (2-fluoro-3-trifluoromethyl-phenyl) -ethyl] -thioureido} -phenyl) -amide 767 470 [1, 2, 3] Thiadiazole-4-carboxylic acid (4- {3- [2- (2-fluoro-5-trifluoromethyl-phenyl) -ethyl] -thioureido} -phenyl) -amide 768 510 [1, 2, 3] Thiadiazole-4-carboxylic acid (4- {3- [2- (3-iodo-phenyl) -ethyl] -thioureido} -phenyl) -amide 769 470 [1, 2, 3] Thiadiazole-4-carboxylic acid (4- {3- [2- (4-fluoro-2-trifluoromethyl-phenyl) -ethyl] -thioureido} -phenyl) -amide 770 463 [1, 2, 3] Thiadiazole-4-carboxylic acid (4- {3- [2- (3-bromo-phenyl) -ethyl] -thioureido} -phenyl) -amide 771 427 2-fluoro-N- (4- {3- [ 1- (4-fluoro-phenyl) -propyl] -thioureido} -phenyl) -benzamide 772 475 2-fluoro-N- (4- {3- [1- (4-fluoro-phenyl) -phenyl-methyl]- Thioured} -phenyl) -benzamide 773 455 2-Fluoro-N- (4- {3- [1- (4-fluoro-phenyl) -pentyl] -thioureido} -phenyl) -benzamide 774 489 2-fluoro-N- (4- {3- [1- (4-fluoro-phenyl) -2-phenyl-ethyl] -thioureido} -phenyl) -benzamide 775 409 2-fluoro-N- {4- [3- (1-o- Tolyl-ethyl) -thioureido] -phenyl} -benzamide 776 409 2-fluoro-N- {4- [3- (1-m-tolyl-ethyl) -thioureido] -phenyl} -benzamide 777 425 2-fluoro-N -(4- {3- [1- (4-methoxy-phenyl) -ethyl] -thiourei } -Phenyl) -benzamide 778 412 2-Fluoro-N- (4- {3- [1- (2-fluoro-phenyl) -ethyl] -thioureido} -phenyl) -benzamide 779 429 N- (4- {3 -[1- (3-Chloro-phenyl) -ethyl] -thioureido} -phenyl) -2-fluoro-benzamide 780 473 N- (4- {3- [1- (3-bromo-phenyl) -ethyl]- Thioureido} -phenyl) -2-fluoro-benzamide 781 429 N- (4- {3- [1- (4-chloro-phenyl) -ethyl] -thioureido} -phenyl) -2-fluoro-benzamide 782 409 2- Fluoro-N- {4- [3- (1-p-tolyl-ethyl) -thioureido] -phenyl} -benzamide 783 473 N- (4- {3- [1- (2-bromo-phenyl) -ethyl] -Thioureido} -phenyl) -2-fluoro-benzamide 784 429 N- (4- {3- [1- (2-chloro-phenyl) -ethyl] -thioureido} -phenyl) -2-fluoro-benzamide 785 462 2 -Fluoro-N- (4- {3- [1- (2-trifluoromethyl-phenyl) -ethyl]- Oureido} -phenyl) -benzamide 786 462 2-Fluoro-N- (4- {3- [1- (3-trifluoromethyl-phenyl-ethyl] -thioureido} -phenyl) -benzamide 787 462 2-fluoro-N -(4- {3- [1- (4-trifluoromethyl-phenyl-ethyl] -thioureido} -phenyl) -benzamide 788 425 2-fluoro-N- (4- {3- [1- (2-methoxy -Phenyl) -ethyl] -thioureido} -phenyl) -benzamide 789 425 2-Fluoro-N- (4- {3- [1- (3-methoxy-phenyl) -ethyl] -thioureido} -phenyl) -benzamide 790 441 2-Fluoro-N- (4- {3- [1- (4-fluoro-phenyl) -2-methyl-propyl] -thioureido} -phenyl) -benzamide 791 419 N- (4- {3- [1 -(3-Cyano-phenyl) -ethyl] -thioureido} -phenyl) -2-fluoro-benzamide 792 419 N- (4- {3- [1- (4-cyano-phenyl) -ethyl] -thioureido}- (Phenyl) -2-fluoro-benzamide 793 4 38 N- (4- {3- [1- (4-dimethylamino-phenyl) -ethyl] -thioureido} -phenyl) -2-fluoro-benzamide 794 438 N- (4- {3- [1- ( 3-dimethylamino-phenyl) -ethyl] -thioureido} -phenyl) -2-fluoro-benzamide 795 473 2-bromo-N- (4- {3- [1- (4-fluoro-phenyl) -ethyl] -Thioureido} -phenyl) -benzamide 796 446 Quinoline-2-carboxylic acid (4- {3- [1- (4-fluoro-phenyl) -ethyl] -thioureido} -phenyl) -amide 797 410 2-fluoro-N -{4- [3- (2-hydroxy-1-phenyl-ethyl) -thioureido] -phenyl} -benzamide 798 332 2-Fluoro-N- [4- (3-isopropyl-thioureido) -phenyl] -benzamide 799 445 2-Fluoro-N- {4- [3- (1-naphthalen-2-yl-ethyl) -thioureido] -phenyl} -benzamide 800 412 3-fluoro-N- (4- {3- [1- ( 4-Fluoro-phenyl) -ethyl] -thioureido} -phenyl)- Nsamide 801 412 4-Fluoro-N- (4- {3- [1- (4-fluoro-phenyl) -ethyl] -thioureido} -phenyl) -benzamide 802 384 2-fluoro-N- {4- [3- (1-furan-2-yl-ethyl) -thioureido] -phenyl} -benzamide 803 395 2-fluoro-N- {4- [3- (1-pyridin-4-yl-ethyl) -thioureido] -phenyl} -Benzamide 804 397 2-Fluoro-N- (4- {3- [1- (1-methyl-1H-pyrroli-2-yl) -ethyl] -thioureido} -phenyl} -benzamide 805 401 2-fluoro-N -{4- [3- (1-thiophen-3-yl-ethyl) -thioureido] -phenyl} -benzamide 806 445 N- {4- [3- (3-chloro-4-ethoxy-phenyl) -thioureido] -Phenyl} -2-fluoro-benzamide 807 459 N- {4- [3- (3-Chloro-4-propoxy-phenyl) -thioureido] -phenyl} -2-fluoro-benzamide 808 459 N- {4- [ 3- (3-chloro-4-isopropoxy-phenyl) -thioureido] -phenyl } -2-fluoro-benzamide 809 473 N- {4- [3- (4-butoxy-3-chloro-phenyl) -thioureido] -phenyl} -2-fluoro-benzamide 810 522 2-fluoro-N- {4 -[3- (3-Iodo-4-methoxy-phenyl) -thioureido] -phenyl} -benzamide 811 475 N- {4- [3- (3-Bromo-4-methoxy-phenyl) -thioureido] -phenyl} -2-fluoro-benzamide 812 520 N- (4- {3- [1- (4-fluoro-phenyl) -ethyl] -thioureido} -phenyl) -2-iodo-benzamide 813 346 N- (4- { 3- [1- (4-Fluoro-phenyl) -ethyl] -thioureido} -phenyl) -propionamide 814 286 N- [4- (3-phenyl-thioureido) -phenyl] -acetamide Example 815 (Method 32) [1, 2, 3] thiadiazole-4-carboxylic acid {4- [3- (2, 5-dichloro-phenyl) -thioureido] -phenyl} -amide 2, 5-dichloroaniline (0. 16 g) in 20 ml of tetrahydrofuran.
Freshly prepared 1,1'-thiocarbonyldiimidazole (0.20 g) is added and the mixture is
Stir at room temperature for about 30 minutes. [1,2,3] thiadiazole-4-carboxylic acid (4-amino-fe
Nyl) amide (0.22 g) is added to the reaction flask and the mixture is stirred for about 6 hours.
The solvent is removed by evaporation under reduced pressure and warm acetonitrile (3 mL) is added
. After 15 hours, the mixture was filtered and the collected precipitate was washed with acetonitrile followed by diethyl ether.
Wash with chill ether and air dry to give the desired product as a white powder.

Using the above procedures and the appropriate starting materials, the following compounds were prepared: Examplesnumber M + H Compound name 816 321 N- {4- [3- (3-chloro-phenyl) -thioureido] -phenyl} -acetamide 817 413 N- {4- [3- (3-chloro-4-methoxy-phenyl) -thioureido]- Phenyl} -benzamide 818 443 N- {4- [3- (3-chloro-4-methoxy-phenyl) -thioureido] -phenyl} -2-methoxy-benzamide 819 443 N- {4- [3- (3- Chloro-4-methoxy-phenyl) -thioureido] -phenyl} -3-methoxy-benzamide 820 443 N- {4- [3- (3-chloro-4-methoxy-phenyl) -thioureido] -phenyl} -4- Methoxy-benzamide 821 431 N- {4- [3- (3-chloro-4-methoxy-phenyl) -thioureido] -phenyl} -4-methoxy-benzamide 822 431 N- {4- [3- (3-chloro -4-methoxy-phenyl) -thioureido] -phenyl} -3-fluoro-benzamide 823 431 N- {4- [3- (3-chloro-4-methoxy-phenyl) -thioureido] -phenyl} -4-fluoro -Benzamide 824 437 furan-2-carbo Acid {4- [3- (3,5-dichloro-4-methoxy-phenyl) -thioureido] -phenyl} -amide 825 511 {4- [3- (5-bromo-2,4-dimethoxy-phenyl) -Thioureido] -phenyl} -carbamic acid hexyl ester 826 481 hexanoic acid {4- [3- (5-bromo-2,4-dimethoxy-phenyl) -thioureido] -phenyl} -amide 827 505 N- {4- [ 3- (5-bromo-2,4-dimethoxy-phenyl) -thioureido] -phenyl} -2-fluoro-benzamide 828 477 furan-2-carboxylic acid {4- [3- (5-bromo-2,4- Dimethoxy-phenyl) -thioureido] -phenyl} -amide 829 501 N- {4- [3- (5-bromo-2,4-dimethoxy-phenyl) -thioureido] -phenyl} -2-methyl-benzamide 830 517 N -{4- [3- (5-Bromo-2,4-dimethoxy-phenyl) -thioureido] -phenyl} -4-methoxy-benzamide 831 395 N- {4- [3- (5-chloro-2-ethoxy) -4-methoxy-phenyl) -thioureido] -phenyl}- Acetamide 832 395 N- {4- [3- (5-Chloro-4-ethoxy-2-methoxy-phenyl) -thioureido] -phenyl} -acetamide 833 423 N- {4- [3- (2-butoxy-5) -Chloro-4-methoxy-phenyl) -thioureido] -phenyl} -acetamide 834 423 N- {4- [3- (4-butoxy-5-chloro-2-methoxy-phenyl) -thioureido] -phenyl} -acetamide 835 457 N- {4- [3- (2-benzyloxy-5-chloro-4-methoxy-phenyl) -thioureido] -phenyl} -acetamide 836 457 N- {4- [3- (4-benzyloxy- 5-chloro-2-methoxy-phenyl) -thioureido] -phenyl} -acetamide 837 421 [1,2,3] thiadiazole-4-carboxylic acid {4- [3- (3-chloro-4-methoxy-phenyl) -Thioureido] -phenyl} -amide 838 424 2- {4- [3- (4-acetylamino-phenyl) -thioureido] -2-chloro-5-methoxy-phenoxy} -acetamide 839 367 N- {4- [ 3- (5-chloro-2-hydro C-4-methoxy-phenyl) -thioureido] -phenyl} -acetamide 840 367 N- {4- [3- (3-chloro-4-methylsulfanyl-phenyl) -thioureido] -phenyl} -acetamide 841 447 N- {4- [3- (3-chloro-4- [methyl- (1-methyl-1-piperidin-4-yl) -amino] -phenyl} -thioureido) -phenyl} -acetamide 842 426 N- (4- {3- [3-chloro-4- (methyl-phenyl-amino) -phenyl] -thioureido} -phenyl) -acetamide 843 509 N- [4- (3- {4-[(1-benzyl-pyrrolidine-3) -Yl) -Methyl-amino] -3-chloro-phenyl} -thioureido) -phenyl] -acetamide 844 418 N- (4- {3- [3-chloro-4- (cyclopentyl-methyl-amino) -phenyl] -Thioureido} -phenyl) -acetamide 845 433 N- [4- (3- {3-chloro-4- [methyl- (1-methyl-pyrrolidin-3-yl) -amino] -phenyl} -thioureido) -phenyl ]-Acetamide 846 419 Furan-2- Carboxylic acid {4- [3- (3-chloro-4-methylsulfanyl-phenyl) -thioureido] -phenyl} -amide 847 447 N- {4- [3- (3-chloro-4-methylsulfanyl-phenyl) ) -Thioureido] -phenyl} -2-fluoro-benzamide 848 465 N- {4- [3- (3-chloro-4-methylsulfanyl-phenyl) -thioureido] -phenyl} -2,6-difluoro-benzamide 849 445 N- {4- [3- (5-chloro-2-methoxy-4-methyl-phenyl) -thioureido] -phenyl} -2-fluoro-benzamide 850 441 N- {4- [3- (5-chloro 2-methoxy-4-methyl-phenyl) -thioleido] -phenyl} -2-methyl-benzamide 851 434 [1,2,3] thiadiazole-4-carboxylic acid {4- [3- (3-chloro-4 -Dimethylamino-phenyl) -thioureido] -phenyl} -amide 852 444 N- {4- [3- (3-chloro-4-dimethylamino-phenyl) -thioureido] -phenyl} -2-fluoro-benzamide 853 517 [1,2,3] cheer Azole-4-carboxylic acid [4- (3- {3-chloro-4- [methyl- (1-methyl-piperidin-4-yl) -amino] -phenyl} -thioureido) -phenyl] -amide 854 579 [ [4- (3- {4-[(1-Benzyl-pyrrolidin-3-yl) -methyl-amino] -3-chloro-phenyl} -thioureido) -phenyl 1,2,3] thiadiazole-4-carboxylate ] -Amide 855 527 N- [4- (3- {3-chloro-4- [methyl- (1-methyl-piperidin-4-yl) -amino] -phenyl} -thioureido) -phenyl] -2-fluoro -Benzamide 856 435 [1,2,3] thiadiazole-4-carboxylic acid {4- [3- (5-chloro-2-methoxy-4-methyl-phenyl) -thioureido] -phenyl} -amide 857 589 N- [4- (3- {4-[(1-benzyl-pyrrolidin-3-yl) -methyl-amino] -3-chloro-phenyl} -thioureido) -phenyl] -2-fluoro-benzamide 858 501 furan-2 -Carboxylic acid {4- [3- (5-chloro-2,4-dimethoxy-phenyl) -thioureido] -3- Trifluoromethyl-phenyl} -amide 859 366 2-fluoro-N- [4- (3-phenyl-thioureido) -phenyl] -benzamide 860 338 furan-2-carboxylic acid [4- (3-phenyl-thioureido)- Phenyl] -amide 861 356 [1,2,3] thiadiazole-4-carboxylic acid [4- (3-phenyl-thioureido) -phenyl] -amide 862 365 N- (4- {3- [3-chloro-4 -(1-Hydroxy-ethyl) -phenyl] -thioureido} -phenyl) -acetamide 863 435 [1,2,3] thiadiazole-4-carboxylic acid (4- {3- [3-chloro-4- (1- (1- Hydroxy-ethyl) -phenyl] -thioureido} -phenyl) -amide 864 365 N- (4- {3- [3-chloro-4- (2-hydroxy-ethyl) -phenyl] -thioureido} -phenyl) -acetamide 865 445 N- (4- {3- [3-chloro-4- (1-hydroxy-ethyl) -phenyl] -thioureido} -phenyl) -2-fluoro-benzamide 866 417 furan-2-carboxylic acid (4- {3- [3-chloro-4- (1- Roxy-ethyl) -phenyl] -thioureido} -phenyl) -amide 867 371 [1,2,3] thiadiazole-4-carboxylic acid {4- [3- (3-amino-phenyl) -thioureido] -phenyl}- Amide 868 501 Furan-2-carboxylic acid {4- [3- (3-bromo-4-trifluoro-methoxy-phenyl) -thioureido] -phenyl} -amide 869 423 N- {4- [3- (3- tert-butyl-phenyl) -thioureido] -phenyl} -2-fluoro-benzamide 870 440 [1,2,3] thiadiazole-4-carboxylic acid {4- [3- (4-chloro-3,5-dichloro- Phenyl) -thioureido] -phenyl} -amide 974 485 N- {4- [3- (1-benzofuran-2-yl-ethyl) -thioureido] -phenyl} -2-trifluoromethyl-benzamide 975 412 N- ( 4-fluoro-phenyl) -4- {3- [1- (4-fluoro-phenyl) -ethyl] -thioureido} -benzamide 976 446 isoquinoline-1-carboxylic acid (4- {3- [1- (4- Fluoro-phenyl) -ethyl] -thio Ureido} -phenyl) -amide 977 468 isoquinoline-1-carboxylic acid {4- [3- (1-benzofuran-2-yl-ethyl) -thioureido] -phenyl} -amide 978 506 isoquinoline-1-carboxylic acid (4 -{3- [1- (4-bromo-phenyl) -ethyl] -thioureido} -phenyl) -amide 979 453 isoquinoline-1-carboxylic acid (4- {3- [1- (4-cyano-phenyl)- Ethyl] -thioureido} -phenyl) -amide 980 435 Benzofuran-2-carboxylic acid (4- {3- [1- (4-fluoro-phenyl) -ethyl] -thioureido} -phenyl) -amide 981 457 Benzofuran-2 -Carboxylic acid {4- [3- (1-benzofuran-2-yl-ethyl) -thioureido] -phenyl} -amide 982 495 Benzofuran-2-carboxylic acid (4- {3- [1- (4-bromo- Phenyl) -ethyl] -thioureido} -phenyl) -amide 983 442 Benzofuran-2-carboxylic acid (4- {3- [1- (4-cyano-phenyl) -ethyl] -thioureido} -phenyl) -amide 984 4 46 Isoquinoline-3-carboxylic acid (4- {3- [1- (4-fluoro-phenyl) -ethyl] -thioureido} -phenyl) -amide 985 468 Isoquinoline-3-carboxylic acid {4- [3- (1 -Benzofuran-2-yl-ethyl) -thioureido] -phenyl} -amide 986 453 Isoquinoline-3-carboxylic acid (4- {3- [1- (4-cyano-phenyl) -ethyl] -thioureido} -phenyl) -Amide 987 506 Isoquinoline-3-carboxylic acid (4- {3- [1- (4-bromo-phenyl) -ethyl] -thioureido} -phenyl) -amide 988 446 Quinoline-3-carboxylic acid (4- {3 -[1- (4-Fluoro-phenyl) -ethyl] -thioureido} -phenyl) -amide 989 446 Quinoline-4-carboxylic acid (4- {3- [1- (4-fluoro-phenyl) -ethyl]- Thioured} -phenyl) -amide 990 446 Quinoline-6-carboxylic acid (4- {3- [1- (4-fluoro-phenyl) -ethyl] -thioureido} -phenyl) -amide 991 446 Quinoline-8-carboxylic acid (4- {3- [1- (4-full L-phenyl) -ethyl] -thioureido} -phenyl) -amide 992 462 N- (4- {3- [1- (4-fluoro-phenyl) -ethyl] -thioureido} -phenyl) -2-trifluoromethyl -Benzamide 993 419 2-cyano-N- (4- {3- [1- (4-fluoro-phenyl) -ethyl] -thioureido} -phenyl) -benzamide 994 473 N- {4- [3- (3- Chloro-4-isobutoxy-phenyl) -thioureido] -phenyl} -2-fluoro-benzamide 995 414 2-fluoro-N- {4- [3- (3-fluoro-4-methoxy-phenyl) -thioureido] -phenyl } -Benzamide 996 475 N- (4- {3- [3-chloro-4- (2-methoxy-ethoxy) -phenyl] -thioureido} -phenyl) -2-fluoro-benzamide 997 398 2-fluoro-N- {4- [3- (3-fluoro-4-methyl-phenyl) -thioureido] -phenyl} -benzamide 998 464 2-fluoro-N- {4- [3- (4-methoxy-3-trifluoro-methyl -Phenyl) -thioureido] -fe Nyl} -benzamide 999 449 N- {4- [3- (2-amino-5-trifluoromethyl-phenyl) -thioureido] -phenyl} -2-fluoro-benzamide 1000 459 N- (4- {3- [ 1- (3-chloro-4-methoxy-phenyl) -ethyl] -thioureido} -phenyl) -2-fluoro-benzamide 1001 417 N- {4- [3- (5-chloro-2-hydroxy-phenyl)- Thioureido] -phenyl} -2-fluoro-benzamide 1002 435 N- {4- [3- (1-benzofuran-2-yl-ethyl) -thioureido] -phenyl} -2-fluoro-benzamide 1003 448 2-fluoro- N- {4- [3- (4-methyl-3-trifluoromethyl-phenyl) -thioureido] -phenyl} -benzamide 1004 473 (S) -N- (4- {3- [1- (4-bromo -Phenyl) -ethyl] -thioureide} -phenyl) -2-fluoro-benzamide 1005 473 N- (4- {3-[(1R) -1- (4-bromo-phenyl) -ethyl] -thioureide} -Phenyl) -2-fluoro-benzamide 1006 494 2-Fluoro -N- (4- {3- [2-methoxy-4- (2,2,2) -trifluoro-ethoxy) -phenyl] -thioureido} -phenyl) -benzamide 1007 399 N- {4- [3- (2-amino-5-fluoro-phenyl) -thioureido] -phenyl} -2-fluoro-benzamide 1008 502 N- (4- {3- [1- (4-dimethylsulfamoyl-phenyl) -ethyl)] -Thioureido} -phenyl) -2-fluoro-benzamide 1009 542 2-Fluoro-N- [4- (3- {1- [4- (piperidine-1-sulfonyl) -phenyl] -ethyl} -thioureido) -phenyl ] -Benzamide 1010 562 N- (4- {3- [2,4-bis- (2,2,2) -trifluoro-ethoxy) -phenyl] -thioureido} -phenyl) -2-fluoro-benzamide 1011 409 2-fluoro-N- (4- {3-[((1S) -1-p-tolyl-ethyl) -thioureido] -phenyl} -benzamide 1012 409 2-fluoro-N- {4- [3-(( 1R) -1-p-tolyl-ethyl) -thioureido] -phenyl} -benzamide 1013 394 2-fluoro-N- {4- [3-((1S) -1 -Phenyl-ethyl) -thioureido] -phenyl} -benzamide 1014 429 N- (4- {3-[(1R) -1- (4-chloro-phenyl) -ethyl] -thioureido} -phenyl) -2-fluoro -Benzamide 1015 429 N- (4- {3-[(1S) -1- (4-chloro-phenyl) -ethyl] -thioureido} -phenyl) -2-fluoro-benzamide 1016 394 2-fluoro-N- { 4- [3-((1R) -1-phenyl-ethyl) -thioureido] -phenyl} -benzamide 1017 432 N- (4- {3- [1- (4-cyano-phenyl) -ethyl] -thioureide} -Phenyl) -2-methoxy-benzamide 1018 447 N- {4- [3- (1-benzofuran-2-yl-ethyl) -thioureido] -phenyl} -2-methoxy-benzamide 1019 485 N- (4- { 3- [1- (4-bromo-phenyl) -ethyl] -thioureido} -phenyl) -2-methoxy-benzamide 1020 419 3-cyano-N- (4- {3- [1- (4-fluoro-phenyl) ) -Ethyl] -thioureido} -phenyl) -benzamide 1021 462 N- (4- {3- [1- (4-fur Oro-phenyl) -ethyl] -thioureido} -phenyl) -4-trifluoromethyl-benzamide 1022 419 4-cyano-N- (4- {3- [1- (4-fluoro-phenyl) -ethyl] -thioureido } -Phenyl) -benzamide 1023 469 2-fluoro-N- (4- {3- [1- (4-fluoro-phenyl) -ethyl] -thioureido} -2,3,5,6-tetramethyl-phenyl) -Benzamide 1024 480 N- (4- {3- [1- (4-cyano-phenyl) -ethyl] -thioureido} -2,5-dimethoxy-phenyl) -2-fluoro-benzamide 1025 473 2-fluoro-N -(4- {3- [1- (4-Fluoro-phenyl) -ethyl] -thioureido} -2,5-dimethoxy-phenyl) -benzamide 1026 530 N- {3,5-dichloro-4- [3- (5-chloro-2,4-dimethoxy-phenyl) -thioureido] -phenyl} -2-fluoro-benzamide 1027 447 N- (3-chloro-4- {3- [1- (4-fluoro-phenyl)- Ethyl] -thioureido} -phenyl) -2-fluoro-benzamide 1028 4 80 2,3,4,5-tetrafluoro-N- (4- {3- [1- (4-fluoro-phenyl) -ethyl] -thioureido} -3-methyl-phenyl) -benzamide 1029 462 2,4 , 5-Trifluoro-N- (4- {3- [1- (4-fluoro-phenyl) -ethyl] -thioureido} -3-methyl-phenyl) -benzamide 1030 427 2-fluoro-N- (4- {3- [1- (4-Fluoro-phenyl) -ethyl] -thioureido} -3-methyl-phenyl) -benzamide 1031 457 2-fluoro-N- (4- {3- [1- (4-fluoro- Phenyl) -ethyl] -thioureido} -2-methoxy-5-methyl-phenyl) -benzamide 1032 443 2-fluoro-N- (4- {3- [1- (4-fluoro-phenyl) -ethyl] -thioureido } -3-methoxy-phenyl) -benzamide 1033 570 N- (2,6-dibromo-4- {3- [1- (4-fluoro-phenyl) -ethyl] -thioureido} -phenyl) -2-fluoro- Benzamide 1034 480 2-Fluoro-N- (4- {3- [1- (4-fluoro-phenyl) -ethyl] -thioureido} -2- Trifluoromethyl-phenyl) -benzamide 1035 541 N- (4- {3- [1- (4-bromo-phenyl) -ethyl] -thioureido} -2-trifluoromethyl-phenyl) -2-fluoro-benzamide 1036 487 N- (4- {3- [1- (4-cyano-phenyl) -ethyl] -thioureido} -2-trifluoromethyl-phenyl) -2-fluoro-benzamide 1037 503 N- {4- [3- (1-benzofuran-2-yl-ethyl) -thioureido] -2-trifluoromethyl-phenyl} -2-fluoro-benzamide 1038 447 N- (2-chloro-4- {3- [1- (4-fluoro -Phenyl) -ethyl] -thioureido} -phenyl) -2-fluoro-benzamide 1039 454 N- (2-chloro-4- {3- [1- (4-cyano-phenyl) -ethyl] -thioureido} -phenyl ) -2-Fluoro-benzamide 1040 437 N- (2-cyano-4- {3- [1- (4-fluoro-phenyl) -ethyl] -thioureido} -phenyl) -2-fluoro-benzamide 1041 498 N- (4- {3- [1- (4-bromo-fe ) -Ethyl] -thioureido} -2-cyano-phenyl) -2-fluoro-benzamide 1042 445 N- (2-cyano-4- {3- [1- (4-cyano-phenyl) -ethyl] -thioureido } -Phenyl) -2-fluoro-benzamide 1043 460 N- {4- [3- (1-benzofuran-2-yl-ethyl) -thioureido] -2-cyano-phenyl} -2-fluoro-benzamide 1044 517 N -(2-benzoyl-4- {3- [1- (4-fluoro-phenyl) -ethyl] -thioureido} -phenyl) -2-fluoro-benzamide 1045 427 2-fluoro-N- (4- {3- [1- (4-Fluoro-phenyl) -ethyl] -thioureido} -2-methyl-phenyl) -benzamide 1046 487 N- (4- {3- [1- (4-bromo-phenyl) -ethyl] -thioureide } -2-Methyl-phenyl) -2-fluoro-benzamide 1047 434 N- (4- {3- [1- (4-cyano-phenyl) -ethyl] -thioureido} -2-methyl-phenyl) -2- Fluoro-benzamide 1048 449 N- {4- [3- (1-benzofuran-2-yl- Tyl) -thioureido] -2-methyl-phenyl} -2-fluoro-benzamide 1049 456 N- (2-dimethylamino-4- {3- [1- (4-fluoro-phenyl) -ethyl] -thioureido}- Phenyl) -2-fluoro-benzamide 1050 526 N- (2-benzyloxy-4- {3- [1- (4-cyano-phenyl) -ethyl] -thioureido} -phenyl) -2-fluoro-benzamide 1051 519 N- (2-benzyloxy-4- {3- [1- (4-fluoro-phenyl) -ethyl] -thioureido} -phenyl) -2-fluoro-benzamide 1052 603 N- [4- {3- [1 -(4-Bromo-phenyl) -ethyl] -thioureido} -2- (2-morpholin-4-yl-ethoxy) -phenyl] -2-fluoro-benzamide 1053 603 N- [4- {3- [1- (4-Bromo-phenyl) -ethyl] -thioureido} -2- (2-morpholin-4-yl-ethoxy) -phenyl] -2-fluoro-benzamide 1054 542 2-fluoro-N- [4- {3- [1- (4-Fluoro-phenyl) -ethyl] -thioureido} -2- (2- Morpholin-4-yl-ethoxy) -phenyl] -benzamide 1055 485 N- (2-butoxy-4- {3- [1- (4-fluoro-phenyl) -ethyl] -thioureido} -phenyl) -2-fluoro -Benzamide 1056 492 N- (2-butoxy-4- {3- [1- (4-cyano-phenyl) -ethyl] -thioureido} -phenyl) -2-fluoro-benzamide 1057 589 N- [4- {3 -[1- (4-Bromo-phenyl) -ethyl] -thioureido} -2- (2-dimethylamino-ethoxy) -phenyl] -2-fluoro-benzamide 1058 528 N- (2- (2-diethylamino-ethoxy) ) -4- {3- [1- (4-Fluoro-phenyl) -ethyl] -thioureido} -phenyl) -2-fluoro-benzamide 1059 589 N- [4- {3- [1- (4-bromo- Phenyl) -ethyl] -thioureido} -2- (2-diethylamino-ethoxy) -phenyl] -2-fluoro-benzamide 1060 457 N- (2-ethoxy-4- {3- [1- (4-fluoro-phenyl) ) -Ethyl] -thioureido} -phenyl) -2-fluoro- Nsamide 1061 464 N- (4- {3- [1- (4-cyano-phenyl) -ethyl] -thioureido} -2-ethoxy-phenyl) -2-fluoro-benzamide 1062 468 2-fluoro-N- [4 -{3- [1- (4-Fluoro-phenyl) -ethyl] -thioureido} -2- (2-nitrilo-ethoxy) -phenyl] -benzamide 1063 475 N- [4- {3- [1- (4 -Cyano-phenyl) -ethyl] -thioureido} -2- (2-nitrilo-ethoxy) -phenyl] -2-fluoro-benzamide 1064 443 2-fluoro-N- (4- {3- [1- (4- Fluoro-phenyl) -ethyl] -thioureido} -2-methoxy-phenyl) -benzamide 1065 489 2-fluoro-N- (5- {3- [1- (4-fluoro-phenyl) -ethyl] -thioureido}- Biphenyl-2-yl) -benzamide 1066 514 Isoquinoline-1-carboxylic acid (4- {3- [1- (4-fluoro-phenyl) -ethyl] -thioureido} -2-trifluoro-methyl-phenyl) -amide 1067 503 Benzofuran-2-carboxylic acid (4- {3- [1- ( 4-fluoro-phenyl) -ethyl] -thioureido} -2-trifluoro-methyl-phenyl) -amide 1068 514 isoquinoline-3-carboxylic acid (4- {3- [1- (4-fluoro-phenyl) -ethyl ] -Thioureido} -2-trifluoro-methyl-phenyl) -amide 1069 471 isoquinoline-1-carboxylic acid (2-cyano-4- {3- [1- (4-fluoro-phenyl) -ethyl] -thioureido} -Phenyl) -amide 1070 460 Benzofuran-2-carboxylic acid (2-cyano-4- {3- [1- (4-fluoro-phenyl) -ethyl] -thioureido} -phenyl) -amide 1071 471 Isoquinoline-3- Carboxylic acid (2-cyano-4- {3- [1- (4-fluoro-phenyl) -ethyl] -thioureido} -phenyl) -amide 1072 460 isoquinoline-1-carboxylic acid (4- {3- [1- (4-Fluoro-phenyl) -ethyl] -thioureido} -2-methyl-phenyl) -amide 1073 449 Benzofuran-2-carboxylic acid (4- {3- [1- (4-fluoro-phenyl) -ethyl]- H Oureido} -2-methyl-phenyl) -amide 1074 460 Isoquinoline-3-carboxylic acid (4- {3- [1- (4-fluoro-phenyl) -ethyl] -thioureido} -2-methyl-phenyl) -amide 1075 396 Pyrazin-2-carboxylic acid (4- {3- [1- (4-fluoro-phenyl) -ethyl] -thioureido} -phenyl) -amide 1076 401 Thiophene-2-carboxylic acid (4- {3- [ 1- (4-Fluoro-phenyl) -ethyl] -thioureido} -phenyl) -amide 1077 401 Thiophene-3-carboxylic acid (4- {3- [1- (4-fluoro-phenyl) -ethyl] -thioureido} -Phenyl) -amide 1078 500 2-Isopropyl-thiazole-4-carboxylic acid {4- [3- (4-chloro-3-trifluoromethyl-phenyl) -thioureido] -phenyl} -amide 1079 466 2-isopropyl- Thiazole-4-carboxylic acid {4- [3- (3,5-dichloro-phenyl) -thioureido] -phenyl} -amide 1080 466 2-Isopropyl-thiazole-4-carboxylic acid {4- [ 3- (3,4-dichloro-phenyl) -thioureido] -phenyl} -amide 1081 534 2-isopropyl-thiazole-4-carboxylic acid {4- [3- (3,5-bis-trifluoromethyl-phenyl) -Thioureido] -phenyl} -amide 1082 480 2-butyl-thiazole-4-carboxylic acid {4- [3- (3,4-dichloro-phenyl) -thioureido] -phenyl} -amide 1083 514 2-butyl-thiazole 4-carboxylic acid {4- [3- (4-chloro-3-trifluoromethyl-phenyl) -thioureido] -phenyl} -amide 1084 480 2-butyl-thiazole-4-carboxylic acid {4- [3- (3,5-dichloro-phenyl) -thioureido] -phenyl} -amide 1085 548 2-butyl-thiazole-4-carboxylic acid {4- [3- (3,5-bis-trifluoromethyl-phenyl) -thioureide ] -Phenyl} -amide 1086 438 2-Methyl-thiazole-4-carboxylic acid {4- [3- (3,5-dichloro-phenyl) -thioureido] -phenyl} -amide 1087 438 2-methyl -Thiazole-4-carboxylic acid {4- [3- (3,4-dichloro-phenyl) -thioureido] -phenyl} -amide 1088 505 2-methyl-thiazole-4-carboxylic acid {4- [3- (3 , 5-Bis-trifluoromethyl-phenyl) -thioureido] -phenyl} -amide 1089 534 2-phenyl-thiazole-4-carboxylic acid {4- [3- (4-chloro-3-trifluoromethyl-phenyl) -Thioureido] -phenyl} -amide 1090 500 2-phenyl-thiazole-4-carboxylic acid {4- [3- (3,5-dichloro-phenyl) -thioureido] -phenyl} -amide 1091 500 2-phenyl-thiazole -4-carboxylic acid {4- [3- (3,4-dichloro-phenyl) -thioureido] -phenyl} -amide 1092 568 2-phenyl-thiazole-4-carboxylic acid {4- [3- (3,5 -Bis-trifluoromethyl-phenyl) -thioureido] -phenyl} -amide 1093 401 2-Fluoro-N- {4- [3- (1-thiazoli-2-yl-ethyl) -thioureido] -phenyl} -benz Amide 1094 588 2-Fluoro-N- [4- (3- {1- [1- (toluene-4-sulfonyl) -1H-indolin-2-yl] -2-yl-ethyl} -thioureido) -phenyl] -Benzamide 1095 446 2-Fluoro-N- {4- [3- (1-quinolin-2-yl-ethyl) -thioureido] -phenyl} -benzamide 1096 446 2-fluoro-N- {4- [3- ( 1-quinolin-4-yl-ethyl) -thioureido] -phenyl} -benzamide 1097 446 2-Fluoro-N- {4- [3- (1-isoquinolin-3-yl-ethyl) -thioureido] -phenyl}- Benzamide 1098 446 2-Fluoro-N- {4- [3- (1-isoquinolin-1-yl-ethyl) -thioureido] -phenyl} -benzamide 1099 446 2-Fluoro-N- {4- [3- (1 -Quinolin-6-yl-ethyl) -thioureido] -phenyl} -benzamide 1100 446 2-Fluoro-N- {4- [3- (1-quinolin-3-yl-ethyl) -thioureido] -phenyl} -benzamide 1101 413 2-Methoxy-N- {4- [3- (1-thiophen-3-yl-ethyl)- Oureido] -phenyl} -benzamide Example 871 (method 33) [1,2,3] thiadiazole-4-carboxylic acid {4- [3- (3,5-dichloro-phenyl) -thioureido] -phenyl} -amide A solution of 3,5-dichloroaniline (0.16 g) in 20 mL of tetrahydrofuran
1,1'-thiocarbonyl-di- (1,2,4) -triazole (0.20 g) was added to
And stir the mixture at room temperature for about 30 minutes. [1,2,3] thiadiazole-4-carboxylic acid (4-
Amino-phenyl) amide (0.22 g) is added to the reaction flask and the mixture is
While stirring. The solvent was removed by evaporation under reduced pressure and warm acetonitrile (
3 mL). After 15 hours, the mixture was filtered and the collected precipitate was washed with acetonitrile.
And then air-dried to give the desired product as a white powder.
Get as. [M + H] 424 Using the above procedure and appropriate starting materials, the following compounds were prepared:number M + H Compound name 872 465 N- {4- [3- (3,5-dichloro-4-methoxy-phenyl) -thioureido] -phenyl} -3-fluoro-benzamide 873 477 N- {4- [3- (3,5- Dichloro-4-methoxy-phenyl) -thioureido] -phenyl} -2-methoxy-benzamide 874 465 N- {4- [3- (3,5-dichloro-4-methoxy-phenyl) -thioureido] -phenyl}- 2-fluoro-benzamide 875 477 N- {4- [3- (3,5-dichloro-4-methoxy-phenyl) -thioureido] -phenyl} -3-methoxy-benzamide 876 399 N- {4- [3- (3,5-dichloro-2-methoxy-4-methyl-phenyl) -thioureido] -phenyl} -acetamide 877 365 N- {4- [3- (3-chloro-4-methoxy-5-methyl-phenyl) -Thioureido] -phenyl} -acetamide 878 331 N- {4- [3- (2-nitro-phenyl) -thioureido] -phenyl} -acetamide 879 331 N- {4- [3- (4-nitro-phenyl) -Thioureido] -phenyl} -acetamide 880 477 N- {4- [3- (3,5-di Loro-4-methoxy-phenyl) -thioureido] -phenyl} -4-methoxy-benzamide 881 351 N- {4- [3- (2-chloro-5-methoxy-phenyl) -thioureido] -phenyl} -acetamide 882 428 2- {4- [3- (4-acetylamino-phenyl) -thioureido]-2,6-dichloro-phenoxy} -acetamide 883 443 {4- [3- (4-acetylamino-phenyl) -thioureido] -2,6-dichloro-phenoxy} -acetic acid methyl ester 884 457 {4- [3- (4-acetylamino-phenyl) -thioureido]-2,6-dichloro-phenoxy} -acetic acid ethyl ester 885 447 N- { 4- [3- (3,5-dichloro-4-phenoxy-phenyl) -thioureido] -phenyl} -acetamide 886 410 N- (4- {3- [3,5-dichloro-4- (2-nitrilo- Ethoxy) -phenyl] -thioureido] -phenyl) -acetamide 887 485 {4- [3- (4-acetylamino-phenyl) -thioureido]-2,6-dichloro-phenoxy} -acetic acid tert- Tyl ester 888 469 [1,2,3] thiadiazole-4-carboxylic acid {4- [3- (3,5-dichloro-2-methoxy-4-methyl-phenyl) -thioureido] -phenyl} -amide 889 335 N- {4- [3- (3-chloro-4-methyl-phenyl) -thioureido] -phenyl} -acetamide 890 335 N- {4- [3- (5-chloro-2-methyl-phenyl) -thioureide ] -Phenyl} -acetamide 891 703 N- {4- [3- (4- {4- [3- (4-acetylamino-phenyl) -thioureido] -2-chloro-phenyldisulfanyl} -3-chloro -Phenyl) -thioureido] -phenyl} -acetamide 892 369 N- {4- [3- (3,5-dichloro-4-methyl-phenyl) -thioureido] -phenyl} -acetamide 893 598 N- {4- [3- (3,5-diiodo-2,4-dimethoxy-phenyl] -thioureido] -phenyl} -acetamide 894 504 N- {4- [3- (3,5-dibromo-2,4-dimethoxy-phenyl) ) -Thioureido] -phenyl} -acetamide 895 317 N- {4- [3- (6-meth C-pyridin-3-yl) -thioureido] -phenyl} -acetamide 896 347 N- {4- [3- (2,6-dimethoxy-pyridin-3-yl) -thioureido] -phenyl} -acetamide 897 457 Acetic acid 2- {4- [3- (4-acetylamino-phenyl) -thioureido] -2,6-dichloro-phenoxy} -ethyl ester 898 365 4- [3- (4-acetylamino-phenyl) -thioureido] -2-Chloro-benzoic acid 899 346 N- {4- [3- (3-Chloro-4-cyano-phenyl) -thioureido] -phenyl} -acetamide 900 512 N- (4- {3- [5-chloro -2- (4-Chloro-phenoxy) -4-pyrroli-l-yl-phenyl] -thioureido} -phenyl) -acetamide 901 355 N- {4- [3- (3,4-dichloro-phenyl) -thioureide ] -Phenyl} -acetamide 902 339 N- {4- [3- (3-chloro-4-fluoro-phenyl) -thioureido] -phenyl} -acetamide 903 447 N- {4- [3- (3-chloro- 4-iodo-phenyl) -thioureido] -phenyl}- Cetamide 904 400 N- {4- [3- (4-bromo-3-chloro-phenyl) -thioureido] -phenyl} -acetamide 905 424 N- [4- (3- {4- [bis- (2-hydroxy -Ethyl) -amino] -3-chloro-phenyl} -thioureido) -phenyl] -acetamide 906 434 N- (4- {3- [3-chloro-4- (hexyl-methyl-amino) -phenyl] -thioureido } -Phenyl) -acetamide 907 406 N- (4- {3- [3-chloro-4- (isobutyl-methyl-amino) -phenyl] -thioureido} -phenyl) -acetamide 908 389 N- {4- [3 -(3-Chloro-4-trifluoromethyl-phenyl) -thioureido] -phenyl} -acetamide 909 441 Furan-2-carboxylic acid {4- [3- (3-chloro-4-trifluoromethyl-phenyl)- Thioureido] -phenyl} -amide 910 459 [1,2,3] thiadiazole-4-carboxylic acid {4- [3- (3-chloro-4-trifluoromethyl-phenyl) -thioureido] -phenyl} -amide 911 469 N- {4- [3- (3- Loro-4-trifluoromethyl-phenyl) -thioureido] -phenyl} -2-fluoro-benzamide 912 435 N- {4- [3- (3,4-dichloro-phenyl) -thioureido] -phenyl} -2- Fluoro-benz-amide 913 407 Furan-2-carboxylic acid {4- [3- (3,4-dichloro-phenyl) -thioureido] -phenyl} -amide 914 425 [1,2,3] thiadiazole-4-carboxylic acid Acid {4- [3- (3,4-dichloro-phenyl) -thioureido] -phenyl} -amide 915 480 N- {4- [3- (4-bromo-3-chloro-phenyl) -thioureido] -phenyl } -2-Fluoro-benz-amide 916 527 N- {4- [3- (3-Chloro-4-iodo-phenyl) -thioureido] -phenyl} -2-fluoro-benzamide 917 452 Furan-2-carboxylic acid {4- [3- (4-Bromo-3-chloro-phenyl) -thioureido] -phenyl} -amide 918 499 furan-2-carboxylic acid {4- [3- (3-chloro-4-iodo-phenyl) -Thioureido] -phenyl} -amide 919 391 Furan-2-carboxylic acid {4- [3- (3-chloro-4-fluoro-phenyl) -thioureido] -phenyl} -amide 920 470 [1,2,3] thiadiazole-4-carboxylic acid {4- [ 3- (4-bromo-3-chloro-phenyl) -thioureido] -phenyl} -amide 921 517 [1,2,3] thiadiazole-4-carboxylic acid {4- [3- (3-chloro-4-iodo) -Phenyl) -thioureido] -phenyl} -amide 922 419 N- {4- [3- (3-chloro-4-fluoro-phenyl) -thioureido] -phenyl} -2-fluoro-benzamide 923 409 [1,2 , 3] Thiadiazole-4-carboxylic acid {4- [3- (3-chloro-4-fluoro-phenyl) -thioureido] -phenyl} -amide 924 388 N- {4- [3- (3-chloro-4 -Isoxazoly-5-yl-phenyl) -thioureido] -phenyl} -acetamido 925 387 N- (4- {3- [3-chloro-4- (1H-pyrazoli-3-yl) -phenyl] -thioureido}- Phenyl) -acetamide 926 355 N- {4- [3- (2,3-dichloro-phenyl) -thiourei ] -Phenyl} -acetamide 927 435 N- {4- [3- (2,3-dichloro-phenyl) -thioureido] -phenyl} -2-fluoro-benzamide 928 408 furan-2-carboxylic acid {4- [3 -(2,3-Dichloro-phenyl) -thioureido] -phenyl} -amide 929 425 [1,2,3] thiadiazole-4-carboxylic acid {4- [3- (2,3-dichloro-phenyl) -thioureide ] -Phenyl} -amide 930 355 N- {4- [3- (2,5-dichloro-phenyl) -thioureido] -phenyl} -acetamide 931 435 N- {4- [3- (2,5-dichloro- Phenyl) -thioureido] -phenyl} -2-fluoro-benzamide 932 407 furan-2-carboxylic acid {4- [3- (2,5-dichloro-phenyl) -thioureido] -phenyl} -amide 933 355 N- { 4- [3- (3,5-dichloro-phenyl) -thioureido] -phenyl} -acetamide 934 435 N- {4- [3- (3,5-dichloro-phenyl) -thioureido] -phenyl} -2- Fluoro-benzamide 935 407 furan-2-carboxylic {4- [3- (3,5-dichloro-phenyl) -thioureido] -phenyl} -amide 936 390 N- {4- [3- (3,4,5-trichloro-phenyl) -thioureido] -phenyl} -Acetamide 937 470 2-Fluoro-N- {4- [3- (3,4,5-trichloro-phenyl) -thioureido] -phenyl} -benzamide 938 442 Furan-2-carboxylic acid {4- [3- (3,4,5-trichloro-phenyl) -thioureido] -phenyl} -amide 939 460 [1,2,3] thiadiazole-4-carboxylic acid {4- [3- (3,4,5-trichloro-phenyl) ) -Thioureido] -phenyl} -amide 940 458 [1,2,3] thiadiazole-4-carboxylic acid {4- [3- (3-chloro-4-isoxazoly-5-yl-phenyl) -thioureido] -phenyl } -Amid 941 457 [1,2,3] thiadiazole-4-carboxylic acid (4- {3- [3-chloro-4- (1H-pyrazoli-3-yl) -phenyl] -thioureido} -phenyl)- Amide 942 391 [1,2,3] thiadiazole-4-carboxylic acid {4- [3- (3-chloro-phenyl) -thiou Reid] -phenyl} -amide 943 373 Furan-2-carboxylic acid {4- [3- (3-chloro-phenyl) -thioureido] -phenyl} -amide 944 401 N- {4- [3- (3-chloro -Phenyl) -thioureido] -phenyl} -2-fluoro-benzamide 945 373 furan-2-carboxylic acid {4- [3- (4-chloro-phenyl) -thioureido] -phenyl} -amide 946 401 N- {4 -[3- (4-Chloro-phenyl) -thioureido] -phenyl} -2-fluoro-benzamide 947 391 [1,2,3] thiadiazole-4-carboxylic acid {4- [3- (4-chloro-phenyl) ) -Thioureido] -phenyl} -amide 948 401 N- {4- [3- (2-chloro-phenyl) -thioureido] -phenyl} -2-fluoro-benzamide 949 396 3- (3- {4-[( Furan-2-carbonyl) -amino] -phenyl} -thioureido) -benzoic acid methyl ester 950 424 3- {3- [4- (2-fluoro-benzoylamino) -phenyl] -thioureido} -benzoic acid methyl ester 951 414 3- (3- {4 -[([1,2,3] thiadiazole-4-carbonyl) -amino] -phenyl} -thioureido) -benzoic acid methyl ester 952 409 N- [4-[[[[3- (aminocarbonyl) phenyl] amino ] Thioxomethyl] amino] phenyl] -2-fluoro-benzamide 953 373 Furan-2-carboxylic acid {4- [3- (2-chloro-phenyl) -thioureido] -phenyl} -amide 954 381 Furan-2-carboxylic acid {4- [3- (3-carbamoyl-phenyl) -thioureido] -phenyl} -amide 955 399 [1,2,3] thiadiazole-4-carboxylic acid {4- [3- (3-carbamoyl-phenyl) -Thioureido] -phenyl} -amide 956 391 [1,2,3] thiadiazole-4-carboxylic acid {4- [3- (2-chloro-phenyl) -thioureido] -phenyl} -amide 957 356 furan-2- Carboxylic acid {4- [3- (3-fluoro-phenyl) -thioureido] -phenyl} -amide 958 383 Furan-2-carboxylic acid {4- [3- (3-nitro-phenyl) -thioureido]- H Nil} -amide 959 411 2-fluoro-N- {4- [3- (3-nitro-phenyl) -thioureido] -phenyl} -benzamide 960 422 furan-2-carboxylic acid {4- [3- (3- Trifluoromethoxy-phenyl) -thioureido] -phenyl} -amide 961 450 2-fluoro-N- {4- [3- (3-trifluoromethoxy-phenyl) -thioureido] -phenyl} -benzamide 962 384 2- Fluoro-N- {4- [3- (3-fluoro-phenyl) -thioureido] -phenyl} -benzamide 963 410 3- {3- [4- (2-fluoro-benzoylamino) -phenyl] -thioureido} -Benzoic acid 964 382 3- (3- {4-[(furan-2-carbonyl) -amino] -phenyl} -thioureido) -benzoic acid 965 408 N- {4- [3- (3-acetyl-phenyl) -Thioureido] -phenyl} -2-fluoro-benzamide 966 502 N- {4- [3- (3-butylsulfamoyl-phenyl) -thioureido] -phenyl} -2-fluoro-benzamide 967 380 furan-2- Cal Acid {4- [3- (3-acetyl-phenyl) -thioureido] -phenyl} -amide 968 447 Furan-2-carboxylic acid (4- {3- [3- (2-hydroxy-ethanesulfonyl) phenyl] -Thioureido] -phenyl} -amide 969 475 2-Fluoro-N- (4- {3- [3- (2-hydroxy-ethanesulfonyl) phenyl] -thioureido] -phenyl} -benzamide 970 474 Furan-2-carvone Acid {4- [3- (3-butylsulfamoyl-phenyl) -thioureido] -phenyl} -amide Example 971 (Method 57) 1- (4-fluoro-phenyl) -2-methyl-propane-1- To a solution of all 4-fluorobenzaldehyde (2.0 g) in 40 mL of diethyl ether was added 0
Add dropwise isopropylmagnesium bromide (2.0 M, 9.6 mL) with stirring at ℃
. After 1.5 hours, the reaction was quenched with aqueous ammonium chloride and diethyl ether
Extract with The diethyl ether extract was washed with saturated sodium chloride and dried
Dry over magnesium sulfate, filter and evaporate to give an oil. This oil
Purify by silica gel chromatography, 10% dichloromethane-hexane
Elution affords the product, a yellow oil (1.76 g).

Example 972 (Method 58) 1- (4-Fluoro-phenyl) -2-methyl-propan-1-one 1- (4-fluoro-phenyl) -2-methyl-propan-1-ol (1.6 To a solution of g) (in 10 mL of acetone) at 0 ° C. is added with stirring John's reagent (20 mL). After 10 minutes, the excess Johns reagent is destroyed by adding isopropyl alcohol. Diethyl ether is added, followed by anhydrous magnesium, and the mixture is filtered and evaporated to give the product, a yellow oil (1.2 g).

Example 973 (Method 59) A solution of 3-dimethylamino-5-trifluoromethyl-benzonitrile 3-dimethylamino-5-trifluoromethylbromobenzene (7.3 g) (20 mL of
Cuprous cyanide (2.7 g) is added to (in N, N-dimethylformamide) and the reaction is heated at reflux for 12 hours. The reaction is diluted with water (40 mL) and dichloromethane is added. The dichloromethane fraction is washed with concentrated ammonium hydroxide and then with water. The solution was dried over anhydrous magnesium sulfate, filtered, and concentrated to give a yellow oil,
This was recrystallized from hexane to give a yellow solid (4.7 g).

The foregoing compounds were tested for activity as herpes virus inhibitors using the following assay.

Human cytomegalovirus yield assay. Monolayer cultures of human foreskin fibroblasts are infected with wild-type HCMV in the presence (at varying concentrations) of inhibitor compounds at a multiplicity of infection typically equal to 0.2. Three days after infection, the total virus produced in such cultures (ie, virus yield) is assessed by collecting and titrating the virus in 12-wells of cultured human foreskin fibroblasts ( In the absence of an inhibitor). Plaque is quantified two weeks after infection. Inhibitors of HCMV are identified by a reduced titer of virus yield in the presence compared to the absence of the compound. The relative anti -HCMV activity of the inhibitor in this assay, typically to calculate the amount of compound required to lower IC ₅₀ or IC ₉₀ value, i.e. virus yield to 50% or 90%, respectively in Is determined by Table I shows the I for compounds tested against HCMV.
Enter the _C50 value. Microtiter plate assay. Cultures of 96-well plates of human foreskin fibroblasts were cultured in the presence of inhibitor compounds with the HCMV recombinant mutant virus. The genome contains the prokaryotic beta-glucuronidase gene whose expression is controlled by the viral promoter [Jefferson, RA , SMBurgess, and D. Hirsh. 1986. Beta-glucuronidase (Beta-glucuro) derived from Escherichia coli as a gene fusion marker
nidase from Escherichia coli as a gene fusion marker), Proc. Natl. Acad. Sci
.USA 83: 8447-8451]｝. An example of such a virus is RV145 [
Jones, TR, VPMuzithras, and Y. Gluzman. 1991, Substitution Mutagenesis of the Human Cytomegalovirus Genome: US10 and US11 Gene Products Are Not Essential (Replacem
ent mutagenesis of the human cytomegalovirus genome: US10 and US11 gene p
roducts are nonessential.), J. Virol. 65: 5860-5872). Because this expression is under the control of a viral promoter, beta-glucuronidase expression is an indirect indicator of HCMV growth and replication in this assay. At 96 hours post infection, infected cell lysates were prepared (50 mM containing 0.1% Triton X-100 and 0.1% sarkosyl).
Sodium phosphate [pH 7.0]), and any enzyme substrate that can be cleaved and measured colorimetrically with a spectrometer or fluorescently with a microfluorometer for beta-glucuronidase activity. Assay. Examples of such substrates are
These are p-nitrophenyl-beta-D-glucuronide and methylumbelliferyl glucuronide, respectively. The presence of an antiviral compound is indicated by a decrease in the expression of beta-glucuronidase in the HCMV genome compared to the absence of the inhibitor. That is, chromophore or fluorophore production in this assay is correspondingly reduced. Data from this assay, generated using varying amounts of inhibitor compound, is also used to predict the IC _{50 of the} inhibitor compound.

HSV Antiviral (ELISA) Assay Vero cells (ATCC # CCL-81) were supplemented with 100 μl of tissue culture DMEM (Dulbecco's modified Eagle's medium) (2% fetal bovine serum (FBS) was supplemented to each well). Plate 3.5 × 10 ⁴ cells per 96-well tissue culture plate. After overnight incubation at 37 ° C. (in 5% CO ₂ ), 30 minutes before infection with HSV-1 (multiplicity of infection equal to 0.006), cells were either untreated or treated with test compound (many Concentration) or reference standard drug control. After incubation for 24 hours at 37 ° C. (in 5% CO ₂ ) from infection, cells are fixed for ELISA assays. The first antibody is mouse anti-HSV
Glycoprotein D monoclonal primary antibody and the secondary antibody is goat anti-mouse IgG conjugated to β-galactosidase. Thus, the degree of virus replication was determined by microscopic fluorometry (365 nm for excitation and 450 nm for emission) using 4-methylumbelliferyl-β-galactoside (Sigma: Sigma # M1633) after addition of the substrate. It is determined by assessing β-galactosidase activity by quantifying the production of the feron fluorescent cleavage product. The antiviral activity (IC ₅₀ ) of the test compound is
The fluorescence obtained in the absence of the compound is determined by comparing it with the fluorescence obtained in the presence. The data is shown in Table I.

VZV Anti-Virus (ELISA) Assay To produce the stock VZV used in this assay, the Ellen strain of VZV (ATCC # V
R-1367) using human foreskin fibroblast (HFF) cells at low multiplicity of infection (<0.1)
And incubated overnight at 37 ° C. in 5% CO ₂ . After overnight incubation, a mixture of uninfected and VZV-infected HFF-infected cells was collected and each well of a 96-well plate (this was tested in 100 μl of DMEM supplemented with 2% FBS per well). Or including a reference standard drug control)
(3.5 × 10 ⁴ cells in 100 μl DMEM supplemented with 2% FBS). 5% C
Incubate at 37 ° C. in O ₂ for 3 days and fix for ELISA assay.
The first antibody is a mouse anti-VSV glycoprotein II monoclonal antibody (Applied
Applied Biosystems Inc. # 13-145-100) and the second antibody is goat anti-mouse IgG conjugated to β-galactosidase. Thus, the degree of virus replication was determined by microscopy fluorometry (365 nm for excitation and 450 nm for emission).
nm), which is measured by assessing β-galactosidase activity by quantifying the formation of 4-methylumbelliferone fluorescent cleavage product after addition of methylumbelliferyl-β-galactoside (Sigma: Sigma # M1633) substrate . The antiviral activity (IC ₅₀ ) of a test compound is determined by comparing the fluorescence obtained in the absence of the compound with the fluorescence obtained in the presence. The data is shown in Table I.

Table I lists IC ₅₀ data for compounds tested against herpes virus.

[0197]

[Table 1]

Thus, according to the present invention, the compounds of the present invention can be administered to a patient suffering from VZV in an amount effective to suppress the virus. That is, the compounds of the present invention are useful for reducing or eliminating the symptoms of VZV infection in mammals, including but not limited to humans.

The compounds of the present invention can be administered to the patient neat or with conventional pharmaceutical carriers.

Applicable solid carriers are as perfumes, lubricants, solubilizers, suspending agents, bulking agents, glidants, compression aids, binders or tablet disintegrants or encapsulating materials. It can include one or more substances that can act. In powders, the carrier is a finely divided solid which is a mixture with the finely divided active component. In tablets, the active component is mixed with the carrier having the necessary compression properties in suitable proportions and compacted in the shape and size desired. The powders and tablets preferably contain up to 99% of the active ingredient. Suitable solid carriers are, for example,
Includes calcium phosphate, magnesium stearate, talc, sugar, lactose, dextrin, starch, gelatin, cellulose, methylcellulose, sodium carboxymethylcellulose, polyvinylpyrrolidine, low melting wax and ion exchange resins.

Liquid carriers can be used in preparing solvents, suspensions, emulsions, syrups and elixirs. The active ingredient of the present invention can be dissolved or suspended in water, an organic solvent, a mixture of both or a pharmaceutically acceptable liquid carrier such as a pharmaceutically acceptable oil or fat. Liquid carriers include solubilizers, emulsifiers, buffers, preservatives, sweeteners, flavors, suspending agents, thickeners, colorants, viscosity modifiers,
Other suitable pharmaceutical additives, such as stabilizers or osmo-regulators, can be included. Suitable examples of liquid carriers suitable for oral and parenteral administration include water (particularly a sodium carboxymethylcellulose solution containing additives such as those described above, for example, cellulose derivatives), alcohols (monohydric and polyhydric alcohols, For example, glycols), and derivatives thereof, and oils (eg, fractionated cocoa butter and peanut oils). For parenteral administration, the carrier can also include oily esters such as ethyl oleate and isopropyl myristate. Sterile liquid carriers are used in sterile liquid form compositions for parenteral administration.

Liquid pharmaceutical compositions which are sterile solvents or suspensions can be used for example by intramuscular, intraperitoneal or subcutaneous injection. Sterile solvents can also be administered intravenously. Oral administration may be in liquid or solid composition.

Preferably, the pharmaceutical compositions are in unit dosage form, for example, as tablets or capsules. In such form, the composition is subdivided into unit doses containing appropriate quantities of the active component; the unit doses may be packaged compositions, for example, packaged powders, vials, ampules and the like. , Prefilled syringes or sachets containing liquids. The unit dosage form can be, for example, a capsule or tablet itself, or the unit dosage form can be a packaged form of a suitable number of any such compositions.

The therapeutically effective dosage used to treat CMV infection must be individually determined by the attending physician. Variables include patient status, age and weight.
The novel methods of the present invention for treating CMV infection comprise administering to an individual, including a human, an effective amount of at least one compound of Formula 1 or a non-toxic pharmaceutically acceptable salt thereof. Consists of The compounds can be administered orally, rectally, parenterally, or topically on the skin and mucous membranes. In general, the daily dose will depend on the particular compound, the method of treatment and the condition of the patient. Usually the daily dose is for oral application
0.01-1000 mg / Kg, preferably 0.5-500 mg / Kg, and 0.1 for parenteral application
100100 mg / Kg, preferably 0.5-50 mg / Kg.

──────────────────────────────────────────────────続 き Continued on the front page (51) Int.Cl. ⁷ Identification symbol FI theme coat ゛ (Reference) A61P 31/12 A61P 31/12 4H006 C07C 335/20 C07C 335/20 335/22 335/22 C07D 277/56 C07D 277/56 285/06 285/06 307/68 307/68 (81) Designated country EP (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE), OA (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG), AP (GH, GM, KE, LS, MW, SD, SL, SZ, TZ, UG, ZW), EA (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM), AE, AL, AM, AT, U, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CR, CU, CZ, DE, DK, DM, EE, ES, FI, GB, GD, GE, GH, GM, HR , HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, UZ, VN, YU, ZA, ZW (72) Inventor D. Grandday, Martin G. Joseph, Congarth Garnett Train 4, 10920, New York, USA (72) Inventor Dasin, Ratsell G. Georges, 10524 Garrison Route 9, Day 667, New York, USA D. 667 (72) Inventor, JEAN , Thomas Richard, 10956 New York, United States United Field Field Crest Drive 4 (72) Inventor Lang, Stanley Albert, 10913 Blobert Colony Drive 7, New York, United States of America (72) Inventor Ross, Adma Antonia 10901 Saf, New York, United States Arn Kyanbelavenue 65 (72) Inventor Telehuenco, Eugene Anthony 18951 Quakertown Live Oak Drive, Pennsylvania, United States 266 (72) Inventor Ohara, Brian Mark, 10965 Par, New York, USA Lulliver Railroad Avenue 124 F term (reference) 4C033 AD16 AD17 AD20 4C036 AD04 AD23 AD27 AD30 4C037 MA03 4C056 AA01 AB01 AC02 AD01 AE03 BA01 BB14 BC01 4C086 AA01 AA02 AA03 BA03 BC69 BC82 BC85 MA04 ZB33 4H006 AA01 AA03 AB29

Claims (20)

[Claims] 1. The formula: embedded image Wherein R ₁ -R ₅ are independently hydrogen, alkyl of 1-6 carbon atoms, alkenyl of 2-6 carbon atoms, alkynyl of 2-6 carbon atoms, 1-6 carbon atoms perhaloalkyl atoms, cycloalkyl of 3 to 10 carbon atoms, 3 to 10 carbon membered heterocycloalkyl, aryl, heteroaryl, _{halogen, -CN, -NO 2, -CO 2} R 6, -COR ₆ , -OR ₆ ,-
SR ₆ , -SOR ₆ , -SO ₂ R ₆ , -CONR ₇ R ₈ , -NR ₆ N (R ₇ R ₈ ), -N (R ₇ R ₈ ) or WY- (CH ₂ ) _n -Z
Wherein at least one of R ₁ -R ₅ is not hydrogen; or R ₂ and R ₃
Or R ₃ and R ₄ together are a 3-7 membered heterocycloalkyl or 3-7
R ₆ and R ₇ are independently hydrogen, alkyl of 1 to 6 carbon atoms, perhaloalkyl or aryl of 1 to 6 carbon atoms; R ₈ is hydrogen, 1 Is alkyl of -6 carbon atoms, perhaloalkyl of 1-6 carbon atoms, cycloalkyl of 3-10 carbon atoms, heterocycloalkyl of 3-10 members, aryl or heteroaryl, or R ₇ and R ₈ can together form a 3-7 membered heterocycloalkyl; R ₉ -R ₁₂ are independently hydrogen, alkyl of 1-4 carbon atoms, 1-4 Perhaloalkyl of carbon atoms, halogen, alkoxy or cyano of 1-4 carbon atoms, or R ₉ and R ₁₀ or R ₁₁ and R ₁₂ together form an aryl of 5-7 carbon atoms. Wherein at least one of R _9-12 is hydrogen Not; W is O, or is NR _6, or is absent; Y is - (CO) - or - (CO ₂₎ - or where absent; Z is 1 to 4 carbon atoms Alkyl, -CN, -CO ₂ R ₆ , COR ₆ , -CONR ₇ R ₈ , -OCOR ₆ , -NR ₆ COR ₇ , -OCONR ₆ , -OR ₆ , -SR ₆ , -SOR ₆ , -SO ₂ R ₆ , SR ₆ N (R ₇ R ₈ ), —N (R ₇ R ₈ ) or phenyl; G is a monocyclic heteroaryl; X is a bond, —NH, 1-6 carbon atoms Alkyl, alkenyl of 1 to 6 carbon atoms,
J is alkoxy of 1 to 6 carbon atoms, thioalkyl of 1 to 6 carbon atoms, alkylamino of 1 to 6 carbon atoms or (CH) J; J is alkyl of 1 to 6 carbon atoms, Or a pharmaceutical salt thereof, wherein cycloalkyl, phenyl or benzyl of 3-7 carbon atoms; and n is an integer of 1-6. 2. The compound of claim 1 wherein R ₁₅ is independently hydrogen, alkyl of one carbon atom, halogen, perhaloalkyl of one carbon atom, OR ₆ or N (R ₇ R ₈ ). . _3. The compound of claim 1 wherein R ₁ , R ₂ and R ₃ are hydrogen and R ₄ and R ₅ are independently halogen or CF ₃ . 4. The compound of claim 1 wherein R ₁ , R ₂ and R ₄ are hydrogen and R ₃ and R ₅ are independently halogen or CF ₃ . 5. The compound of claim 1, wherein G is thiazolyl, thiadiazolyl, oxazolyl or furyl. 6. The compound according to claim 1, wherein G is furyl. 7. The compound of claim 1, wherein R ₆ -R ₁₂ are independently hydrogen, halogen, methyl, methoxy and cyano. 8. The compound of claim 1, wherein X is a bond. 9. The compound of claim 1, wherein X is a straight chain alkyl. 10. The compound of claim 1, wherein X is alkyl of one carbon atom. 11. Furan-2-carboxylic acid {4- [3- (5-chloro-2,4-dimethoxy-phenyl) -thioureido] -2,5-dimethoxy-phenyl} -amide, furan-2-carboxylic acid Acid {4- [3- (5-chloro-2,4-dimethoxy-phenyl) -thioureido] -3-trifluoromethyl-phenyl} -amide, furan-2-carboxylic acid {3-chloro-4- [3 -(5-chloro-2,4-dimethoxy-phenyl)-
Thioureido] -phenyl} -amide, furan-2-carboxylic acid {5-chloro-4- [3- (5-chloro-2,4-dimethoxy-phenyl)-
Thioureido] -2-methyl-phenyl} -amide, furan-2-carboxylic acid {5-chloro-4- [3- (5-chloro-2,4-dimethoxy-phenyl)-
Thioureido] -2-hydroxy-phenyl} -amide, furan-2-carboxylic acid {4- [3- (5-chloro-2,4-dimethoxy-phenyl) -thioureido] -3-cyano-phenyl} -amide, Furan-2-carboxylic acid {4- [3- (5-chloro-2,4-dimethoxy-phenyl) -thioureido] -3-methyl-phenyl} -amide, furan-2-carboxylic acid {4- [3- (5-chloro-2,4-dimethoxy-phenyl) -thioureido] -2-methoxy-5-methyl-phenyl} -amide, furan-2-carboxylic acid {4- [3- (5-chloro-2,4 -Dimethoxy-phenyl) -thioureido] -3-methoxy-phenyl} -amide, furan-2-carboxylic acid {4- [3- (5-chloro-2,4-dimethoxy-phenyl) -thioureido] -2-tri Fluoromethyl-phenyl} -amide, furan-2-carboxylic acid {2-chloro-4- [3- (5-chloro-2,4-dimethoxy-phenyl)-
Thioureido] -phenyl} -amide, furan-2-carboxylic acid {4- [3- (5-chloro-2,4-dimethoxy-phenyl) -thioureido] -2-cyano-phenyl} -amide, 5- [3 -(5-chloro-2,4-dimethoxy-phenyl) -thioureido] -2-[(furan-2-carbonyl) -amino] -benzoic acid, furan-2-carboxylic acid {4- [3- (5- Chloro-2,4-dimethoxy-phenyl) -thioureido] -2-phenylcarbamoyl-phenyl} -amide, furan-2-carboxylic acid {2-benzoyl-4- [3- (5-chloro-2,4-dimethoxy) -Phenyl) -thioureido] -phenyl} -amide, furan-2-carboxylic acid {4- [3- (5-chloro-2,4-dimethoxy-phenyl) -thioureido] -2-methyl-phenyl} -amide, Furan-2-carboxylic acid {4- [3- (5-chloro-2,4-dimethoxy-phenyl) -thioureido] -naphthalen-1-yl} -amide, and furan-2-carboxylic acid {4- [3 -(5-chloro-2,4-dimethoxy-phenyl) -thiou The compound of claim 1, wherein the compound is selected from the group consisting of: [Reid] -2-methoxy-phenyl} -amide, or a pharmaceutical salt thereof. 12. The formula: embedded image Wherein R ₁ -R ₅ are independently hydrogen, alkyl of 1-6 carbon atoms, alkenyl of 2-6 carbon atoms, alkynyl of 2-6 carbon atoms, 1-6 carbon atoms perhaloalkyl atoms, cycloalkyl of 3 to 10 carbon atoms, 3 to 10 carbon membered heterocycloalkyl, aryl, heteroaryl, _{halogen, -CN, -NO 2, -CO 2} R 6, -COR ₆ , -OR ₆ ,-
SR ₆ , -SOR ₆ , -SO ₂ R ₆ , -CONR ₇ R ₈ , -NR ₆ N (R ₇ R ₈ ), -N (R ₇ R ₈ ) or WY- (CH ₂ ) _n -Z
Wherein at least one of R ₁ -R ₅ is not hydrogen; or R ₂ and R ₃
Or R ₃ and R ₄ together are a 3-7 membered heterocycloalkyl or 3-7
R ₆ and R ₇ are independently hydrogen, alkyl of 1 to 6 carbon atoms, perhaloalkyl or aryl of 1 to 6 carbon atoms; monocyclic R ₈ is Hydrogen, alkyl of 1 to 6 carbon atoms, perhaloalkyl of 1 to 6 carbon atoms, cycloalkyl of 3 to 10 carbon atoms, 3 to 10 membered heterocycloalkyl, aryl or heteroaryl Or R ₇ and R ₈ can together form a 3-7 membered heterocycloalkyl; R ₉ -R ₁₂ are independently hydrogen, alkyl of 1-4 carbon atoms, 1- Perhaloalkyl of 4 carbon atoms, halogen, alkoxy or cyano of 1-4 carbon atoms, or R ₉ and R ₁₀ or R ₁₁ and R ₁₂ together form 5-7 carbon atoms With the proviso that at least one of R _9-12 Is not hydrogen; W is O, NR ₆ or absent; Y is-(CO)-or-(CO ₂ )-or absent; Z is 1-4 Carbon atom alkyl, -CN, -CO ₂ R ₆ , COR ₆ , -CONR ₇ R ₈ , -OCOR ₆ , -NR ₆ COR ₇ , -OCONR ₆ , -OR ₆ , -SR ₆ , -SOR ₆ ,- SO ₂ R ₆ , SR ₆ N (R ₇ R ₈ ), —N (R ₇ R ₈ ) or phenyl; G is a monocyclic heteroaryl; X is a bond, —NH, 1-6 Alkyl of carbon atoms, alkenyl of 1-6 carbon atoms,
J is alkoxy of 1 to 6 carbon atoms, thioalkyl of 1 to 6 carbon atoms, alkylamino of 1 to 6 carbon atoms or (CH) J; J is alkyl of 2 to 6 carbon atoms, And n is an integer from 1 to 6 or a pharmaceutically acceptable salt and a pharmaceutically acceptable carrier or diluent, wherein the compound is cycloalkyl, phenyl or benzyl of 3 to 7 carbon atoms. A pharmaceutical composition. 13. The formula: embedded image Wherein R ₁ -R ₅ are independently hydrogen, alkyl of 1-6 carbon atoms, alkenyl of 2-6 carbon atoms, alkynyl of 2-6 carbon atoms, 1-6 carbon atoms perhaloalkyl atoms, cycloalkyl of 3 to 10 carbon atoms, 3 to 10 carbon membered heterocycloalkyl, aryl, heteroaryl, _{halogen, -CN, -NO 2, -CO 2} R 6, -COR ₆ , -OR ₆ ,-
SR ₆ , -SOR ₆ , -SO ₂ R ₆ , -CONR ₇ R ₈ , -NR ₆ N (R ₇ R ₈ ), -N (R ₇ R ₈ ) or WY- (CH ₂ ) _n -Z
Wherein at least one of R ₁ -R ₅ is not hydrogen; or R ₂ and R ₃
Or R ₃ and R ₄ together are a 3-7 membered heterocycloalkyl or 3-7
R ₆ and R ₇ are independently hydrogen, alkyl of 1 to 6 carbon atoms, perhaloalkyl or aryl of 1 to 6 carbon atoms; R ₈ is hydrogen, 1 Is alkyl of -6 carbon atoms, perhaloalkyl of 1-6 carbon atoms, cycloalkyl of 3-10 carbon atoms, heterocycloalkyl of 3-10 members, aryl or heteroaryl, or R ₇ and R ₈ can together form a 3-7 membered heterocycloalkyl; R ₉ -R ₁₂ are independently hydrogen, alkyl of 1-4 carbon atoms, 1-4 Perhaloalkyl of carbon atoms, halogen, alkoxy or cyano of 1-4 carbon atoms, or R ₉ and R ₁₀ or R ₁₁ and R ₁₂ together form an aryl of 5-7 carbon atoms. Wherein at least one of R _9-12 is hydrogen Not; W is O, or is NR _6, or is absent; Y is - (CO) - or - (CO ₂₎ - or where absent; Z is 1 to 4 carbon atoms Alkyl, -CN, -CO ₂ R ₆ , COR ₆ , -CONR ₇ R ₈ , -OCOR ₆ , -NR ₆ COR ₇ , -OCONR ₆ , -OR ₆ , -SR ₆ , -SOR ₆ , -SO ₂ R ₆ , SR ₆ N (R ₇ R ₈ ), —N (R ₇ R ₈ ) or phenyl; G is a monocyclic heteroaryl; X is a bond, —NH, 1-6 carbon atoms Alkyl, alkenyl of 1 to 6 carbon atoms,
J is alkoxy of 1 to 6 carbon atoms, thioalkyl of 1 to 6 carbon atoms, alkylamino of 1 to 6 carbon atoms or (CH) J; J is alkyl of 2 to 6 carbon atoms, A cycloalkyl, phenyl or benzyl of 3 to 7 carbon atoms; and n is an integer of 1 to 6, or a pharmaceutical salt thereof, comprising contacting the compound with a herpes virus. A method of inhibiting replication. 14. The method of claim 13, wherein the herpes virus is human cytomegalovirus. 15. The herpes simplex virus according to claim 1, wherein the herpes virus is a herpes simplex virus.
Method 3. 16. The method of claim 13, wherein the herpes virus is varicella-zoster herpes virus. 17. The formula: embedded image Wherein R ₁ -R ₅ are independently hydrogen, alkyl of 1-6 carbon atoms, alkenyl of 2-6 carbon atoms, alkynyl of 2-6 carbon atoms, 1-6 carbon atoms perhaloalkyl atoms, cycloalkyl of 3 to 10 carbon atoms, 3 to 10 carbon membered heterocycloalkyl, aryl, heteroaryl, _{halogen, -CN, -NO 2, -CO 2} R 6, -COR ₆ , -OR ₆ ,-
SR ₆ , -SOR ₆ , -SO ₂ R ₆ , -CONR ₇ R ₈ , -NR ₆ N (R ₇ R ₈ ), -N (R ₇ R ₈ ) or WY- (CH ₂ ) _n -Z
Wherein at least one of R ₁ -R ₅ is not hydrogen; or R ₂ and R ₃
Or R ₃ and R ₄ together are a 3-7 membered heterocycloalkyl or 3-7
R ₆ and R ₇ are independently hydrogen, alkyl of 1 to 6 carbon atoms, perhaloalkyl or aryl of 1 to 6 carbon atoms; R ₈ is hydrogen, 1 Is alkyl of -6 carbon atoms, perhaloalkyl of 1-6 carbon atoms, cycloalkyl of 3-10 carbon atoms, heterocycloalkyl of 3-10 members, aryl or heteroaryl, or R ₇ and R ₈ can together form a 3-7 membered heterocycloalkyl; R ₉ -R ₁₂ are independently hydrogen, alkyl of 1-4 carbon atoms, 1-4 Perhaloalkyl of carbon atoms, halogen, alkoxy or cyano of 1-4 carbon atoms, or R ₉ and R ₁₀ or R ₁₁ and R ₁₂ together form an aryl of 5-7 carbon atoms. Wherein at least one of R _9-12 is hydrogen Not; W is O, or is NR _6, or is absent; Y is - (CO) - or - (CO ₂₎ - or where absent; Z is 1 to 4 carbon atoms Alkyl, -CN, -CO ₂ R ₆ , COR ₆ , -CONR ₇ R ₈ , -OCOR ₆ , -NR ₆ COR ₇ , -OCONR ₆ , -OR ₆ , -SR ₆ , -SOR ₆ , -SO ₂ R ₆ , SR ₆ N (R ₇ R ₈ ), —N (R ₇ R ₈ ) or phenyl; G is a monocyclic heteroaryl; and X is a bond, —NH, 1-6 carbons Atomic alkyl, alkenyl of 1 to 6 carbon atoms,
J is alkoxy of 1 to 6 carbon atoms, thioalkyl of 1 to 6 carbon atoms, alkylamino of 1 to 6 carbon atoms or (CH) J; J is alkyl of 2 to 6 carbon atoms, A cycloalkyl, phenyl or benzyl of 3 to 7 carbon atoms; and n is an integer of 1 to 6, requiring a therapeutically effective amount of a compound having or a pharmaceutical salt thereof. A method of treating a patient suffering from a herpes virus infection comprising administering to the patient. 18. The method of claim 17, wherein the herpes virus is human cytomegalovirus. 19. The method according to claim 1, wherein the herpes virus is a herpes simplex virus.
Method 7. 20. The method of claim 17, wherein the herpes virus is varicella-zoster herpes virus.